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Abstract
The origins of adult disease have been a prime topic for research, as deciphering causes can lead to strategies for preventions
and cures. There has been recent intrigue focused on the environment in the womb. Records from England and Wales in 1911
show that those who suffered from cardiovascular disease were geographically correlated with regions high in infant mortality in
the past, seventy years before the study.When looking into the cause of the neonatal death rates, low birth weight, poor maternal
health, and high maternal death rates during childbirth were clearly associated. Barker inferred that there is much happening in
the intrauterine environment that ultimately affects our quality of life. This research helps support the concept that rather than
looking at childhood adversity and socioeconomic circumstances to help explain adult disease, we might need to reach further
back (Barker,1990).
Through epigenetic mechanisms, alterations to the physical expression of our DNA can take place without changing the sequences of the actual DNA. Epigenetics is what is responsible during fetal development for the differentiation of stem cells to specific
cells by adding or subtracting methyl groups to silence or activate particular genes. When an egg and sperm unite all previous
methylation patterns are stripped from the newly formed diploid. However, by the time it becomes a blastocyst, new patterns have
already formed. It is during this crucial stage of development that new patterns and changes to our epigenome our founded and
passed down (Powledge, 2009).
The purpose of this paper is to determine if chronic health issues in adulthood have their roots in the environment and changes
experienced by the fetus in the womb. Environmental exposures like nutrition, stress, and toxicants are evaluated and tested for
their potential hand in setting the course for adult disease. Many studies show correlation between malnutrition and the development of metabolic diseases like obesity, type II diabetes, and even hypertension. Likewise, stress during gestation has been linked
to anxiety, depression, and posttraumatic stress disorder (PTSD) in offspring. Toxicants like bisphenol-A are the likely culprit for
genetically expressed abnormalities that range from cancers of the reproductive system to attention/deficit hyperactive disorder
(ADHD) in exposed offspring.The “how” and the “why” are explored in this paper. If we can better understand the origins of adult
disease then we are better equipped to defend our future generations against it. Furthermore, the notion that our DNA is not at
fault for these outcomes, but rather epigenetic adjustments written on top of our DNA, provides hope that just as easily as it can
be added on, we can take it off (Powledge, 2009).
Introduction: What is Epigenetics?
The concept that the in utero environment causes adult diseases later in life was first proposed by DJ Barker in the famous, “Barker Hypothesis,” some twenty years ago, but the
term, “epigenetics,” was originally coined by developmental
biologist Conrad Waddington in the early 1940s. Waddington
labelled it as, “the interactions of genes with their environment,
which brings the phenotype into being.” He was referring to
the phenomenon that all cells share the same DNA, yet they
express complete differences in their phenotype and function.
Moreover, skin cells, liver cells, and brain cells are only capable
of producing more of their type within their same phenotypic
expression, so whatever mechanism is accounting for the differentiation is clearly able to be inherited. These modifications
usually take place on certain regions of DNA, cytosine-phosphate-guanine dinucleotides, at the carbon-5’ position of cytosine. The most common mechanism seen in the fetal environment includes methylation, the adding or removing of a methyl
group to and from the carbon-5’ position. The usual methyl
donor is S-adenosylmethionine (SAM), which the methyl transferase uses as a source of methyl to the DNA molecule. During
methylation, methyl-transferase adds on the methyl group, preventing binding of transcription elements, thereby silencing gene
expression (figure 1) (Odom, Taylor, 2010).

Figure 1
The silencing of genes via methylation occurs by obstruction
of the binding of transcriptional machinery that needs contact
with the cytosine, in the major groove of the double helix.
Methylation can also function by methylating the promoter region of DNA. Methylation can sometimes lead to activation of
a gene by obstructing the binding of transcription repressors,
ultimately activating certain genes. Another common mechanism involves post translational histone modification, with the
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addition or subtraction of different compounds like methyl, acetate, or phosphate groups to histone proteins, causing changes
in chromatin packaging. The adding on of these compounds to
the four pairs of proteins that make up the “octameric histone
core…restricts physical access of nuclear factors to the DNA
and alters gene expression” (Odom, Taylor, 2010).
Methylation happens at very critical times in development.
During gametogenesis, haploid cells demethylate from the
development of primordial germ cells until the period before
preimplantation, to return the cell to its pluripotent state. The
pluripotency refers to the cells ability to take the shape and responsibility of any cell type in the body. After implantation of the
embryo, remethylation begins to differentiate each cell, forming
cell specific DNA methylation patterns (Odom, Taylor, 2010).
Methylation and histone modification are seen as adaptive
responses. In other words, it is a mechanism to protect the
fetus from the volatile environment in which it is developing.
For example, in a situation of food shortage, metabolic adaptations are made to increase the energy storage. Problems
arise, however, when the adult environment does not match
the environment in the womb. When the fetus is subsequently
born into a nutrient-rich environment, suddenly its metabolic
adaptations can lead it on a path of obesity and all its associated
medical complications. (Odom, Taylor, 2010) It is with this idea
that we construct a hypothesis that links adult chronic disease
to in utero environmental exposures.

Methods
This comprehensive review is based on critical analysis of literature on epigenetics obtained using the Touro College Online library and PubMed publishing, analyzing the information and opinions that were expressed in various experiments. Review articles
were useful in providing additional references to source material.

Discussion: Nutrition
Malnutrition
Nutrition is extremely significant when looking at studies to link
fetal environment to adult disease. The majority that is known
on the epidemiology of epigenetics comes from animal studies,
yet the Dutch Famine of 1944-1945 affords a unique opportunity to study the effects of malnutrition on a human population.
The period of the famine was clearly defined, the food rations
were documented, and registries and health care documentation remained intact. (Heijmans et al., 2008)
Insulin-like growth factor II (IGF-2) is one of the most epigenetically controlled loci. IGF-2 is integral for human growth and
development, is known to play a significant role in “metabolic
regulation of glucose homeostasis, cardiovascular functions, and
lipid metabolism,”(Rijlaarsdam et al., 2016), and is maternally
imprinted. This means that while both alleles are inherited, the
maternal allele is silenced via methylation. If hypomethylation,
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the decrease of methylation via subtracting of methyl groups,
takes place in these regions, bi-allelic expression of IGF-2 occurs, leading to detrimental outcomes in adult health. (Heijmans
et al., 2008)
A previous study involving 372 twins shows that the methylation of IGF-2 largely depends on genetic factors and has
methylation marks that are stable at least up until middle age
(Heijmans et al., 2008). Therefore, any alterations from the genetic disposition in the methylation patterns done during gestation would be able to be detected many years later. The many
different diseases that have been linked to the Dutch Famine
are thought to be mediated by abnormal methylation of IGF-2.
A study was done to test methylation patterns of children
conceived during The Dutch Famine in comparison to their
same sex siblings. The study was careful to segregate those that
experienced famine in the periconceptional period and those
that experienced famine during late gestation. Blood was drawn
from the 122 subjects and their same sex siblings, treated with
bisulfite to segregate methylated regions of IGF-2, and then
amplified using polymerase chain reaction (PCR). The region
contained five CpG islands, areas that are rich in cytosine-phosphate-guanine dinucleotides. In the 60 adults whose mothers
experience the famine in early gestation, all but one island
showed hypomethylation of between 5-6%. Interestingly, those
that were exposed to the famine during late gestation did not
have differing methylation patterns than their siblings, suggesting
that methylation pattern of the IGF-2 allele are susceptible to
environmental influences at a critical window in early development (figure 2).Those exposed during late gestation did exhibit
lower birth weight than the other groups, a birth feature that
was previously associated with adult disease. This study shows
that while low birth weight might be indicative of malnutrition, it
is epigenetic modifications that are thought to hold responsibility for deteriorating adult health. (Heijmans et al., 2008)
Coronary artery disease (CAD) is strongly linked to fetuses
exposed to the Dutch Famine. Developing organ systems respond negatively to a lack of nutrients available, especially during
periods of critical development. Using a registrar of 2,414 infants from the Dutch Famine Birth Cohort born between the
dates of November 1, 1943 and February 28,1947, Painter et al.
extracted a group of 975 participants that experienced a caloric
intake under 1,000 calories for at least 13 weeks of gestation
during the famine. Various medical information was collected
from participants at age 50 and 58, including blood pressure,
glucose tolerance test results, total cholesterol levels, and electrocardiogram information. (Painter et al., 2006)
By the end of this study, 83 candidates developed coronary
artery disease, with the highest cumulative incidence of coronary artery disease at 13% seen in those exposed during early
gestation. Interestingly, it was those born in mid and late gestation that were born with the lowest birth weights with mothers
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Figure 2, showing different methylation patterns between those exposed periconceptionally and those exposed in late gestation (Heijmans et al. 2007)
that weighed the least. Yet, those that developed coronary
artery disease after exposure in mid to late gestation did not
show a significant difference in cumulative incidence compared
to those that were unexposed. On average, coronary artery
disease manifested three years earlier in adults exposed in
early gestation than in persons unexposed. (Painter et al., 2006)
These results support the previous study that hypomethylation
affects fetuses exposed to lack of nutrition in early gestation,
thus linking hypomethylation of IGF-2 to adult disease as opposed to small birth weight. (Heijmans et al., 2007) That being
said, any exposure to famine correlated with elevated glucose
concentrations at 120 minutes and elevated ratios of LDL (low
density lipoproteins) to HDL (high density lipoproteins). Most
of the subjects were also being treated for type II diabetes and
hypocholesterolemia (Painter et al 2006).
Schizophrenia is also linked to this critical window. A cohort
of persons born in cities in western Netherlands during 19441946 were compared for their risk of schizophrenia. The study
included those exposed in early gestation compared with those
exposed at other points of pregnancy. A national psychiatric
registry of the region was referenced to see the frequency of
patients hospitalized at age 24 to 48 years in the two groups of
subjects. The results attested to the fact the those conceived at
the height of the famine (i.e., that were exposed in early gestation) had a statistically significant twofold increase in the risk for
schizophrenia (Susser et al., 1996).

High-Sugar-High Fat Diet
High fat high sugar diets are associated with development of
ADHD, conduct problems (CP), and their co-occurrence. IGF-2
may also be linked to ADHD, as it is a major modulator of placental and fetal growth, as well as brain development after birth.
Previous animal studies have linked IGF-2 to developmental abnormalities in structure and/or function of the cerebellum and
hippocampus, two regions that play significant roles in ADHD.
As previously noted, IGF-2 is easily influenced by diet during

critical periods of development (Heijmans et al., 2008). Studying
a sample of cohorts of mothers and 164 children with early
onset conduct problems (EOP) or low conduct problems (CP),
researchers considered the link between prenatal diet, IGF-2
methylation status, current conduct problems, and risk symptoms for ADHD (Rijlaarsdam et al., 2016).
DNA methylation information was extracted from cord blood
of the children from birth and peripheral blood at age seven. It
was then bisulfite converted using the EZ-DNA methylation kit.
A large number of probes,139, were extracted that are mapped
to IGF-2 or overlapping regions, with methylation at factor 1 the
most relevant to the study. Researchers assessed the mothers’
diets during pregnancy via The Food Frequency Questionnaire
(FFQ), recording the maternal dietary patterns at 32 weeks of
gestation and child’s diet at age 3, 4.5, and 7 years of age.The FFQ
recorded the frequency of consumption of particular foods with
higher frequency indicated by higher scores. High scores in processed foods (chips, fried foods, pasties) and confectionery foods
(chocolate bars, cakes, biscuits) indicated a prenatal and postnatal
high-fat and sugar diet. At three different occasions (age 7, 10, and
13), ADHD symptoms were assessed with the Development and
Well-Being Assessment (DAWBA), a semi-structured interview
with open and closed questions directed toward parents about a
range of symptoms seen in their children relevant to ADHD, oppositional defiant disorder (ODD), generalized anxiety disorder
(GAD), conduct disorder (CD), and major depressive disorder
(MDD) (Rijlaarsdam et al., 2016).
Results from this study indicate that youth with early onset
persistent conduct problems (n= 83) exhibited higher levels
of ADHD symptoms than youth with low conduct problems
(n=81).The study also found that early onset persistent conduct
problems youth showed high factor 1 methylation at birth of
IGF-2 with symptoms of ADHD, but at age 7, methylation levels
were negatively correlated with postnatal cumulative risk, with
risk domains including life events such as relative’s death, contextual risk like financial problems, or direct victimization like
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Figure 3, “Prospective interrelationships between unhealthy diet, IGF2 methylation and ADHD for youth with early‐onset persistent (n = 83) versus
low (n = 81) conduct problems. Multiple group path analysis. Solid arrowed lines indicate standardized path coefficients that survived bootstrap‐
corrected confidence intervals (i.e. significant paths) for EOP versus low CP youth or averaged across all youth” (Rijlaarsdam et al., 2016).
bullying.This can be seen as further proof that the prenatal environment is the true origin for postnatal disease development, as
opposed to what the child experiences after birth. IGF-2 methylation did not correlate with ODD, GAD, or MDD symptoms
(Rijlaarsdam et al., 2016).
Cross-lagged associations showed that prenatal diet was associated with IGF-2 methylation at birth for both early onset persistent conduct problems and low conduct problems. However,
associations between methylation at birth and ADHD symptoms
at ages 7-13 was significantly higher in early onset problem youth
than in low conduct problem youth, even though the maternal
diet was significant in both domains (figure 3). In early onset
persistent conduct problems youth, high methylation did predict
ADHD symptoms, linked through the epigenetic modifications
that were caused from unhealthy eating habits. It is possible that
this vulnerable developmental pathway presents a specific risk
factor for EOP children only (Rijlaarsdam, et al., 2016).

Methyl-Supplements
Methylation, the addition of methyl groups to cytosine-phosphate-guanine dinucleotides or to histone proteins, is what
causes much of the gene silencing that takes place during
fetal programming and early development. For methylation to

8

happen, methyl donors like the B vitamins are vital in our diets.
Methylation frequently occurs at transposable elements, DNA
sequences that are unique in their ability to “jump” positions
on the genome. At first glance, they seem rather parasitic, the
source of genetic diseases and mutations by a series of rearrangements and recombination. However, mobile DNA has
recently been discovered to have an important role in biodiversity and evolution. A concept known as “molecular domestication” claims that open reading frames, complete RNA, and
coding exons are thought to have originated from transposed
DNA (Bohne et al., 2008). When methylation patterns differ on
transposable elements, they account for epigenetic “mosaicism”
and varying phenotypes. They are likely the cause of differential
gene expression in identical twins. These regions are also metastable and therefore, very susceptible to nutritional influences
(Waterland and Jirtle, 2013).
To analyze the effect methyl donors might have on the developing epigenome, yellow agouti mice were used. The murine
agouti gene encodes for a paracrine signaling molecule that instructs follicular melanocytes to switch from black eumelanin
production to yellow phaeomelanin, resulting in yellow fur. This
is known as the agouti A allele with the pseudoexon 1A pointing
away from the agouti allele. The agouti “a” allele is caused from
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a loss-of function mutation in A, causing homozygotic “a” allele
mice to be black. In contrast, the Avy allele is caused by the insertion of an intracisternal A particle (IAP) retrotransposon to
the 5’ end of the A allele, within the agouti exon 1A.This ectopic
gene is transcribed from a cryptic promoter in the proximal end
of the intracisternal A particle (figure 4). The CpG methylation
of this region varies largely among different mice, inversely correlated with ectopic agouti expression. This variability is also
responsible for a wide variation of hair color, adiposity, glucose
tolerance, and tumor susceptibility in Avy/a mice that are otherwise isogenic (Waterland and Jirtle, 2003).

Figure 4, “IAP insertion site in Avy allele. (A) Exon 1A of the murine
agouti gene lies within an interrupted 4.1-kb inverted duplication
(shaded block arrows).The duplication gave rise to pseudoexon 1A
(PS1A). “(Waterland and Jirtle et al., 2003)
If a/a dams are given specific dietary supplementation before
mating with Avy mice, their Avy/a offspring exhibit a shift in coat
color from yellow to pseudoagouti brown. Because the coat
color correlates with Avy methylation status, it is inferred that
supplementation influences this phenotypic shift via methylation
of the Avy gene.To test this hypothesis, a population of congenic
Avy mice that had been sibling mated for forced heterozygosity
for 200 generations were prepared. In another group, a/a female
mice that were 8 weeks old were randomly assigned to either
NIH-31 diets or NIH-31 diets supplemented with methyl donors and cofactors like folic acid, vitamin B12, choline chloride,
and anhydrous betaine. The diet was issued for two weeks before mating with the Avy mice, as well as throughout pregnancy
and lactation. At age 21 days, the Avy/a offspring were weighed,
tail tipped, photographed, and evaluated for coat color of yellow,
slightly mottled (a bit of brown mixed in with yellow), mottled
(half yellow, half brown), heavily mottled (greater than half is
brown), or pseudoagouti. Pseudoagouti refers to the silencing of
ectopic agouti expression, causing the brown agouti phenotype
of an A/- mouse (Waterland and Jirtle, 2003).
The supplemented dams did in fact express the brown color
of pseudoagouti phenotype. Using tail tip DNA, researcher

quantified the result from seven different CpG sites of the region, showing methylation at each site, whereas the non-supplemented dams seemed to have methylation distributed bimodally
with the epigenetic switch in one of two different states. This
observation further proves the notion that methylation of Avy
is the mediator of the affects of nutrition on coat color (figure
5). Furthermore, methylation patterns in the tail correlated with
methylation patterns in the liver, kidney, and brain, representing
the early embryo layers of endoderm, mesoderm, and ectoderm, respectively. This continued to show that such methylation patterns were created at the earliest stages of embryo
development and were maintained throughout development
(Waterland and Jirtle, 2003).

Figure 5 shows that once adding methylation to the model, no
correlation was significant between supplement and color alone.
Methylation was the clear mediator.
Forty percent of the human genome is made of transposable
elements, with copying number exceeding double the magnitude of classical genes. Much variation can be made by simple
recombination and transposition of the elements in different
areas. Epigenetic modification is likely in these areas (Bohne et
al., 2008). Furthermore, many human genes are also transcribed
from a cryptic promoter, similar to how the ectopic agouti
transcription originates from the Avy intracisternal A particle.
This study provides compelling evidence that much of our own
phenotypic variability and “epigenetic mosaic” can be influenced
by early nutrition (Waterland and Jirtle, et al., 2003).
The restriction of methyl donors has previously been linked
to neural tube defects in infants. Pregnant women are careful
to take folic acid to avoid this fatal outcome. However, the fetus’s epigenome is so sensitive, that even exposure like slightly
improper methyl donor levels can bring about its own set of
variations. Sinclair et al. experimented by restricting specific B vitamins and methionine within the normal physiological
range to explore its effect on adult offspring. He administered
a specific diet to adult female sheep from six days before conception until eight weeks after conception. Diets were formed
containing all nutrient requirements with decreased vitamin B
and sulfur amino acids, yet within the physiological range in both
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sheep and human to be considered non-toxic. Because gametes
and preimplantation embryos go through extensive methylation
reprogramming, this experiment was used to test, “the extent
to which periconceptional availability of methyl groups altered
DNA methylation of gene-associated CpG islands and affected
adult health status” (Sinclair, et al., 2007).
Twenty five ewes that were placed on the ‘methyl deficient’
(MD) diet showed homocysteine levels in follicular fluid, plasma,
and in granulosa cell lysates higher than the 25 ewes that were
in the control diet with no methyl deficiency. Most importantly,
the incorporation of methionine into S-adenosyl methionine
(SAM), as well as S-adenosyl methionine into adenosyl-homocysteine (SAH) were both reduced in ewes on the MD diet. At
day 6, the blastocysts were transferred to 203 normal eating
ewes. Those that became pregnant gave birth to typical weight
babies on both diets, yet the growth weight to weaning for the
MD babies were higher, persisting at 22 months of age, resulting
in heavier MD offspring. Male offspring of the MD diet experienced an increase immune response to a single intramuscular
bolus of ovalbumin both at 1 year of age and in the weeks following the vaccination.The MD males were also proportionately fatter with less muscle mass than control males. MD males
also showed the greatest response to an i.v glucose infusion,
showing signs of glucose resistance independent of body fat.
In terms of cardiovascular function, MD males showed 11 mm
Hg higher blood pressure than the controls, as well as a higher
systolic, diastolic, and mean arterial pressure response to angiotensin II infusions given in increments.
To test whether these results were linked to epigenetic modification, DNA was processed to look at 1,400 CpG sites using
restriction landmark genome scanning (RLGS). Methylation sensitive restriction enzyme, NotI, was used to digest the unmethylated CpG sites, resulting in spots on the autoradiograph. Fifty
seven loci were found to be altered in two or more MD animals,
which is more than was expected if it were to be distributed
randomly between the MD group and control group. Eighty
eight percent of these loci were found to be unmethylated or
hypomethylated compared to the control group. The other loci
appeared to be hypermethylated. Again, a majority of these alterations occurred in males (Sinclair, et al., 2007). These studies continue to support the notion that the etiology of human
disease can stem from epigenetic gene regulatory mechanisms
that originate early in development from simple aspects of our
daily nutrition. This knowledge can be utilized as a cautionary
tale for intending mothers to start preventing the conception of
unhealthy adults (Waterland and Jirtle, et al., 2003).

Toxicants
Bisphenol A
Bisphenol A (BPA) is an endocrine disruptor used in the manufacturing of polycarbonate plastics found in food and drink
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containers, baby bottles, and dental composites. Endocrine disruptors are chemicals that mimic endocrine hormones, interfering with the homeostasis of our various organ systems. The
endocrine disruptor known as BPA has previously been linked
to heavier body weight, increased risk of breast or prostate cancer, and abnormal reproductive function. BPA has been detected in 95% of human urine samples, attesting to the widespread
exposure of BPA in the general public (Dolinoy, et al., 2007).
BPA is most known for its effect on genetic expression of
homeobox gene Hoxa10, a gene that controls uterine organogenesis. Because BPA is an endocrine disrupting chemical, it
has the ability to mimic the actions of these hormones in vitro,
disrupting normal development. Hoxa10 gene expression alterations have previously been linked to human cancers, as well
as endometriosis in females. BPA seems to work through an
epigenetic mechanism to disrupt Hoxa10. In a study by Bromer
et al., pregnant mice were treated with an intraperitoneal injection of BPA in sesame oil on days 9-16 of gestation, at a
dose of 5mg/kg of maternal body weight. In comparison, mice
in a control group were injected with just sesame oil. Offspring
were then euthanized at two or six weeks after birth. Genomic
DNA was treated with sodium bisulfite with unmethylated regions converted to uracil, while methylated regions remained
unchanged. Via quantitative real time PCR, it was concluded
the Hoxa10 expression increased by 25% after BPA exposure,
as per the mRNA expression seen in comparison to controls.
Immunohistochemistry, staining using antibodies specific for a
target protein, showed consistent results, as Hoxa10 protein
was seen throughout the uterus of female offspring. To determine if these changes were epigenetic in nature, bisulfite
conversion, PCR amplicon cloning, and sequencing were done
to determine DNA methylation levels. 100% of control mice
showed methylation in the promoter region while only 38%
of BPA-treated mice showed any sort of methylation. CpG
islands in the intronic region showed methylation in 100% of
control mice and only 57% of BPA-exposed mice. In summary,
demethylation or hypomethylation was observed in all regions
in all BPA-treated mice. However, no methylation changes were
found in the pregnant mice that were treated with the intraperitoneal dose (Bromer, et al., 2010).
Hoxa10 gene is also known to be a weakly estrogenic compound, with the ability to bind to estrogen receptor α and β.
With decreased methylation, Hoxa10 has an increased ability
to bind to estrogen receptors (ER) . Therefore, the estrogen receptor element (ERE) of Hoxa10 becomes more occupied by
estrogen receptor α and β, causing a heightened reactivity to
estrogen levels. The health implications of this were examined
by testing estradiol sensitivity in MCF-7 cells. MCF-7 cells are
estrogen receptor expressing breast carcinoma cells, with a
well characterized estrogen response. In this study, MCF-7 cells
were transfected with either methylated or unmethylated ERE
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containing Hoxa10-promoter sequence. The cells with unmethylated containing sequences had significantly increased activity
with the addition of estradiol, while the methylated cells showed
no change in activity (figure 6). These results can explain disease risks in later life due to increased estrogen responsiveness,
perhaps explaining some reproduction system abnormalities or
cancers of the reproductive system. In summary, these epigenetic
changes that are spurred by uterine BPA exposure can be one of
the suspects of health problems in adult life (Bromer, et al., 2010).

Figure 6 shows the reactivity of unmethylated Hoxa10-promoter
to the addition of estradiol, while the methylated Hoxa10-promter
shows a loss of response (Broner et al., 2010)
As mentioned previously, although most tissue-specific DNA
methylation levels don’t vary much across the mammalian genome, methylation is randomly determined at transposable element insertion sites. This can potentially affect the expression
of neighboring genes, creating a site of metastable expression.
As noted before, this site is particularly susceptible to environmental exposures early in development. The agouti mouse is
a frequently studied case because it features the insertion of
the intracisternal A particle, causing ectopic Avy transcription
via a cryptic promoter at its proximal end, potentially leading
to yellow fur, obesity, diabetes, and tumorigenesis (figure 6).
Furthermore, methylation of the cytosines near the intracisternal A particle is inversely correlated to ectopic Avy expression
and varies tremendously amongst isogenic individuals, causing a
wide range of fur colors. BPA was hypothesized to demethylate
this area, causing transcription and its phenotypic outcomes
(Dolinoy, et al., 2007).
In this study, two groups of female a/a mice were prepared.
The control received with one a phytoestrogen-free AIN-93G
diet.. The experimental group received the diet with 50 mg of
BPA/kg. Both diets were administered two weeks before mating with a Avy/a male until after gestation and lactation. There
were 120 resulting offspring in the control group and 124 resulting offspring in the experimental group, with 60 and 73 Avy/a
offspring, respectively. Maternal BPA exposure was shown to
dramatically shift the coat color of genetically identical Avy/a

offspring toward yellow, showing demethylation. 21% of offspring from the group exposed to BPA were labelled as yellow
in comparison to 10% of the control group. To assess methylation levels, nine CpG sites in the cryptic promoter regions
of the intracisternal A particle were measured using bisulfite
treatment and sequencing.The BPA exposed offspring exhibited
significantly lower levels in the nine CpG sites, with around 27%
methylation compared to around 39% methylation in the offspring control group. After entering BPA dietary exposure, intracisternal A particle methylation, and offspring coat color into
a mediational regression analysis model, it was determined that
there was little relationship between BPA exposure and coat
color directly, but rather methylation was the real mediator
of effects. Methylation levels found in the tail corresponded to
methylation levels found in the brain, kidney, and liver, revealing
that these methylation patterns were established before germ
layer differentiation in the embryo. BPA was also seen to affect
other metastable epialleles, causing hypomethylation in multiple
loci across the genome (Dolinoy, et al., 2007).
In an effort to test BPA levels in human subjects, 244 mothers
and their 3-year-old children were recruited for a longitudinal
study to measure BPA concentrations in maternal and child
urine samples. Maternal urine samples were taken at week 16
and 26 of pregnancy and within 24 hours after delivery. Child
urine samples were taken at ages 1, 2, and 3 years old. Behavior
and executive functions of the children were also measured
using the Behavior Assessment System for Children 2 (BASC2), a 134-item test of a parent’s assessment of a child’s behavior
in a home and public setting. Parents were also administered
the Behavior Rating Inventory of Executive Function-Preschool
(BRIEF-P), a 63 question, parental report test that analyzes the
child’s ability to modulate emotion, control behavioral responses (inhibition), plan for future events, set goals, grasp main ideas,
transition from event to event, and hold information to complete a task. For both tests, higher scores indicated more severe
impairment. It is intriguing that of the mothers who completed
all the assessments, the majority were white, married, between
25 to 34 years old, wealthier, and more educated. Interestingly,
these mothers had lower gestational BPA urine concentration
than mothers who did not complete the assessment. Children
from families of lower maternal education and income also had
higher scores on BASC-2 and BRIEF-P.(Braun, et al., 2011)
Gestational urinary BPA concentrations were found to positively correlate with BASC-2 anxiety, hyperactivity, and depression scale scores at three years old, with the magnitude seen
greater in females (almost double the association of the whole
sample). Lack of emotional control and behavior inhibition suggest that BPA exposure may affect a neurobehavioral domain
that is associated with behavioral regulation. Gestational urinary
BPA concentrations were also positively correlated with emotional and inhibition scores on the BRIEF-P, with higher scores
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attributed to girls again. In general, the effects of gestational
BPA concentration were larger among girls than boys and had
varying effects (boys had less hyperactivity). Neurobehavior and
test scores were not predicted at all by childhood urinary BPA
concentration. Only gestational BPA exposure can be implicated
in altered neurobehavior, and specifically in females, as well.
The findings of these studies are consistent with previous
animal studies that assess the effect of BPA exposure on neurodevelopment. BPA exposure might be responsible for the disruption of sexual differentiation in the brain, altering behavior in
a “gender dependent manner,” by disrupting endocrine or other
neurotransmitter pathways. It is interesting to observe that all
of the outcomes of BPA are traced to the exposures inside the
womb, with no correlation at all to the postnatal environment
(Braun, et al., 2011).
Remarkably, when the formerly mentioned agouti mice of the
study done by Dolinoy et al. were supplemented with methyl
donors or genistein in the experimental BPA diet, coat color distribution was observed as closer to what was seen in the control
group (Dolinoy et al., 2007). Ten to thirteen percent of BPA- exposed -methyl/genistein supplemented offspring exhibited yellow
fur color as opposed to the 21% seen in the non-supplemented
BPA group, showing that maternal nutrition clearly modified the
effects of BPA exposure on methylation patterns. Genistein at
high levels had the same effect, even though it is not a methyl
donor. Interventions as subtle as maternal nutrition is enough to
counteract the effects of an estrogenic endocrine disruptor. This
information implies that we are able to reduce disease susceptibility by making small changes in maternal nutrition, giving us the
ability to affect generations to come (Dolinoy, et al., 2007).

Nicotine
The in utero effects of maternal smoking are infamous in their
detrimental ways. Offspring exposed to smoking after birth
do not experience the same adverse affects as those that are
exposed as fetuses, hinting to a mechanism that is biologically
mediated. It has previously been proven that rodents exposed
to nicotine prenatally experienced a direct impact on brain
development, reporting “abnormal dendritic morphology, and
reduced synapse density in the cerebral cortex and nucleus accumbens” (Chatterton, et al., 2017). Nicotine exposure during
gestation is also known to upregulate nicotinic acetylcholine
receptors, causing cell death, altered cell size, and increased risk
for behavioral impairment. A study done by Chatterton et al.
examines the possible epigenetic modifications that are responsible for these developmental differences that have been found
to persist even until adolescence. Fetuses aborted during the
second trimester were studied and classified based on whether
they were exposed to maternal smoking or not. In total, 24
fetuses were tested. The brains of the fetuses were removed
to examine the dorsolateral prefrontal cortex, an area known
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to be involved in decision-making, memory, and neurodevelopment. It is also known to be compromised in function in different psychiatric conditions, including autism spectrum disorder.
Methylation microarray analysis was performed to determine
differentially methylated regions between the exposed and unexposed groups. Although differences did not remain significant
after multiple testing correction (likely due to the small sample
size), hypomethylation was found on two genes in the exposed
fetuses; SDHAP3 and GNA15. The hypomethylation during second trimester of these two genes is indicative of developmental
delays. This resulted in up-regulation of this gene as evident by
the increase of mRNA in the samples, an effect mediated by
maternal smoking (Chatterton et al., 2017).
Between early and late second trimester, many methylation
changes are meant to occur to proceed with development.
However, in fetuses exposed to maternal smoking, less change
was observed. There was a delay in the upregulation of the
SYCE3 gene, a gene that is responsible for synaptic initiation
that results in meiotic arrest. As previously stated, SDHAP3 and
GNA15 also displayed developmental delays. SDHAP3 is a subunit of the succinate dehydrogenase complex that functions in
the electron transport chain. A mutation in this subunit can actually increase levels of oxidative stress. This same differentially
methylated region was shown to be hypermethylated in patients
with autism spectrum disorder and differentially methylated in
the dorsolateral prefrontal cortex of patients with schizophrenia. GNA15 was also found to be differentially methylated in
the prefrontal cortex of patients with autism spectrum disorder
(Chatterton et al., 2017).
These results show a potential risk that smoking introduces to the fetus in the development of neural abnormalities. All
in all, this study supports the concept that smoking exposure
during gestation leads to changes in developmental patterns of
DNA methylation and gene expression, causing reduced mature
neuronal content via nicotine. Unfortunately, the damage can be
everlasting (Chatterton et al., 2017).
Smoking during pregnancy has also been linked to obesity
because of the shared presence of chemerin, an inflammatory
adipokine that is responsible for adipocyte differentiation. It acts
as a ligand for chemokine-like receptor 1 (CMLKR1), which is
highly expressed in adipocytes. It is found to be elevated in both
individuals who smoke and obese individuals.
Obesity has become a national epidemic with 35% of
American adults and 20% of children obese, with a total of $200
million is spent each year in obesity-related healthcare costs.
Finding the roots to this epidemic can help prevent and treat
future cases. The hypothesis that the perinatal environment is
responsible for the programming of adult disease is in question
as it has been previously shown that fetal exposure to nicotine
increases the risk of developing obesity and type II diabetes.
The mechanism behind the correlation has yet to be confirmed,
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as 15-18% of pregnant mothers continue to smoke throughout
pregnancy and lactation (Reynolds et al., 2018).
In this study, two separate cohorts (2012-2013 and 2015-2016)
of postpartum women were recruited from the University of
Kentucky Chandler Hospital, Labor and Delivery Unit. Subjects
were then identified as either smokers or non-smokers. All had
full term pregnancies, singletons, and birthed male infants with
circumcision performed less than 72 hours after birth. In the first
cohort, foreskin tissue was then taken and dissected, snap frozen,
and analyzed for chemerin mRNA expression. Of the 46 samples,
31 belonged to offspring of non- smokers with 15 belonging to
offspring of smokers. Chemerin mRNA was analyzed in all samples while DNA methylation levels were analyzed in a subset of
the samples (12 non-smokers, 7 smokers) (Reynolds et al., 2018).
In the second cohort, foreskin samples were collected from
24 newborns with 13 of them born to smoking mothers. Of
these samples, only eight were able to be used due to cell contamination or lack of cell growth. These samples were dissected
for the dermal/epidermal layer and incubated. The epidermis
was separated from the dermal layer, and the dermal cells were
processed and plated. RNA was then collected and isolated
from the samples, and chemerin gene expression was analyzed
from each sample using qPCR. Maternal and infant characteristics such as weight, height, and body mass index (BMI) were
collected for both cohorts (Reynolds et al., 2018).
The results demonstrated that the weight and lengths of infants born to smokers were significantly reduced compared to
those whose mothers did not smoke. The foreskin
Figure 7a and 7b compares chemerin mRNA expression and
chemerin methylation in non-smoking exposed and smoking exposed infant foreskin samples. (Reynolds et al.,2018)
tissue of babies exposed in utero showed increased chemerin
gene expression (figure 7a). Methylation percentages of chemerin CpG sites showed reduced levels of methylation. CpG site
3 of chemerin showed the most significant reduction of methylation with chemerin gene expression inversely correlated with
methylation at site 3 (figure 7b).

The dermal fibroblasts that grew in cultures for the second
cohort were then stimulated with an adipogenic cocktail. Babies
of smokers produced cell plates that showed elevated chemerin
gene expression, compared to the cells isolated from babies of
non-smokers (figure 8). These results correspond with another
study that demonstrates that although babies exposed to cigarette smoke in utero tend to be smaller, they have a greater rate
of obesity as they get older, suggesting an altered developmental
programming. This phenomenon known as, ‘catch up growth,’
puts babies at risk of developing cardiovascular disease, type II
diabetes, or obesity later in life (Power, Jeffries, 2002).
This study involving the two cohorts supports the findings

Figure 8, (Reynolds et al. 2017)
of Power and Jeffries et al., further linking cigarette smoking
and obesity to methylation and chemerin gene expression. Of
course, official causation cannot be completely determined
without more research. The study has other limitations, as well:
only testing male babies, testing dermal tissue and not adipose
tissue, small sample size of the smoking group, and not taking
into account second hand smoking are just to name a few. That
being said, the overall conclusion is in agreement with other
studies on this subject: Smoking alters chemerin gene expression in neonatal tissue of babies exposed to smoking, possibly
causing obesity later in life. And perhaps the mediator in this
change is epigenetic in nature (Reynolds, et al., 2018).

Trauma

Figure 7a and 7b compares chemerin mRNA expression and chemerin methylation in non-smoking
exposed and smoking exposed infant foreskin samples. (Reynolds et al.,2018)

Many people can be exposed to
the same trauma, but only some
will develop post-traumatic
stress disorder (PTSD). So, it
begs the question: Is there a biological basis or risk factor for
the development of PTSD?
A cohort of 40 Holocaust
survivors and their 31 offspring
were studied in comparison
to individuals of the same age
that were not living in Europe
in the time of the Holocaust.
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Epigenetic changes in the FKBP5 allele, a glucocorticoid binding
sequence at intron 7, were measured. Psychiatric analysis was also
obtained from the subjects, showing that Holocaust survivors and
their offspring suffered more from PTSD and anxiety and/or depression, respectively. After a whole blood examination, bisulfite
treatment, and pyrosequencing were performed on the DNA
isolates, both Holocaust survivors and their offspring showed
differences in methylation on intron 7 of the allele at the bin3/
site 6 region, in comparison to the control group. This highlights
that Holocaust exposure in the parent was the sole predictor of
methylation levels in the offspring. However, survivors showed
10% higher methylation, while their offspring showed significantly
lower methylation (Yehuda, et al., 2016).
Offspring methylation levels were inversely related to their
wake-up salivary cortisol levels, as well. This might be due to
a “intergenerational biological accommodation” (Yehuda et
al., 2016). A similar notion is seen with the 11β-HSD-2 allele,
another moderator of glucocorticoid action. Increased activity
of this allele in offspring was seen as a counteraction to the
decreased levels of activity seen in mothers. In mothers, this decrease in activity was an accommodation due to high circulating
glucocorticoids. However, in children, upregulation was needed
to optimize glucocorticoid levels again. Similarly, because hypermethylation is occurring at the maternal FKBP5 allele to lessen
the effects of circulating glucocorticoid, offspring exhibited demethylation to optimize glucocorticoid levels, as well. Although
10% less methylation seems relatively small, differential gene
expression has previously been observed with methylation differences between 1%-2%. This lack of glucocorticoid sensitivity
can lead to increased risk of psychopathology in the offspring
generation, something that the offspring exhibited according to
psychiatric evaluation (Yehuda et al., 2016).
A recent study that included Holocaust survivors, as well,
discovered that parental PTSD is an important risk factor for
the development of PTSD in offspring. Physically, children of
survivors had lower 24 hour mean urinary cortisol excretion,
an important symptom as lower cortisol levels are also linked
to people who have suffered previous traumas. Previous trauma is another risk for the development of PTSD. If cortisol is
associated with the risk of developing PTSD, prenatal influences
must be investigated as the hypothalamic-pituitary-adrenal axis
is programmed during early development. Maternal exposure to
glucocorticoids while pregnant can lead to higher levels in the
offspring and lower birth weight, a condition linked to various
adult diseases including hypertension, insulin resistance, and depression, as well (Yehuda et al., 2005).
To test this correlation, 38 women from a larger cohort of
187 women directly exposed to the World Trade Center collapse on September 11, 2001 while pregnant, agreed to partake
in a longitudinal study along with their children. At the ninth
month checkup, mothers and infants were asked for their
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salivary samples at wake up and bedtime to assess cortisol levels. Probable maternal PTSD and severity were assessed with
a PTSD checklist, and depression was assessed with the Beck
Depression Index. Mothers with PTSD reported more depression than mothers without. Salivary cortisol levels in children
of mothers with PTSD were significantly lower than those of
mothers without PTSD, a trend that continued throughout the
first year of infancy (Yehuda et al., 2005).
It is interesting to note that while the trimester of gestation
did not affect maternal PTSD, the effect glucocorticoids had on
the baby did differ slightly depending on the trimester of exposure.The babies born to mothers exposed in their third trimester
showed even lower cortisol levels.That being said, the severity of
PTSD symptoms in the mother correlated with cortisol levels in
infants regardless of trimester (figure 9). The results highlight the
critical windows of development that are available for reprogramming at each point of gestation, a principle that is important in
most epigenetic modifications (Yehuda et al., 2005).

Figure 9, (Yehuda et al., 2005)
Many people are mistaken in assuming that children of
Holocaust survivors or of parents with PTSD suffer mentally
because of their postnatal upbringing by a traumatized and emotionally incapable parent. However, in Yehuda et al., 2016, the sole
predictor for methylation levels in the offspring was parental exposure to trauma. According to the study, emotional abuse and
childhood adversity actually did not show any significant correlation to methylation levels and glucocorticoid abnormality. This
latter experiment is another testament to the effects the in utero
environment can have on the future of the child, as opposed to
postnatal “..vicarious traumatization of the offspring by the parents’ communication of their trauma to the child or other consequences of parental symptoms (e.g. poor parenting)” (Yehuda,
page 4). Babies in Yehuda et al., 2005 were only nine months
old at the time of their endocrine testing, so glucocorticoid
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programming in utero and/or underlying genetic susceptibility is
more relevant then the postnatal environment.Yes, there is always
the argument that postnatal care by mothers suffering from PTSD
can show inconsistent behavior towards their offspring, affecting
their glucocorticoid regulation. However, the stronger correlation
to PTSD shown in offspring of the third trimester does implicate
prenatal factors (Yehuda et al., 2005).

Stress
The hypothalamic-pituitary-adrenal axis controls growth, reproduction, metabolism, and behavior. It is also extremely active in
a human’s ability to ‘defend’ itself during stressful situations via
the glucocorticoid receptor (GR). Transgenerational epigenetic
modifications can affect the programming of the hypothalamic-pituitary-adrenal axis during early development, affecting
glucocorticoid function, as stated previously. In a study that examined intimated partner violence during pregnancy, it was determined that the glucocorticoid promoter gene’s methylation
status can originate in the womb while a mother’s remains unchanged, and sustain itself throughout adolescence. In this study,
25 mother and children pairs were evaluated to determine if
gestational maternal adverse experience can cause methylation
in offspring that persists for years after pregnancy. Children
were between ten and nineteen years old at the time of the
study (Radtke et al., 2011).
Mothers were given the Composite Abuse Scale (CAS) test
three different times to evaluate intimate partner violence before, during, and after pregnancy (see Table 1). Blood was taken
from the mother and child with which she was pregnant with at
the time of abuse. The methylation status was evaluated at ten
CpG sites found in a transcription factor binding site that are
known to have their methylation statuses influenced by early
life circumstances. Methylation was detected in 7 of the 10 CpG
sites of the glucocorticoid promoter region, with methylation
levels ranging from zero to 20%. There was significant correlation of methylation to maternal exposure to intimate partner
violence that was experienced during pregnancy only, but no
significant correlation was found between offspring methylation and intimate partner violence before or after pregnancy.
There was also no correlation between maternal methylation
and offspring methylation (figure10). This attests to the prenatal
transgenerational influence that stress can have on the hypothalamic-pituitary-adrenal axis. This is consistent with previous
studies that have shown that prenatal anxiety has caused sustained elevation of basal hypothalamic-pituitary-adrenal activity,
causing behavioral and emotional problems that can continue
throughout the lifetime of an individual. Methylation of the
glucocorticoid promoter is the potential mechanism in which
prenatal stress can influence psychological function. It is interesting that although this is transgenerational in nature, methylation was not inherited along the germ line, as there was no

Figure 10
correlation between maternal methylation and offspring methylation (Radtke et al., 2011).
While direct stressors, like the aforementioned intimate partner violence on the mother, have been tested, indirect stress can
also prove to be dangerous to a developing fetus. The perinatal
environment is extremely impactful on the future of an offspring,
with the malleable fetal brain susceptible to even the most subtle of experiences. Mychasiuk et al. studied the phenomenon
known as “bystander stress” to demonstrate the effects it might
have on the brain, behavior, and development of the epigenome.
In this study, eight pregnant dams were separately caged with
eight non-pregnant dams. On day 12 and 16 of gestation, the
non-pregnant dams were placed on elevated Plexiglass platforms and exposed to bright light for thirty minutes, twice a
day. In the control study, the cage mates were moved to another
room twice a day for thirty minutes and returned unstressed.
To examine data, researchers recorded ultrasonic vocalizations
from the rats after the thirty minutes of stress were administered. After the birth of the 120 pups, the pups were also examined in various behavioral procedures to assess their brain
development. Afterward their frontal cortex and hippocampus
were examined for DNA methylation (Mychasiuk et al., 2011).
At baseline, all ultrasonic vocalizations were the same.
However, after the stress procedure, the stressed dams had
an increased number of low frequency calls while the bystander dams showed an increased number of high frequency calls.
Previous research has demonstrated that low frequency calls
are emitted during particular distressing situations, while high
frequency calls are emitted in positive situations, such as in
times of reward. The researchers suggest that it was the pregnant dam’s attempt to soothe the distressed dam by emitting
the high frequency call.The stressed dam had a loss of fur on female rats and were more aggressive toward their handlers than
the pregnant dams. Once the 120 pups were born to the sixteen
mothers, further analysis was done. Brain weight was not affected, but female pups exposed to “bystander stress” showed a
decrease in body weight, confirming that the experience proved
to be a stressful one (Mychasiuk et al., 2011).
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Pups were then tested on their negative geotaxis to assess
brain development. Negative geotaxis depends on “vestibular
and proprioceptive detection, processing of the vestibular and
proprioceptive inputs by the central nervous system, and motor
competence to change orientation” (Mychasiuk et al., 2011).This
is generally used to detect milestones in the sensorimotor development of rats. After being placed downward at a 40 degree
angle, pups were tested on their ability to stay upward on the
Plexiglass for the longest amount of time. Pups exposed to “bystander stress” spent less time facing upward on the Plexiglass
platform with stressed females specifically receiving the lowest
scores in the exercise. The pups were then tested in open field
to assess their activity levels.The pups were placed in the center
of a transparent Plexiglass box divided into 130 squares. Pups
were scored based on how many novel squares they touched
with their paw. The “bystander stressed” pups scored less than
the control group, with females scores significantly lower than
the males. This seems to show the hesitance and unwillingness
to explore novel environments exhibited by these young pups.
However, as they age, they will lose this inhibition, as seen in
previous research (Mychasiuk et al., 2011).
Hippocampus
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3

2
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3
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157
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Frontal Cortex

Figure 11 shows the differentially expressed genes found in stressed
male and female pups.(Mychasiuk et al., 2011)
In terms of global DNA methylation, all animals in the “bystander stress” cages showed increase in methylation in the
frontal cortex and hippocampus with a total of 558 genes differentially expressed between stressed male and female pups
combined.There was minimal overlap of differentially expressed
genes in brain regions between the sexes (figure 11). This suggests a preexisting difference in brain structure and genetic
influence exhibited by males versus females, allowing them to
respond differently to “bystander stress.” This was clearly seen
in their behavioral assessment after birth, as the females did
significantly poorer than the males on both negative geotaxis,
open field, and lower birth weight. That being said, while the
genes did not overlap much, the biological processes that these
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genes control are very similar between the sexes, with most
of genes controlling processes that are important for plasticity
of the brain (i.e. cell communication, motion, and transport).
Interestingly, a gene that was identical between the sexes in
its abnormal expression was the SLC6A1 gene. This gene was
downregulated in the frontal cortex. It encodes for a GABA
transporter, removing GABA from the synaptic cleft. With its
downregulation, GABA would be elevated in the frontal cortex, influencing processes like attention, response inhibition, and
working memory.This study is groundbreaking in suggesting that
indirect social stressors are just as harmful to the development
of offspring as direct stressors, hinting to the intense sensitivity of the fetus. That being said, because blood was not drawn
from the mother or “bystander” dam, the mechanism behind
this stressed induced methylation cannot be understood completely and is in need of further experimentation (Mychasiuk et
al., 2011).
It is vital to realize that while there is much evidence to support the concept that overactivation of the hypothalamic-pituitary-adrenal axis via heightened maternal glucocorticoids puts
the infant at a great disadvantage that persists until adolescence,
most experiments have been done with animals or small sample
sizes. To properly test these results on humans, a cohort of 481
mother-infant pairs were taken from the Barwon Infant Study
of Barwon, Australia. Maternal mental well-being was assessed
using the Perceived Stress Scale (PSS) questionnaire, a well validated scale that assesses the biological impact of psychological distress. Maternal mental health was also tested using the
Edinburgh Postnatal Depression Scale (EPDS) questionnaire at
28 weeks of pregnancy, a 10 item questionnaire used to assess
symptoms of depression with a subscale of questions used to
assess anxiety. A survey was also distributed to determine information on the physical and mental health of the mother, family medical history, lifestyle, demographic, education, maternal
drinking, and other confounding factors. Many exposures were
considered to eliminate narrow results that only reflected a
specific measure of mental well-being (Table 1). Umbilical cord
blood from infants were also collected from participants, as
well as blood from the placenta before placental delivery, when
possible. DNA was then extracted from the sample of blood
and bisulfite converted using MethylEasy DNA conversion kits.
Primers were used to amplify a 403 base pair region of the
NR3C1 glucocorticoid promoter, spanning 47 CpG sites. After
PCR amplification of the region, in vitro transcription and cleavage, DNA methylation was then quantified (Mansell et al., 2016).
The results revealed a strong correlation between the three
tests. 65% of depressed mothers were also anxious, while 74%
of anxious mothers were also depressed. Methylation levels of
NR3C1 in three CpG units were shown to be higher in mothers with increased adverse maternal mental well-being; CpG 1.2,
CpG 3.4.5, CpG 47. The aforementioned regions all correlated
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to different mental well-being exposures. CpG 1.2 and CpG
3.4.5 were both correlated with perceived maternal distress.
Maternal anxiety was correlated with CpG 47. Yet another region, CpG 12.13 was weakly correlated with maternal depression. The covariates like hypertension, preeclampsia, maternal
age, antidepressant use, and smoking were correlated with
hypo/hypermethylation at different CpG sites, independent of
the three that were correlated to mental well-being. That being
said, although this was the largest study of its kind performed
on the association of methylation and mental-well being, after
taking into account the multiple tests and numerous CpG islands affected by the three exposures and the covariates, none
of the associations remained significant. This experiment essentially questions all previous experiments that were done with
smaller sample sizes and lack of multiple testing. While there is
consistency amongst the studies to suggest that it is more than
just chance that links maternal depression, anxiety, and adverse
well-being to methylation and offspring behavior abnormalities,
this study highlights the caution needed in interpreting results
and evaluating the studies without bias. The results do support
previous findings, like the role of cortisol on fetal “programming,” yet it also reveals how the proof is not yet strong enough
to withstand a bigger sample size and multiple exposures. In
conclusion, more studies, including longitudinal observations,
are needed to fully link maternal mental well-being to methylation, as well as to determine the phenotypic implications
(Mansell, et al., 2016).

Limitations
Although there has been much speculation and experimentation
in the field of epigenetics, no study has yet to link the interplay
between genes and epigenetics. When dealing with the cohorts
in human studies, genetic dispositions might play a larger role in
phenotypic outcome than is given credit. For example, in studies of trauma effect of Holocaust survivors, all subjects were
of Eastern European Jewry (Yehuda et al., 2016). It is possible
that the effects of methylation on the FKBP5 allele is specific
to individuals within the gene pool of Ashkenazic Jewry, while
other genetic population would not experience this specific
outcome between genes and epigenetics. The fact that there
are some Holocaust survivors that have PTSD and not others,
also was not explored and hints to a genetic disposition, as well.
Furthermore, many human studies relied on questionnaires that
were geared toward the mothers or children that were being
studied. It is hard to believe that every subject answered with
only factual information as opposed to biased and emotional
responses. These studies already create a bias from the start,
as all subjects consented to the study, thereby aware of what
the study was about. Perhaps they agreed because of their feelings of relevance, removing randomness from the population.
Another limitation as discussed in Mansell et al. concerns the

sample sizes and multiple testing of the experiments. Most of
the sample sizes, especially in the human experiments, are not
big enough to be relied on completely. Even many of the animal experiments involved less than 100 samples, something
that definitely takes away from the credibility of the results.
Furthermore, as Mansell et al. clearly stated, multiple testing
procedures usually eliminate any significant correlation found.
While there is definitely integral information for epidemiology
within the field of epigenetics, future experiments and reports
should focus on expanding the sample size and designing experiments to survive multiple testing (Mansell et al., 2016).

Conclusion
Epigenetics refers to covalent bond changes that happen above
the level of DNA that affects gene expression. Many researchers
have speculated about a link between the prenatal environment
and adult health.This link is thought to exist because of epigenetic
alterations that happen to the fetus because of different environmental exposures. Epigenetic programming takes place during
early development in the fetus, thereby presenting a vulnerable
and malleable setting for modification.
The purpose of this paper was to investigate the possible link
between the in utero environment and adult health, along with
the biological mechanism behind it. While there were many limitations to the studies as previously mentioned, there is overwhelming proof that environmental exposures like nutrition,
vitamin B, smoking, BPA, stress, and trauma have negative effects
on the health and quality of life of offspring. Studies have linked
prenatal exposures to obesity, hypertension, coronary artery
disease, cancers, and mental illness. According to the aforementioned studies, the events a mother experiences and the decisions
that she makes during gestation can seriously deter the path of
health for her future adult child. More research and samples are
definitely needed to further back this hypothesis, but there is unquestionably enough evidence to support the correlation. It is
also important to note that it is possible to avoid some of the
detrimental effects of these exposures. As seen in Dolinoy et al.,
a simple methyl supplement was enough to modify the effects of
BPA on an exposed mouse (Dolinoy et al., 2007).
There is no shortage of adult disease victims in America.
The Heart Disease and Stroke Statistics of the American Heart
Association stated that as of 2019, 46% of Americans suffer from
hypertension.The National Institute of Mental Illness stated that
1 in 6 Americans suffer from mental illness. By educating expectant mothers, maybe we can prevent the development of
adult disease in at least a percentage of patients. Furthermore,
as Powledge mentioned in her article, epigenetics is not permanent like our DNA. More research in this area can help us
learn how to rid ourselves of the modifications, or use these
modifications to rid ourselves of other undesirable genetic information (Powledge, 2009).
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Abstract
Type 2 diabetes mellites has become an increasingly prevalent worldwide epidemic. The tremendous economic burden, coupled
with the numerous secondary risks associated with the disease, have encouraged researchers to search for causes as well as
treatment methods. This research paper focuses on the effect of physical activity as a preventative measure for those at risk for
diabetes and as a treatment method for those already diagnosed with the disease. The articles collected included meta-analysis,
randomized controlled trials, cohort studies, surveys, etc. The studies that were analyzed have indicated an inverse relationship
between physical activity and type 2 diabetes. Since there are multiple variables involved, it is challenging to pinpoint the specific
level of effect that physical activity has. However, the majority of the research has shown some level of correlation.
Introduction
The drastic increase in type 2 diabetes mellitus has caused many
to research the risk factors associated with this disease. Type 2
diabetes is characterized by the body resisting the effect of insulin or insufficient insulin production. Insulin is a hormone that
regulates blood glucose levels. High blood glucose levels over a
prolonged period can cause damage to the eyes, heart, nerves,
and kidneys. More than 1.6 million new cases of type 2 diabetes
arise in the US each year, and millions more are at high risk.
(ADA, 2018) It is rated as the seventh deadliest disease in the
world by the World Health Organization (WHO). Furthermore,
individuals diagnosed with this disease are 2-4 times more likely
to develop secondary complications such as stroke, peripheral
vascular, and cardiovascular disease.
The various complications caused by type 2 diabetes have
created a severe physical and economic burden on our society.
Those suffering from this disease have medical costs around
2.3 times higher than those who do not have diabetes. (ADA,
2015). An estimated $21.6 billion is spent in New York each
year for the treatment of diabetes and prediabetes. It has thus
become a priority to identify those who are at a higher risk and
provide preventative measures to help decrease the likelihood
of acquiring the disease.
The vast research conducted regarding the numerous risk
factors contributing to this disease has concluded that type 2
diabetes results from the interaction between a genetic predisposition and behavioral and environmental risk factors
(Tuomilehto et al., 2001). Can lifestyle modification, specifically
physical activity, prevent or decrease associated diseases/symptoms of type 2 diabetes mellites.

Methods
The research articles used throughout this paper have been collected through various databases, including Google Scholar as
well as the databases available through Touro College Libraries
such as PubMed and ProQuest.

Lifestyle Intervention Reducing Incidence of Diabetes
Lifestyle is one of the factors that may impact the presence of
type 2 diabetes (Ahmad, Crandall, 2010). Examples of lifestyle
characteristics include dietary intake, sleeping patterns, and

physical activity. Recent clinical trials, as well as several large
cohort studies, have shown that physical activity can reduce the
incidence of type 2 diabetes (Sigal et al., 2004).
Exercise and insulin promote the transfer of GLUT4, a glucose carrier protein, which aids in glucose uptake into the muscles. (Colberg et al., 2010). When we exercise, intramuscular
glycogenolysis and glucose uptake are increased to meet metabolic demands for energy. There is often an issue with GLUT4
transport for type II diabetic patients. However, exercise allows
for an increase in GLUT4 levels and the movement of GLUT4
to the plasma membrane. Therefore, this becomes a non-insulin
dependent pathway for glucose to be transported into the skeletal muscle.This glucose uptake has the potential to be equal to
normal glucose uptake in non-diabetics.
The Da Qing IGT and Diabetes Study were one of the earliest randomized trials. It analyzed lifestyle interventions which
can prevent type 2 diabetes. Individuals with impaired glucose
tolerance (IGT) have a high risk of developing NIDDM (non-insulin dependent diabetes mellitus/type 2 diabetes). The study
recruited 577 men and women in a Chinese community who
had impaired glucose tolerance. They were randomized into
four groups, exercise only, diet only, diet plus exercise and control. The 6-year follow up found that the three intervention
groups had a risk reduction of 31-46% versus the control group.
The long term-follow up had shown that a majority had progressed to the disease, with a lower risk in intervention groups.
Although this study may have shown a significant short term
(6 years) risk reduction in diabetes, the long-term follow up
showed a minor difference between the groups thus indicating
that physical activity may not have such a significant long-term
effect (Xiao et al., 1997).
The Finnish Diabetes Prevention Study, a more recent study,
analyzed the influence of intensive lifestyle changes in the reduction of diabetes). The study randomly assigned 522 overweight
(350 women and 172 men), middle-aged (mean age of 55 years
individuals who had impaired glucose tolerance to a control or
intervention group. The subjects in the intervention group received specific exercise guidelines and dietary recommendations.
The 3-year follow-up showed a clinically significant impact of the
interventions in the reduction of diabetes. The group had a 58%
reduced risk compared to the control group.The study also found
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that at least 2.5 hours of moderate to vigorous activity per week
caused a 63-69% reduction of diabetes. Furthermore, an extended follow- up revealed that the intervention group maintained
a 36% reduction of diabetes incidence. This percentage suggests
that benefits can be maintained even after the active intervention was completed. The results of this study clearly show that
intensive lifestyle changes (diet and exercise) have the potential
to reduce the risk of diabetes in individuals with impaired glucose
tolerance (Tuomilehto et al., 2001).
The Diabetes Prevention Program, an additional study of the
effect of intensive lifestyle changes, is an even larger randomized controlled trial, recruiting over three thousand overweight,
nondiabetic participants with impaired glucose tolerance. The
participants were separated into three intervention groups;
placebo, metformin (an oral diabetes medicine that helps control blood glucose levels) and intensive lifestyle changes (ILS).
The subjects presented with a mean BMI of 34.0 and a mean
age of 51 years. Forty-five percent of the subjects were from
minority groups, who often display a higher risk for diabetes.
The ILS group was given a specific regimen to follow including a
low calorie and fat diet and 150 minutes of exercise per week.
Furthermore, they joined a 16-week class to learn about diet,
exercise, and behavioral modification. Results from a 2.8 year
follow up displayed a 58% decrease in diabetes development in
the ILS group and 31% reduction in the metformin group compared to the placebo. Results also indicated that weight loss was
the main predictor of diabetes reduction (16% reduction per 1
Kg./2.2 Ib weight lost).The participants who did not lose the targeted amount of weight but participated in the physical activity
still displayed a 44% reduction in diabetes incidence compared
to the placebo group. The results support the hypothesis that
type 2 diabetes can be prevented or delayed in persons at high
risk for the disease. This study shows that specific guidelines,
coupled with a wealth of information about health and wellness, can have the potential to impact the incidence of diabetes.
The subjects were provided with a lot of knowledge which lasts
even after the conclusion of the study. Furthermore, although
this thesis does not focus on other forms of diabetes prevention, it is significant to note that physical activity could have
a greater effect when combined with additional risk reduction
methods such as metformin (Knowler et al., 2002).
A large-scale observational study examined how physical
activity impacted the development of type 2 diabetes. The
study included 5,990 males from the alumni of the University
of Pennsylvania, aged 39–68 years. The subjects were followed
for an average of 14 years. A follow-up showed that the disease
had developed in 202 of the men. Leisure-time physical activities were measured in kilocalories, and examples included stair
climbing, walking, and sports. The study showed that the more
the subject participated in leisure-time physical activity, the less
likely they were to develop type 2 diabetes. The researchers
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observed that for each 500 kcal/wk of activity, there was an average of 6% lower risk of type 2 diabetes. It is important to note
that since this study is an observational study, it is less conclusive
than the previous randomized controlled trials. Furthermore,
the study focused on leisure-time physical activities as opposed
to more intensive, regimented exercise. This may have been the
reason why there was only a 6% risk reduction. On the other
hand, it is nice to see that simply engaging in leisure-time physical activity can have a positive impact on one’s physical health
(Helmrich et al., 1991).
A study was conducted by the use of a questionnaire and a
12-year incidence report to determine if physical activity reduces the incidence of type 2 diabetes in postmenopausal women
(age 55-69). During a follow up 1,997 out of the original 350,000
women had reported a new onset of diabetes. There was a
negative association with both moderate and vigorous physical
activity and diabetes incidence. Furthermore, the most active
women had half the risk of diabetes compared to the least frequently active women.The results of this study also showed that
reducing adiposity through participating in physical activity can
partially prevent diabetes (Folsom et al., 2000).

Lifestyle Intervention Preventing Secondary Risks
Results of these multiple studies have displayed the role of lifestyle modification, specifically physical activity, in the positive
reduction in diabetes incidence. The question remains whether
physical activity can also benefit those who are already diagnosed with type 2 diabetes in preventing secondary risks.
Recently diagnosed diabetics were grouped to measure the effect of flexibility, aerobic, and resistive exercises on cardiovascular disease risk factors. These risk factors included lipid profile,
exercise capacity, flexibility, glycemic control, and body composition. The outcomes displayed that, body fat triglyceride levels
and postprandial glucose levels decreased, while aerobic ability
and flexibility increased after exercise. These results led to a
decrease in the cardiovascular risk profiles in diabetic patients,
thus reducing their intrinsic complications. This study showed
that even those already diagnosed with the disease can decrease
their risk for secondary diseases that are often associated with
type 2 diabetes (Acar et al., 2014).
A similar study also focusing on the secondary risk of cardiovascular disease on type 2 diabetic women showed that physical
activity allows for a considerable decrease in high sensitivity
C reactive protein levels, fasting glucose and total cholesterol
(Alizadeh et al., 2012). On the other hand, it causes high-density
lipoproteins to increase. Additionally, the study showed that an
eight-week exercise schedule could help lower glycemic and
lipid profile, thus reduce the risks of cardiovascular disease in
type 2 diabetic women.
A thorough 2005 literature review concluded that regular
physical activity provides health beneﬁts in individuals who have
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already expressed clinical diabetes. Indeed, several prospective
observational studies have shown that among individuals with
impaired fasting glucose or diabetes, higher levels of activity and
ﬁtness are associated with a lower incidence of cardiovascular
events and mortality from all causes and cardiovascular disease
(LaMonet et al., 2015).
A prospective cohort of 1,263 men, who all had type 2 diabetes, was analyzed. The purpose of the study was to evaluate
the relationship of mortality in men with type 2 diabetes, with
low fitness and physical inactivity. These men were given a thorough medical examination, which included their fitness level and
participation in physical activity. A self-reported baseline was
used to document their physical activity while fitness was measured by an exercise test. One hundred and eighty subjects
died during a 12-year follow up. Diabetic men in the low-fitness
group and physically inactive had a two times greater risk for
mortality than fit men and active men (Wei et al., 2000).

Various Forms of Physical Activity
One study meta-analyzed how different modes of exercise training affects glucose control as well as other complications associated with type 2 diabetes. The study included 27 controlled trials
involving the estimates for the effect of aerobic training, resistive
training, and combined training.There was a total of 1,003 patients
with type 2 diabetes that were followed for a 5-104-week period.
Results of the meta-analysis indicated that all forms of exercise
allow for small-moderate benefits in A1C, the main measure of
glucose control. The effects of exercise training seemed to be
similar to those of drug, dietary, and insulin treatment. Additional
research is imperative to conclude about factors that could affect
the outcomes of an exercise program, such as the patient’s sex.
However, this study indicates that prescribing an exercise program to patients with type 2 diabetes can provide small positive
results (Snowling, Hopkins, 2006).
Another study examined the benefits of vigorous activity vs.
walking and the incidence of type 2 diabetes in women. The
design was a cohort study completed in 1986 (updated in 1988
and 1992). It included surveys of over 70,000 female nurses between the ages 40 to 65 years from the original Nurses’ Health
Study cohort, which began in 1976.These women did not have a
diagnosis of diabetes, cardiovascular disease, or cancer. Although
earlier analysis of the original cohort study showed an inverse
relationship between vigorous activity and the risk of type 2
diabetes occurrence, there was a lack of evidence regarding the
possible role of walking which is a more common form of physical activity in women. In this study, vigorous activity is defined
as something which requires 6 METs (metabolic equivalent
task-hours) or greater such as jogging, lap swimming, bicycling,
etc., as opposed to walking which requires only 2-4.5 METs.The
study concluded that both walking and vigorous activity are related to a significant reduction in type 2 diabetes risk in women.

These findings support the current guidelines from the National
Institute of Health and the Centers for Disease Control and
Prevention that recommend a minimum of 30 minutes of moderate intensity physical activity daily (Webster, 2018).
A randomized control trial was conducted comparing the impact of aerobic training (AT) and progressive resistive training
(PRT) on the health status of a multi-ethnic Asian population.
Progressive resistive training is a program that builds physical
strength by lifting progressively heavier weights and is based
on the individual’s maximum strength. Both programs were
completed over 8 weeks with 60 middle-aged adults who had
a diagnosis of type 2 diabetes mellites. Health status was measured using the Short-form 36 Questionnaire (SF-36), a self-administered assessment measuring eight aspects of functional
health. The subscales are divided into the physical component
summary score (PCS) and mental component summary score
(MCS). Results of the scoring showed significant improvement
in both the PRT and AT groups with both physical and mental
health benefits. Furthermore, PRT may have some added benefits since there were significant changes in more domains of the
SF-36 than in the AT group. Although the benefits of both forms
of physical activity are apparent, it is not necessarily certain that
the same positive results would apply to a different population.
Each population has many factors that can have an impact on
health (Ng et al., 2011).
In an additional study, the same questionnaire, SF-36, was
completed by subjects which led sedentary lives and were diagnosed with type 2 diabetes. The purpose of this study was
to determine if a 10-week moderate aerobic exercise regimen
would affect the quality of life (QOL) as well as the physical
health of these subjects. The survey was completed by a group
of subjects who participated in the training, three days a week
for 20-45 minutes. The survey was also completed by the group
of control subjects who did not receive the training. Results
of this study showed a decrease in percent body fat and an increase in lactate threshold in the training group. However, there
was no significant difference in the mental health component of
the quality of life survey (Holton et al., 2003).
A study determined if adults with or at risk for diabetes participate in physical activity. A survey was collected by the Medical
Expenditure Panel (a nationally representative survey of the
U.S. population) regarding the physical activity of 23,283 adults.
Additional information such as health conditions (diabetic vs.
nondiabetic) and sociodemographic characteristics where self-reported. Results of the survey showed that 58% of adults without
diabetes were physically active versus 39% of adults with diabetes.
The number of non-diabetic individuals who responded that they
were physically active decreased as the amount of type 2 diabetes risk factors increased. Income level, depression, severe obesity
(BMI >40kg), and limitations in physical function were the strongest
factors correlating with being physically active or not. The study
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concluded that those who have type 2 diabetes or those who are
at a higher risk for developing the disease do not participate in
physical activity regularly. Thus, it is imperative to create efforts to
target this population to increase the levels of their engagement
in physical activity by reinforcing its value and ability to help curb
rising diabetes and obesity epidemic (Morrato et al., 2003).
As previously noted, most American adults who have type 2 diabetes or those who are at risk for developing the disease do not
regularly engage in physical activity. A joint positional statement
written by The American College of Sports Medicine and The
American Diabetes Association concluded that self-efficacy (associated with the confidence in the ability to exercise) and social
support are two of the most reliable predictors of greater levels
of engagement in physical activity (Colberg et al., 2010). Family,
friends, and health care professionals may be a source of support
for these individuals. By taking the necessary precautions, individuals with type 2 diabetes can maintain a safe exercise routine. An
exercise program or leisure-time physical activity is critical for
the overall health of those suffering from this disease.

Conclusion
Many people assume that high-calorie diets, which are very prevalent in our society (due to fast food, etc.) is the main contributor to obesity and causes a higher risk for diabetes. The studies
documented in this research paper highlight another key behavioral factor which contributes to the high rate of this disease.
The research has indicated that low physical activity and leading
a sedentary life has a great effect on the risk of developing type 2
diabetes. There is also strong evidence that leading an active and
ﬁt life has the potential to reduce mortality risk in individuals who
already have this diagnosis. Over the past few years, our society
has morphed into a technological hub in which the majority of
our daily responsibilities can be taken care of with just a few
clicks. Thus, it has become common for individuals to be physically inactive and lead sedentary lives. This phenomenon already
starts at a young age. For example, our children no longer feel the
need to play sports outdoors when they can play the video game
version. It is, therefore, imperative to continue researching the
effects of physical activity on diabetes risk to bring about global
awareness and to halt this fatal epidemic.
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Abstract
Modern science takes at face value the fact that exercise is beneficial for man’s health. In recent years, medical health professionals have begun to harness exercise as a treatment for a broader range of maladies. Since various studies found increased exercise
to correlate with higher levels of endorphins, most believed that the endorphins were directly responsible for what the vernacular
dubbed “Runner’s High.” Scientists have sought to either augment or wholly disprove the endorphin hypothesis with further
studies. Major Depressive Disorder, or MDD, is an affective condition affecting a significant portion of the general population.
Aerobic exercise is increasingly being revealed to be an encouraging treatment for all types of depression and anxiety. The HPA
Axis allows one to comfortably exercise without experiencing the extremely stressful symptoms that characterize psychological
stress, such as depression, anxiety, fear, etc. Runners’ High is the “…happiness, elation…inner harmony, boundless energy, and…
reduction in pain sensation” that ensues following prolonged aerobic activity. Endorphins are the body’s naturally occurring opiates.
The Neurogenesis Hypothesis states that “a decrease in the synthesis of new neurons in the adult hippocampus might be linked
to major depressive disorder.” Further research implicates BDNF (Brain-Derived Neurotrophin Factor) in exercise-induced neurogenesis. The thought was that beta endorphins are what stimulate increased neurogenesis, in turn causing a decrease in MDD.
β-endorphins are large molecules that are too bulky to pass through the BBB and therefore cannot be the cause any changes to
occur within the brain. Researchers and scientists have thus turned their attention to endogenous endocannabinoids as the true
source of analgesia, sedation, anxiolysis and reduced depression found in endurance exercisers. Chief ligand anandamide (AEA)
engenders elevated levels of BDNF (Brain Derived Neurotrophic Factor) during exercise and return-to-baseline levels post-exercise. Endocannabinoids modulate nociception by affecting the Periaqueductal Gray system (PAG). Endogenous cannabinoids and
exogenous cannabinoids (marijuana) act in similar fashions, leading to the addictive qualities of exercise. Compelling evidence has
ascertained that endogenous endocannabinoids are the underlying cause of the many positive effects of aerobic activity.
Introduction
Modern science takes as face value the fact that exercise is
beneficial for man’s health. Hippocrates was known to say,
“Even when all is known, the care of a man is not yet complete,
because eating alone will not keep a man well; he must also
take exercise...” While to a contemporary society this concept
seems rather primitive and simplistic, it is a truth that forms
the basis of modern health sciences. However, it has only been
in recent years that medical health professionals have begun to
harness exercise as a treatment for a broader range of maladies.
Exercise is widely known to help keep one’s weight down, tone
muscles and enhance physical fitness. Scientists are perpetually
expanding their knowledge of exercise and what kind of effects
it has on the brain and the body’s systems. An understanding
of the neuronal activity, neurotransmitter actions and chemical
releases that are the responses to varying degrees of exercise
can be applied to treat disease and improve lives. One such
application is exercise as a treatment for Major Depressive
Disorder (MDD). MDD had previously been treated solely with
antidepressants, but more recently is being dealt with using a
combination of medication and exercise. Various case studies
have undertaken to prove the relationship between exercise
and positive changes in the MDD brain. Once the neuronal and
chemical effects of exercise were established, it naturally led
to the conclusion that depressive symptoms lessened due to a
proliferation of certain positive hormones that were released
into the brain in response to exercise. With further investigations, the popular conclusion was that the feel-good high associated with exercise is caused by endorphins, opioid hormones
that appear to increase in response to exercise. Since various
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studies found increased exercise to correlate with higher levels
of endorphins, most believed that the endorphins were directly
responsible for what the vernacular dubbed “Runner’s High.”
Since then, scientists have sought to either augment or wholly
disprove the endorphin hypothesis with further studies.

Methods
The search engines used include ProQuest, EbscoHost, and
GoogleScholar. Tributary information was also obtained using
Wikipedia, the New York Times and WebMD.

Discussion
Major Depressive Disorder, or MDD, is an affective condition
affecting a significant portion of the general population. In
America today, about 5% of all people will eventually be diagnosed with MDD. Quality of life with MDD is radically impaired,
and basic life functions such as eating, sleeping and maintaining
personal hygiene can be affected. It has been found that roughly 10% of people diagnosed with MDD will probably commit
suicide. This is all due to the overwhelming, pervasive feelings of severe depression that characterize Major Depressive
Disorder. Deficits in executive function are also consequences
of MDD. Patients tested with a Stroop Task, Go/No Go Task,
Task-Switching Paradigm and Flanker Tasks all scored low in
reaction times, indicating deficits in executive function ability
(Ernst, et al. 2006). Previously, MDD had been treated solely
with antidepressant medications such as SSRIs (selective serotonin reuptake inhibitors). The anti-depressant medication field
is an ever-growing industry, despite limited success and many
unwarranted side effects. For examples, anti-depressants stop
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working after a while, since the body and brain become accustomed to the drug and gain a tolerance for it. In such a case,
the dose would have to continuously be raised in order to have
any effect. Furthermore, if one abruptly stops taking the dosage
of medication, withdrawal symptoms such as “dizziness, loss of
coordination, fatigue, tingling, burning, blurred vision, insomnia,
and vivid dreams” may incur. Additionally, the patient may experience “nausea or diarrhea, flu-like symptoms, irritability, anxiety,
and crying spells.” This tendency is called the “Discontinuation
syndrome” and is obviously best to be avoided. Other negative side effects might include insomnia, diarrhea and stomach
aches, headaches, joint and muscle pain, reduced blood clotting
capacity due to lowered concentration of serotonin in platelets and possible increased tendency towards violence and/or
self-destructive behaviors. A Black Box warning was even issued
in 2004 by the FDA against SSRIs, warning of the possible risk of
“suicidal thoughts, hostility, and agitation in children, teens and
young adults” (Harvard, 2019).
Between 30-35% of patients on medication do not even respond to the antidepressant treatment at all. The unpleasant
side effects considerably compromise the patients’ quality of
life in many areas and make the medications undesirable as a
primary treatment for depression. Furthermore, there is a high
relapse rate found in patients treated with antidepressants, leading to a need for alternative and/or supplementary treatments
(Blumenthal, et al. 1999).
Aerobic exercise is increasingly being revealed to be an encouraging treatment for all types of depression and anxiety
(Heijnen, et al. 2016). A study was performed testing MDD
symptoms in response to exercise. Participants were accepted
for the study if they displayed depressive criteria as expressed
in the DSM-IV and other symptoms such as “sleep disturbance,
weight loss…psychomotor retardation or agitation, feelings of
worthlessness or excessive guilt, impaired cognition…and recurrent thoughts of death.” They also had to receive a score of
at leave 13 on the HAM-D test. The HAM-D is a clinical rating
scale used to measure levels of depression. Scores of thirteen
to eighteen is mildly depressed, above 18 is severely depressed.
Each of the subjects of the study were assigned to one of three
groups – exercise treatment, medication treatment, and a combination of exercise and medication treatment. The assignment
of groups was a randomized procedure to ensure that equally
depressed participants were assigned across the groups. The
exercise group met three times a week for 16 weeks, engaging
in personalized exercise protocol according to their individual
heart rate capability. The classes were overseen by a “trained
exercise physiologist.” The medication group was administered
the SSRI sertraline, specifically used due to its “documented
efficacy and favorable side effect profile.” Dosages were administered by the staff psychiatrist at intermittent weeks. The combination group concurrently received the same medication and

exercise regimens described above. Results were generally positive. Firstly, patients who engaged in exercise showed improvements in aerobic capability, with an 11% increase in the exercise
group and a 9% increase in the combination group. Secondly,
depressive symptoms improved equally across all three groups.
Improvements on the HAM-D scores did not differ across
groups, and neither did the scores based on DSM-IV depression criteria. “…The percentage of patients who were no longer classified as clinically depressed at the end of the 4-month
treatment period did not differ across treatment groups.” The
only difference found that they patients benefited more rapidly
in the combination group than did the patients in the exercise
or medication groups alone. This study demonstrated that exercise treatment as an intervention for depression is equally as
effective as medication treatment (Blumenthal, et al. 1999).
Numerous other studies, all of which sought to prove the efficacy
of exercise have tested people who suffer from depression across
the spectrum. One set of studies has shown that participants, ranging from young to elderly, who engage in daily exercise regimens
are far less likely to develop MDD. Subsequent investigation further
demonstrated that daily exercise improves depressive symptoms,
even in people who have not been diagnosed with MDD. Exercise
studies performed with healthy adults with no depressive symptoms also found positive results. These adults reported improved
cognitive function, elevated mood and a general sense of well-being.
One study tested how well exercise treated “moderate-to-severe”
depression, concluding that the depression was highly improved.
Another treated MDD patients with a combination of antidepressant medication and exercise regimens. A control group received
medication and “health education” lessons. The medication/exercise group responded significantly better than the control group.
Yet another tested a group of adults suffering from MDD, exercising with varying intensities of exercise. They found here that the
most intense exercise group improved the most. A significant edge
that exercise has over medication is that the effects of exercise may
extend past the actual regimen, with the positive feelings enduring
(in one study) up to almost two years past the experiment (Ernst,
et al. 2006). This is in sharp contrast to antidepressant medication,
of which the healing abilities curtail immediately with the end of
dosage.This is why people on medication require concurrent therapy so that they can manage their life even after their medication
dosage is over. On the other hand, exercise is found to be even
superior to therapy itself in many instances, with various “young
and middle-aged adults” positing that aerobic exercise helped their
depressive symptoms more than therapies like psychotherapy, CBT
and occupational therapy (Blumenthal, et al. 1999).Aerobic exercise
performed by patients with depression and anxiety may improve
cognitive function. (Heijnen, et al. 2016) Patients who scored poorly
on various task functions, such as Stroop and Flanker Tasks, scored
significantly higher following 30 minutes of aerobic exercise (Ernst,
et al. 2006).All of these studies have consistently found lower MDD
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and anxiety levels in response to exercise training, in addition to
higher psychosocial functioning, increased positive affect and elevated mood (Blumenthal, et al. 1999).
The obvious question that troubles scientists and mental
health specialists is why exercise has such a potent effect on the
human psyche. While the physical action of aerobic exercise is
known to cause weight loss and increased fitness due to burning
of calories and fat and muscle toning, the reason behind the
mental effects are not as simple to extrapolate. Exploring the
neuroendocrine response that takes place in response to aerobic exercise may help to ascertain the underlying cause.
Exercise that activates the heart rate from its resting point
and raises the maximum capacity of oxygen intake (VO2max) at
least 60% can be classified as a physical stressor. In response to
such a stressor, the hypothalamus secretes “corticotrophin-releasing hormone, which travels…to the anterior pituitary to
induce adrenocorticotropic hormone (ACTH) release” into the
general circulation. Arrival of this hormone at the adrenal cortex stimulates cortisol release into the bloodstream. Cortisol
acts as an inhibitor and, through the use of medial prefrontal
cortex (mPFC) receptors, inhibits “overexcitability of the amygdala” that naturally occurs when a stressor arrives in the bloodstream (Heijnen, et al. 2016). This stress response is known as
the Hypothalamic-Pituitary-Adrenal (HPA) Axis, so named for
the journey of hormones from the hypothalamus, through the
anterior pituitary and into the adrenal cortex, causing relaxation from the body’s increased stress levels (Blumenthal, et al.
1999).The elevated levels of cortisol can last up to 2 hours after
the actual exercise action, and the amount of cortisol released
is proportional to the amount of exercise. Equally important
in the stress response is the inactivation of cortisol back into
cortisone. This homeostatic cycle ensures that frequent exercisers do not suffer from extreme cortisol levels that can lead
to “hypertension, hyperglycemia, major depressive episode and
anorexia nervosa” (Heijnen, et al. 2016).Thus, ACTH is a regulatory mechanism that acts as the body’s natural stress response.
This allows one to comfortably exercise without experiencing
the extremely stressful symptoms that characterize psychological stress, such as depression, anxiety, fear, etc. (Angelopoulos,
2001). However, while this neuroendocrine response accounts
for the control of increased psychological stressors while exercising, it could hardly account for the flood of “euphoria, anxiolysis (reduction of anxiety), sedation, and analgesia (relief from
physical pain)” that characterize what we call Runner’s High
(Reynolds, 2015).
Runner’s high is the reason that America has its plethora of
addicted runners clocking miles in their sneakers every day.
Every athlete can describe the “…happiness, elation…inner harmony, boundless energy, and…reduction in pain sensation” that
ensues following prolonged aerobic activity (Dietrich, 2004).
This so-described high is experienced frequently by endurance
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athletes, but really by anyone who exercises profusely for an
extended amount of time. Scientists have struggled for decades
with the reason behind runner’s high and many hypotheses have
been debuted and disproven over time. For years the Endorphin
Hypothesis was the most popular by scientists and the overall
population, gaining strength through hearsay and seemingly impenetrable evidence.
Endorphins are the body’s naturally occurring opiates. When
a person exercises, these chemicals are released in the brain,
seeming to improve the athlete’s mood and promote endurance.
While exercise is known to be a healthful practice to engage in
for one’s physical health, it can cause degrees of discomfort or
even pain. Therefore, it would make sense that in response to
exercise, endogenous opiates with antinociceptive properties
similar to morphine would be released (Reynolds, 2015). Any
kind of intense endurance exercise can induce endorphin release, and it seems that the greater the exercise, more mood-altering endorphins are proportionately released (Kolata, 2008).
Endorphins are “cleaved from the preprohormone pro-opiomelanocortin (POMC)…a protein found in the pituitary gland and
the brain” (Ernst, et al. 2006). The C-terminus of the POMC
protein in turn gives rise to hormones such as opiate peptides.
In one experiment, researchers used PET (positron emission
tomography) scans to compare endorphin levels in the brains
of athletes. Ten athletes did a two-hour run and were tested
for opiate levels before and after the run. Additionally, the runners took a psychological test pre and post-run, intended to
measure their moods before, and in response to, the flood of
endorphins. The researchers did find increased levels of endorphins attaching themselves to the limbic and prefrontal areas of
the brain, zones typically associated with emotion. The athletes
also reported higher mood and euphoria in a seemingly direct
relation to higher endorphin levels in the brain (Kolata, 2008,
Heijnen, et al. 2016). Technically, all this study proved was that
there is indeed a flood of endorphins in the brain in response to
exercise. While there seems to also be a correlation between
the elevated opiate levels and mood, the proof was not – yet
– impenetrable.
A study performed at the Iranian Academic Center for
Education, Culture and Research (ACECER) attempted to ascertain how endorphin levels are affected due to exercise. The
researchers included subjects with fibromyalgia (FM) as well as
healthy patients.The study was based on the assumption that exercise increases release of endogenous β-endorphins, and that
β-endorphins lessen pain perception. Exercise has previously
been used as a treatment for diseases such as FM, with a strong
role in nociception and elevated pain threshold. Specifically in
FM cases, however, the “analgesic effect” or lessening of pain
perception seemed significantly dulled. According to the results
of the study, this would seem to be due to the fact that FM patients produce less β-endorphins as they exercise and therefore
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are less capable of blocking pain. All of the subjects first rested
in a supine position in order to attain their basal heart rate, a
range of 60 to 100 beats per minute. Blood from the anti-cubital
vein was drawn at baseline and at the end of the exercise test
in order to compare β-endorphins levels. The exercise test was
a treadmill routine that continued as long as the subject was
able, until the onset of “fatigue, pain, or physical exhaustion”.
Every three minutes the incline of the treadmill as well as the
speed increased according to specific intervals. As soon as 70%
of the patients HRMax (maximum heart rate) was achieved, the
subject was told to continue for 15 more minutes only, and
their level of exercise intensity was recorded. The post exercise
blood was drawn directly afterwards, when the heart rate was
still at its maximum. The results were rather interesting. The
mean exercise times for the FM and healthy groups revealed
that it took a much shorter time for the FM subjects to achieve
HRMax than the healthy group. The majority of subjects who
were able to reach their HRMax at later stages of exercise were
from the healthy group. Ninety three percent of the healthy
group, as opposed to the mere 30% of FM subjects, reached
HRMax during stage four of exercise. This indicated that FM
patients were unable to exercise to the same extent that the
healthy participants were. While the blood samples indicated
that both groups had amounts of β-endorphins, the FM subjects
has significantly lower levels in both their baseline blood and
in the post-exercise blood. This means that while both groups
experienced a rise in β-endorphins due to the exercise, the FM
patients were unable to produce the same influx of β-endorphins as the healthy group.These blunted levels of β-endorphins
may explain why FM patients are more immune to the analgesic
effects of exercise that usually take over post-exercise. Usually,
aerobic exercise stimulates elevated β-endorphins levels which
in turn seem to stimulate decreased nociception, elevated
mood and psychological stability. However, due to “failure of
normal elevation of [endogenous] β-endorphins,” FM patients
seem less able to produce the same analgesic effects. Therefore,
they might be more prone to develop chronic allodynia (pain
from a non-painful stimulation of the skin) and heightened nociception with the absence of normal β-endorphins levels (Bidari,
et al. 2016).
Scientists have explored how endorphin levels rise in response to exercise. A study sought to verify the elevated levels
of endorphins, with and without naloxone (opiate antagonist).
It has already been proven than exercise with an intensity of
75% of VO2max and 80% of HR (heart rate) causes an elevated
release of beta endorphins into circulation. However, this study
examined whether longer lengths of activity cause even further
increased endorphin levels, and how long one must exercise to
stimulate endorphin release. The study included “nine healthy,
fit males.” In this double-blind experiment, some subjects were
injected with naloxone, and some with a mere placebo. They

all took a graded exercise test (GXT) to assess their physical
capabilities and then performed exercise on treadmills, running
until they were too exhausted to go on. Phlebotomy techniques
were used to draw blood and measure beta endorphin levels.
Levels of VO2max, HR (heart rate) and hematocrit (ratio of
RBC volume in blood) were measured during 10 min, 20 min
and 30 min intervals for both trials. No changes in Hct levels
were found between trials.
β-endorphin concentration across the trials were recorded
and trials showed significant differences. Before exercise, β-endorphins levels were at roughly 40 ml; across 10, 20 and 30-minute intervals, influxes of 80 to 90 ml of β-endorphins were recorded. Of note is that after the initial rise in β-endorphins, the
volumes leveled off and stopped rising across time during exercise - it stayed constant. β-endorphin levels were significantly
higher under naloxone administration.To summarize the results
of the study, a significantly large increase in β-endorphin were
found during and throughout exercise as compared to resting
levels. They also found that the men injected with Naloxone experienced even higher levels of β-endorphins. Additionally, tests
with low to moderate levels of exercise showed no changes
at all in β-endorphin levels. Therefore, this suggests that it is
only intense aerobic exercise that induces significant increases
in β-endorphins. This elevation occurs rapidly from the onset
of exercise and remains level through the duration. This test
found much higher β-endorphin levels in the naloxone-injected
participants as compared to the placebo participants. However,
other experiments did not find much of a difference between
naloxone test and placebo test. This is an obvious disparity that
may be due to “differences in the exercise protocol, method of
administration of the antagonist, and in the stereo-specificity of
the antagonist used in the respective experimental protocols”
(Angelopoulos, 2001).
Now the question stands, what is it that causes this drastic β-endorphins rise during exercise? The researchers suggest
that Naloxone attaches to the opioid receptor, blocking any
other opiates and signaling the pituitary gland to release more
β-endorphins. These β-endorphins do glucoregulation during
exercise, “augmenting glucagon levels and attenuating insulin
release.” Glucagon keeps blood glucose at high enough levels
to allow the body to function normally (Glucagon, Diabetes.
Co). This is a positive feedback loop – more β-endorphin is released, it does more glucoregulation, and so more β-endorphin
is released. This may be why endorphin levels were higher with
Naloxone injections.
ACTH also increases under stressful condition, just like β-endorphins. ACTH is also secreted by the pituitary and regulates
cortisol in the bloodstream. Just like the endorphins in this
study, ACTH levels rise with an injection of Naloxone. Thus, it
seems that both β-endorphins and ACTH are regulatory mechanisms, acting to ensure the body’s homeostasis despite outside
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stressors. However, ACTH regulates the psychological stress
response and endorphins normalize the physical response.
This study demonstrated how and why β-endorphins levels
were significantly elevated over the course of aerobic activity
(Angelopoulos, 2001).
It is clear that aerobic exercise indeed causes an influx of
β-endorphins to be released into blood circulation.The next step
would be to secure as fact that it is indeed the flood of endorphin
opiates that lowers depressive symptoms and induces a euphoric
affect. The following study attempted to ascertain the possible
link between aerobic exercise and the subjects’ emotional state.
The study involved middle aged subjects engaging in physical activity. First off, the subjects’ emotional states were evaluated using
FaceReader. FaceReader is a facial analysis software that assesses
emotional state based on 6 primary emotions - happy, sad, angry,
disgusted, scared, and surprised. The subjects were also interviewed personally to assess how they were feeling just then.After
the facial analysis the researchers drew blood from the median
cubital vein of each subject to have a baseline sample of blood
plasma levels. The physical activity was measured using a veloergometer load test.A veloergometer is similar to an elliptical exercise bike, however it is equipped with specialized hardware capable of measuring physical prowess.This exercise regimen is called
a load test, and it commenced for a half hour, with increasing
load every three minutes. After the load test, the pre-test procedures – FaceReader, interview and phlebotomy – were repeated
and analyzed. The pre and post blood measures were tested for
plasma beta endorphin levels to see if there was an increase in
endorphins in response to the exercise. If an increase was accompanied by a similar increase in mood, this would provide evidence
that it is endorphins that cause the elevated mood associated
with physical activity.The results showed an endorphin increase in
only half of the subjects. However, in regard to positive affect, the
data found a general increase across the subjects. A 20% increase
in happiness was found and all except one showed a decrease in
negative emotions. (One subject showed an increase in disgust
due to unpleasant lab conditions) (Kundzina, et al. 2014). These
findings definitively supported the hypothesis that extended aerobic exercise of at least 60% VO2 intensity is directly linked to
increased positive affect and decreased depressive symptoms. It
is of significance to note, however, that only half of the subjects
showed a marked increase in circulating beta endorphin levels.
Here we introduce a hypothesis that closely allies with the subject at hand. This is the Neurogenesis Hypothesis, which states
that “a decrease in the synthesis of new neurons in the adult hippocampus might be linked to major depressive disorder (MDD).”
Anti-depressant medications such as SSRIs have been used for
years as treatment for MDD. Anti-depressants act to stimulate
synthesis of new neurons in the adult brain. Eventually, a link was
drawn between the anti-depressants and neurogenesis, since the
time it takes for medication to have an effect is the same span of
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time it takes for the newly synthesized neurons to gain functionality. Returning to our exercise hypothesis, an experiment with
lab rats found a 2 to 3-fold increase in neurogenesis in rats who
had “regular access to a running wheel when they are compared
with control animals.” This discovery naturally led to the awareness that exercise assuages depressive symptoms by inducing
increased neurogenesis, the “growth of new neurons in the adult
[mammalian] brain.” While it was once thought that neurogenesis
is limited to the developmental stages of growth, it is now known
that certain areas of the adult mammalian brain retain active progenitor cells that are constantly synthesizing new neurons and glial
cells.There are two major sites of adult neurogenesis, the dentate
gyrus of the hippocampus and the subventricular zones adjacent
to the lateral ventricles. Based on experiments performed with
lab mice and rats, roughly 9,000 new neurons are synthesized
daily in the dentate gyrus alone. Research indicates that these
numbers are reflective of human neurogenesis as well (Ernst, et
al. 2006). One site of adult neurogenesis is the subventricular
zone (SVZ) that is adjacent to the lateral ventricles of the brain.
“Numerous proliferative precursor cells” line the walls of the
ventricles that are composed of ependymal cells. The precursor
cells are contained in this zone and eventually mature into new
neurons and glial cells.The second site is the dentate gyrus (DG),
located on the hippocampus in the brain. The hippocampus, a
“bilateral limbic structure that plays a role in…learning and memory....” has two distinct areas – the Cornu Ammonis (CA) and the
dentate gyrus. The CA has three subfields filled with pyramidal
cells, multi polar neurons that act as primary excitation neurons
in the brain. The dentate gyrus is connected to the CA and is
“composed of small, round granule cells” that form a C shaped
area. It is underneath these granule cells that active progenitor
cells are housed and give rise to new neurons and glia, giving the
area its name – the subgranular zone (SGZ) of the dentate gyrus.
The two zones are closely adjacent to each other but develop
differently. Active progenitor cells in the dentate gyrus give rise
to daughter cells that migrate into the granule layer above.There,
they develop and send out axons into the Cornu Ammonis region
3 (CA3). Over the course of four to five weeks, these daughter
cells mature and act like fully grown granule cells. The daughter
cells in the subventricular zone give rise to daughter cells that
migrate into the olfactory bulbs to act as local interneurons.Thus,
there is adult neurogenesis occurring daily at a rapid rate in the
healthy mammalian brain. The neurogenesis theory states that if
this complex process should somehow be impaired and fewer
neurons would be created, the result would be the expression
of depressive symptoms. The introduction of anti-depressant
medications would promote neurogenesis and get the brain back
on track. The plot thickens with the discovery that exercise too,
promotes neurogenesis in the hippocampus of the brain. This
strongly links exercise as a reliable therapeutic intervention for
treatment of MDD (Ernst, et al. 2006).
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Several research experiments have sought to augment the
proof with concrete data. Firstly, MRI (magnetic resonance imaging) data have shown that hippocampal volume is severely
compromised in the brains of depressed patients. This would
give strength to the idea that it is reduced neurogenesis in the
dentate gyrus that gives rise to depressive symptoms. Other
studies showed that the corticosteroids released from the adrenal gland as part of the natural stress response (HPA Axis)
negatively impact neurogenesis in the hippocampus, thus causing the “decreased hippocampal volume associated with MDD.”
The stress response is thus amplified, sustaining a vicious cycle
of continuous depression and stress response. It’s important to
note that the decreased size of the hippocampus is not due to
the degeneration of pre-existing neurons. Therefore, it would
follow that fewer neurons are being created in the first place.
Comparatively, researchers found increased hippocampal volume in direct relation to aerobic exercise. Lab rats that engaged
in aerobic exercise consistently displayed large increases in hippocampal volume due to subsequent supplementary neurogenesis. As compared to control mice and rats with no access to a
running wheel, active mice displayed double the number of new
neurons in the subgranular zone of the dentate gyrus of the
hippocampus. Furthermore, it has been ascertained that treatments for MDD, such as SSRIs (selective serotonin reuptake
inhibitors) or electroconvulsive shock therapy, also cause an increase in neurogenesis. This expresses a direct relationship between neurogenesis and lessening depressive symptoms. A third
proof involves the timing. Newly generated neurons typically
require four to five weeks to become fully functioning neurons.
This is a “latency similar to the onset of therapeutic benefit
for most…antidepressant medication[s].” This information also
supports the idea that proper neurogenesis is integral to reducing depressive symptoms. Research has even shown that in
certain cases, aerobic exercise can foster the same therapeutic
effects as cognitive therapy (Ernst, et al. 2006).
Further research implicates BDNF (Brain-Derived
Neurotrophin Factor) in exercise-induced neurogenesis. BDNF
promotes “neuronal survival and regeneration” in the adult
brain. Aerobic exercise causes elevated levels of BDNF to be
produced specifically in the CNS. This specificity indicated that
BDNF plays a particularly central role, namely in the brain. One
study found that exercise in mice led to increases in BDNF.They
also noted that in a case with depressed lab animals, exercise led
to an increase in both BDNF levels and hippocampal neurogenesis. On the other hand, it is known that it is neurogenesis that
causes the anti-depressant effects of exercise; therefore, it was
concluded that elevated levels of BDNF contribute to increased
neurogenesis, thus playing an indirect role in lowering the depressive symptoms. BDNF stimulates cell proliferation specifically in the subgranular zone of the dentate gyrus, and also
supports long-term survival of these new neurons. A positive

cycle can thus be recognized: exercise increases BDNF, BDNF
enhances neurogenesis and neuronal survival, causing increased
positive affect, probably leading to further exercise to prolong
the effect (Ernst, et al. 2006).
The obvious question is: why does exercise stimulate neurogenesis; what endogenous substance causes the brain to up the
ante on neurogenesis when the body is engaged in aerobic activity? This returns us to the endorphin hypothesis. The thought
was that endorphins are what stimulate increased neurogenesis,
in turn causing a decrease in MDD. Studies have found that not
only do infusions of opiate peptides seem to cause an increase
in neurogenesis in the dentate gyrus, but also that “opiate receptor antagonists” seem to cause a decrease in adult neurogenesis. Therefore, endorphins may have a role in the survival
and/or formation of new neurons and glia (Ernst, et al. 2006).
The Endorphin Hypothesis seemed sound, and was sustained
for decades in the medical arena and among lay athletes at
large. However, significant holes in the hypothesis were sprung
that threatened the authenticity of its claims. Among other
problems, the most substantial issue was that of the Blood
Brain Barrier (BBB). Blood Brain Barrier describes the precise “microvasculature of the central nervous system.” It is a
semipermeable border separating the blood circulation from
the brain and ECF (extracellular fluid of the CNS). This system of tightly packed endothelial cells (in the capillary wall),
astrocytes (covering the capillaries) and pericytes (embedded
in the basement membrane of the capillaries) is able to control
the movement of substances to and from the brain and blood
circulation. Substances such as “molecules, ions, and cells” are
screened heavily by the BBB to ensure that no harmful microbes or other destructive substances reach the brain. This
system ensures proper neuronal function and protection of the
brain and spinal cord against “toxins, pathogens, inflammation,
injury, and disease” (Daneman, R, et al. 2015). Since the cells of
the BBB are so tightly packed, certain molecules that are too
large are unable to pass through to gain access to the Central
Nervous System. An example of such large molecules are beta
endorphins. They are too bulky to pass through the BBB and
therefore cannot be the cause any changes to occur within the
brain. So, while endorphins are indeed released during exercise and may staunch peripheral muscle pain that results from
exercise, they cannot be the source of any Runners’ High or
diminished depressive affect (Reynolds, 2015, Fuss, et al. 2015,
Dietrich, 2004). Other “methodological confounds” inherent in
the endorphin hypothesis are as follows:
1. Firstly, the possibility of cross reactivity is very strong. Cross
reactivity occurs when two antigens are very similar in
their amino acid makeup and therefore an antibody raised
against one antigen might also bear an affinity for the similar antigen. The antibody is “programmed” to find the first
antigen but it also recognizes the second. Beta endorphins
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bear almost identical amino acid sequences with adrenocorticotropic hormone (ACTH) and other pro-opiomelanocortins.Therefore, any detecting antibody would possibly
cross-react, making it difficult to detect which is which.
(Proteintech, 2018) This is a serious confound for scientific experiments involving the authentication of the beta
endorphin hypothesis and possibly invalidates much of the
proof presented from these experiments. The fact that endorphins have similar structure specifically to ACTH is a
further confound, since ACTH is also known to increase
with endurance exercise.
2. Furthermore, when beta endorphins bind to a µ opioid receptor, it activates the “endogenous opioid system” that further
activates the “analgesic and euphoric properties” inherent in
the opiate system. It is also known, however, that symptoms
such as “severe respiratory depression, pinpoint pupils, and
inhibition of gastrointestinal motility” are all characteristic of
endogenous opioid activation (Dietrich, 2004). If it were beta
endorphins that were activating the opioid system, these
symptoms would also be present in runners and endurance
athletes. Since they are not, we are forced to reevaluate what
it is that truly causes Runners’ High.

Endocannabinoids
Researchers and scientists have now turned their attention
to endogenous endocannabinoids as the true source of analgesia, sedation, anxiolysis and reduced depression found in
endurance exercisers (Dietrich, 2004, Heijnen, et al. 2016).
More recent studies are focusing on endocannabinoids and
what is it about them that makes exercise “mildly intoxicating” (Reynolds, 2015). Endogenous endocannabinoids are the
body’s natural chemicals that improve mood and reduce nociception. They are endogenous lipids that “engage cannabinoid
receptors, producing analgesic and euphoric effects just like
those of exogenous cannabinoids, namely marijuana (or cannabis - Δ-9-THC ((–)-trans-Δ9-tetrahydrocannabinol; THC) (Lu,
et al. 2016, Reynolds, 2015). While we now know that opiate
endorphins mediate analgesia on a peripheral level, we have
seen that there are still analgesic effects that occur irrespective
of a working opioid system. This supports the evidence that
cannabinoid induced analgesia also takes place at a central level
(Dietrich, 2004). Endocannabinoids are what tell the hypothalamus to induce the release of endorphins. Therefore, any analgesic effects that endorphins do have are actually mediated
by endocannabinoids (Heijnen, et al. 2016). Unlike endorphins,
endocannabinoids are small enough to cross the Blood Brain
Barrier and bind to brain receptors, thus enabling them to induce peripheral as well as central effects (Fuss, et al. 2015). An
interesting feature of cannabinoid function is that way they are
produced. Classic neurotransmitters are created ahead of time
and stored in their respective synaptic vesicles for whenever
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they might be needed. Cannabinoids, on the other hand, are created and released almost immediately on demand. When called
upon, for example, by G protein coupled receptors or during
depolarization, endocannabinoids will be “liberated in one or
two rapid enzymatic steps and released into the extracellular
space” to produce a rapid effect on the system (Lu, et al. 2016).
There are two types of identified endocannabinoids, CB1 and
CB2. CB1 can be found in the CNS, “densely concentrated” in
the cerebral cortex, hippocampus, basal ganglia; amygdala, hypothalamus and cerebellum (Dietrich, 2004). Most CB1 receptors
are found on axon terminals and pre-terminal axon segments,
not on the active zones (Lu, et al. 2016). This further elevated endocannabinoids over endorphins, for while endorphins
cannot even cross over in to the brain, endocannabinoids are
located in the places one would assume pain relievers and analgesics would be found. The hippocampus is a site for memory,
as well as neurogenesis which reduces depression; the amygdala
regulates the fear response; the hypothalamus is the “master
gland” of the brain and orchestrates all incoming and outgoing
activity. The cerebral cortex is a massive conglomeration with
numerous functions that would be affected by endocannabinoids.The frontal lobe of the cortex cares for “higher executive
functions” such as “emotional regulation, planning [and] reasoning…” The parietal lobe is responsible for sensory integration
such as touch, temperature and pain perception. Thus, is makes
sense that these areas would abound with CB1 receptors. CB2
receptors are mainly located in the PNS, expressing themselves
on immune cells, microglia and vascular elements to protect the
CNS. (Lu, et al. 2016) There are also cb1 receptors on peripheral nerve terminals. For example, “pain sensing [small diameter] C fibers, large diameter Aß and Aδ fibers… [and] dorsal
root ganglia” (Dietrich, 2004). Therefore, we see that ECBs are
synthesized both centrally and peripherally, unlike endorphins
which hare only synthesized in the Peripheral Nervous System.
The possibility of a third cB receptor is currently being investigated and may turn out to account for some of the Runners’
High effects.
Chief ligands of CB1 and CB2 receptors are anandamide
(arachidonoyl ethanolamine) and 2-arachidonoyl glycerol (2AG) (Lu, et al. 2016). They are derived from fatty acid derivatives. Anandamide is known to bind with cb1 receptors over
cb2 receptors, indicating higher central activity over peripheral
activity (Dietrich, 2004). Anandamide (AEA) is a “highly lipophilic” fatty chemical and therefore can easily cross in to the brain
proper (Heijnen, et al. 2016). This would implicate anandamide in
activating analgesic effects in the brain (Dietrich, 2004). AEA increased gradually when cortisol is released during the HPA Axis,
demonstrating a role in regulation of stress and amygdalar over
excitability (Heijnen, et al. 2016). Rats showed an increase in hippocampal anandamide after running on a wheel for an extended
period of time, indicating that anandamide plays a role in exercise
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and homeostatic regulation (Fuss, et al. 2015). Additionally, anandamide acts as a vasodilator and produces hypotension, facilitating blood flow during exercise (Dietrich, 2004).
Anandamide (AEA) also engenders elevated levels of BDNF
(Brain Derived Neurotrophic Factor) during exercise and return
to baseline levels post-exercise. As mentioned above, BDNF is
part of the neurotrophin family and plays a strong role in exercise-induced neurogenesis. In addition to promoting positive
affect due to neurogenesis, BDNF also “exerts beneficial effects
on cognition through its ability to enhance neurogenesis, synaptic plasticity and long-term potentiation, the basis of learning.”
Therefore, enhanced release of AEA due to exercise stimulates
BDNF to stimulate heightened cognition and learning. Indeed,
psychological stress and mood disorders have been found to reduce BDNF levels in the brains of rats and mice. Physical stress,
or aerobic exercise, does just the opposite. A study among an
elderly population showed that “moderate intensity walking”
over a year served to intensify BDNF levels, further causing task
switching functioning to remain constant. The control group of
sedentary elderly showed a diametric decline in BDNF and
in task switching as well (Heijnen, et al. 2016). Other studies
have shown that aerobic activity “ranging from 20 to 90 min
of 40–75% of maximal power output or 40–60% of VO2max
or 75% of maximal heart rate” causes noticeable increases in
BDNF levels (Heijnen, et al. 2016). Thus endocannabinoids play
a role in cognition and mood as well.
Scientists noted that there were elevated levels of both endorphins and endocannabinoids in the plasma of mice, post run
(Reynolds, 2015). In one experiment, the cB receptors in mice
were blocked, noticeably inhibiting the Runners’ High that is
usually induced post run. The mice were anxious and sensitive
to pain perception. Blocking the endorphin receptors had no
effect and the mice experienced the calming and antinociceptive
effects of runners’ high as usual (Fuss et al., 2015, Reynolds,
2015). A similar study also involved lab mice running in a wheel.
First off, increased running directly increased levels of endocannabinoids, effectively inducing a reduction in anxiety and pain.
Furthermore, ablation of the mice’s cb1 receptors completely
inhibited the runners’ high effect, eliminating anxiolysis. When
the mice were injected with blockers of their cB receptors,
the analgesic effects were further inhibited (Fuss, et al. 2015).
Yet another study with mice divided the mice into running and
non-running groups. The running mice were at ease to spend
more time in bright light areas, something anxious mice don’t
do. This indicated that the running induced sedation. The mice
were also tested for pain perception with a hot plate test. The
runners did not jump in pain or lick their paws as much as
normal, indicating that running induced antinociception, endowing the mice with heightened “thermal pain sensitivity.” All of
these studies found that reductions in anxiety and elevated sedation in mice are due to increased CB1 receptors in forebrain

GABAergic neurons, while antinociception was caused by cb1
and cb2 receptors in the PNS (Fuss, et al. 2015). This antinociceptive effect can even rival that of morphine (Dietrich, 2004).
Another study engaged healthy male athletes running at
“varying degrees of intensity” over a period of four days. Each
running session induced a 70-80% raise in basal heart rate, and
was performed at 50-90% of maximal intensity capacity. A sharp
increase in cB1 receptors was found in the “frontal cortex,
amygdala, hippocampus, and…hypothalamus” all known to be
essential areas that regulate affective homeostasis (Heijnen, et
al. 2016). A similar study involved male college athletes exercising on treadmills or stationary bikes at 70-80% maximal heart
rate. After about an hour, drastically raised levels of anandamide
were measured in their blood circulation (Dietrich, 2004).
Another way that endocannabinoids modulate nociception
is by affecting the Periaqueductal Gray system (PAG). The PAG
serves an important role in modulating ascending pain transmission, fielding “afferents from nociceptive neurons in the spinal
cord [and sending] projections to thalamic nuclei that process
nociception.” In regard to descending pain inhibition, the PAG
inhibits neurons in the dorsal horn of the spinal cord.The major
functions of the midbrain periaqueductal gray (PAG) include
suppressing pain, fear and anxiety, and promoting analgesia and
cardiovascular control” (Bebehani, 1995). “Electrical stimulation
of [both] the dorsal and lateral periaqueductal gray system”
causes not only bindings to cb1 receptors but a subsequent release of anandamide into circulation. Additionally, an experiment
revealed that “subcutaneous injection of the chemical irritant
formalin” caused a direct infusion of the ligand anandamide into
the periaqueductal gray. This implicates anandamide as a nociceptive agent for central chemogenic pain (Dietrich, 2004).
Upon observation, it can be noted that runners’ high is only
found in response to endurance exercise, as opposed to exercise in spurts. Sports such as “sprinting…weightlifting…track,
soccer, football, tennis [and] basketball” doubtfully engage the
endocannabinoid system since they do not involve long term
exertion (Dietrich, 2004). Running, dancing or biking are examples of activities that would engage the ECB system and
induce a runners’ high. As mentioned earlier, endorphins play
a role in moderating only peripheral chemogenic pain in the
muscles. In addition to the central effects of anandamide, we
find that cannabinoids also act similarly to inhibit edema and
muscle inflammation that might occur during intense exercise.
This moderation is important for endurance athletes because
muscle pain is a cause and effect of lactic acidosis, which in turn
introduces symptoms like muscle ache, nausea and stomach
pain (Dietrich, 2004).
Endogenous cannabinoids and exogenous cannabinoids (marijuana) act in similar fashions. “The psychoactive constituent of
marijuana, Δ-(9)-tetrahydrocannabinol (THC), exhibits high affinity for the CB1 receptor, which is densely expressed in brain
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regions implicated in the control of emotion and cognition.”
Therefore, just like marijuana, ECBs can induce sedation, analgesia, reduced anxiety, euphoria and even impaired spatial learning
(Dietrich, 2004). This essentially means that prolonged exercise
produces the same effects as marijuana.
This leads into the addictive quality of endurance exercise.
The endocannabinoid system is closely linked with the dopaminergic reward system of the brain. Dopamine is the brain’s
pleasure hormone, and dopamine receptors D1 and D2 are
modulated by endocannabinoids. The two main ECB ligands
anandamide and 2-arachidonoylglycerol (2-AG) proliferate in
dopaminergic pathways as a “retrograde feedback system” for
GABA nerve terminals. There, they modulate dopamine transmission (Bloomfield, et al. 2016). Additionally, cBs affect dopamine activity by increasing firing rates in the medial forebrain
bundle, ventral tegmentum and substantia nigra. In the same
vein, withdrawing the cB presence would induce withdrawal
symptoms similar to that characteristic of marijuana withdrawal.
This is due to reduced firing of the pleasure hormone dopamine.Therefore, endogenous as well as exogenous cannabinoids
(CB1) are what cause the influx of dopamine release into circulation, thus causing a feel-good high or a “Runners’ High.” Just
like exogenous ECB cause drug addiction, so too endogenous
ECBs engender an addiction to that which brings on the dopaminergic feelings, namely aerobic exercise.This explains exercise
addiction; exercise causes elevated levels of ECBs, ECBs in turn
cause increased firing of dopamine, inducing an addictive “high.”
Indeed, it has been found that even just blocking dopamine
receptors inhibits Runners’ High. Athletes who are forced to
refrain from their routine endurance exercise (for example, in
the case of an injury) report withdrawal symptoms not unlike
those of drug withdrawal (Dietrich, 2004).

Conclusion
The analgesic, euphoric and anti-depressant effects that take
hold in response to aerobic exercise have been a major source
of contention among the medical, scientific and lay community
for decades. The endorphin hypothesis certainly took center
stage for quite a time as the source behind what the vernacular
aptly termed “Runners’ High.” However, compelling evidence,
experimental proofs and biological veracities have enabled scientists to ascertain that endogenous endocannabinoids are the
underlying cause of the many positive effects of aerobic activity.
Included in these positive effects are: elevated ACTH to regulate
the stress response, heightened BDNF production to promote
neurogenesis and neural survival, analgesia, anxiolysis, decreased
anxiety and depression, euphoria, enhanced cognition, and numerous others. Endorphins do not cause Runners’ High; however, they do engender other positive effects during exercise.
Exercise has been seen to induce Runners’ High in all ages and
stages, be it depressed or emotionally healthy, young or elderly,
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and male or female. With this knowledge, the proof holds true
that enhanced release of endogenous endocannabinoids due
to aerobic activity reliably and consistently induces a Runners’
High, and thus decreases the depressive symptoms inherent in
Major Depressive Disorder.
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Abstract
Polycystic ovary syndrome (PCOS) is recognized as the most common reproductive disorder in women. Obesity is believed to play
a central role in the development of PCOS, as many women with this condition are reported to be overweight or obese. A strong
correlational relationship exists between PCOS and obesity. This paper examines the relationship between PCOS and obesity in
order to determine whether PCOS causes obesity as opposed to obesity causes metabolic changes that lead to PCOS. Analysis was
conducted by reviewing and comparing many studies related to the topic. Factors such as insulin resistance, hyperandrogenemia
and body fat distribution were examined in obese and non-obese PCOS subjects. Most studies included in this review could not
conclusively determine whether PCOS contributed to obesity or vice versa. The important points raised in the literature showed
that obesity could be an important factor to predict PCOS. In women who are predisposed to PCOS, the metabolic and hormonal
issues that are present such as insulin resistance and hyperandrogenism, can lead to weight gain and eventually obesity. Obesity
in turn can exacerbate the symptoms of PCOS such as further metabolic issues and reproductive abnormalities.
Introduction
Polycystic ovary syndrome (PCOS) is a common metabolic and
endocrine disorder effecting 15- 20% of women of reproductive
age. This disorder, originally known as Stein-Leventhal syndrome,
was discovered in 1935. Its clinical features include obesity, hirsutism, acne, infertility, and oligomenorrhea. PCOS is also attributed to several hormonal and metabolic disturbances, including
increased androgen production and disordered gonadotropin
secretion leading to menstrual irregularity, hirsutism, and infertility. Aside from interfering with reproductive function, PCOS
also disrupts the metabolism of women, affecting insulin action
and β-cell function, increasing the risk for glucose intolerance and
type 2 diabetes (Liu et al. 2017; Raisbeck 2009).
The origin of PCOS remains unclear, but research has shown that
one of the characteristics of this disorder is the excess production of androgens in the ovaries (Alanbay et al. 2012). Androgen
secretion is the result of abnormal response of the ovary to gonadotropins, insulin and insulin-like hormones such as insulin-like
growth factor-1 (IGF-1), which enhances LH-stimulated androgen secretion by theca cells. Although the condition is not life
threatening, the lack of treatment could lead to more serious
health issues in the future, such as increased risk of infertility,
dysfunctional bleeding, endometrial carcinoma, obesity, type 2 diabetes mellitus, dyslipidemia, hypertension, and increased risk for
cardiovascular diseases (Raisbeck 2009).
Among the risk factors associated with PCOS, overweight (body
mass index (BMI) 25–29.9 kg/m2) and obesity (BMI ≥30 kg/m2)
have been considered as major contributing factor to overall
health concerns among women worldwide. Obesity has also
been a determined as a contributing factor to reproductive health
problems such as anovulation.As body weight increases, incidence
of anovulation also increases significantly. Another contributor to
reproductive dysfunction is the accumulation of abdominal fat,
indicating a higher risk associated with insulin resistance (IR). IR
in obese women has been associated with anovulation and increased androgen secretion (Kuchenbecker et al. 2011).
Several studies relate obesity as a risk factor of PCOS (Reinehr
et al. 2005; Soydinc et al. 2013). Some studies report that
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overweight and obesity incidence in females with PCOS is as
high as 80%.The mechanisms by which obesity influences PCOS
‘ pathophysiology and clinical expression are not fully understood, but obesity is independently associated with IR (Rojas
et al. 2014) and sex steroid imbalances that may lead to an increased risk of menstrual irregularities and hyperandrogenemia,
similar to PCOS symptoms (Pasquali and Gambineri 2006). On
the other hand, others proposed that regardless of physical condition PCOS could occur. PCOS may develop in women with a
BMI in any range including both underweight and overweight
women. (McEwen and Hartmann 2018). The consistent association between PCOS and obesity suggests a biological basis for
this observation. Obesity exacerbates many of the reproductive
and metabolic abnormalities associated with PCOS. Considering
the close association between PCOS and obesity, the question
remains whether PCOS causes obesity or does obesity cause
metabolic changes that lead to PCOS?

Method
A critical appraisal of the literature on the topic was conducted.
A search for related studies was conducted using the access of
Touro’s library in various databases, such as EBSCO, ProQuest,
PubMed, MEDLINE, CINAHL, Cochrane Reviews, and Sage online publications. Other information was sourced from Google
Scholar. Keywords used to obtain the relevant documents included PCOS, obesity, insulin resistance, reproductive health
abnormalities and PCOS, metabolic anomalies and PCOS. In
addition, a library search was also conducted for references in
text books, relevant articles and other research findings using
the same keywords.

Discussion
Metabolic Factors
One of the main contributors to PCOS is insulin resistance (IR).
Insulin is an important hormone produced by beta cells in the
pancreas. It is responsible for the metabolism of glucose reduction of blood glucose levels by stimulating the glucose intake in
insulin-sensitive tissue such as those found in the skeletal muscles.
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IR is common and an early predictor of metabolic diseases. IR
is the “inability of insulin to optimally stimulate the transport of
glucose into the body’s cell” (McEwen and Hartmann 2018).
Several studies investigated IR among women diagnosed with
PCOS regardless of BMI. Fasting insulin levels in both lean and
obese women diagnosed with PCOS were determined and compared with control subjects. A total of 64 women with PCOS
and 20 healthy subjects were evaluated using anthropometry,
oral glucose tolerance tests, and insulin tolerance tests. Glucose
levels were then measured using glucoseoxidase, whereas serum
C-peptide and insulin levels were obtained using immunoradiometric assays. Insulin sensitivity and β-cell function were derived
from fasting values of insulin and glucose or from oral glucose
tolerance tests or insulin tolerance tests measurements. Results
revealed that β-cell function is elevated in both lean and obese
women with PCOS. In obese women suffering from PCOS, reduced values in fasting state-derived disposition index were
found, whereas lean women suffering from PCOS were found
to have increases in these variables when oral glucose tolerance
tests were determined. The authors suggested that insulin hypersecretion may be an important mechanism in the pathogenesis
of PCOS. Further, prevention of serious metabolic complications
could be achieved with the early screening of impaired insulin
action and secretion in women with PCOS (Vribikova et al. 2002).
Under normal conditions, the relationship between insulin
secretion and sensitivity is constant to maintain normal glucose
tolerance. If the sensitivity of insulin varies, the secretion of
insulin also changes. Obese and lean females with PCOS have
lower production of insulin sensitivity compared to the amount
of insulin secreted in response to blood glucose levels than
weight-matched healthy women (Dunaif 1999).
Another study investigated the association of IR to the increased risk for cardiovascular disease among women with
PCOS. They examined the effects of IR on myocardial microcirculation and peripheral artery function in patients with PCOS.
A total of 55 women (28 with PCOS without IR, 18 with PCOS
and IR, and 11 normal controls) participated in the study. All
subjects were examined using high-resolution vascular ultrasound and real time myocardial contrast echocardiography
(RTMCE). Results indicated that women with PCOS and IR had
depressed replenishment velocity and myocardial blood flow
reserve, but no changes in endothelial dysfunction or intima–
media thickness. By contrast, women with PCOS but without IR
were found to have isolated depression in replenishment velocity, suggesting that this condition could be an early indicator of
myocardial flow abnormality (Aldrighi et al. 2015).
IR and hyperinsulinemia are exacerbated in obese individuals. The accumulation of excess intra-abdominal fat increases
IR because of its sensitivity to lipolysis and releases more free
fatty acids in the circulation and produces several cytokines
(i.e. tumor necrosis factor-α [TNF-α], IL-6, leptin, resistin) that

occur in IR (Carpentier 2008). Circulating free fatty acids can accumulate in non-adipose tissues, causing lipotoxicity and insulin
resistance. In obesity, IR is also related to TNF-α that enhanced
serine phosphorylation of IRS-1 and inhibits insulin receptor
signaling (Hotamisligil et al. 1996). Furthermore, IR associated to
obesity induces leptin resistance and reduced adiponectin levels,
which are two factors that may reduce fatty acid oxidation and
promote lipotoxicity (Carpentier 2008).
The mechanisms causing insulin resistance in PCOS have
many similarities with those seen in relation to visceral adiposity
(Kabir et al. 2005). Excess free fatty acids derived from lipolysis/
hydrolysis of acylglycerol in adipocytes accumulate in the hepatic
portal veins, and this induces hepatic dysfunction. This condition
contributes to elevated glucose secretion, stimulates pancreatic
insulin secretion and glucose uptake in adipose tissue (Bergman
et al. 2000). This specific insulin resistance, also known as hepatic
insulin resistance, is only present in obese women with PCOS and
not in healthy women of comparable body weight (Dunaif 1999).
The results of these studies demonstrate only a correlational relationship rather than a causal one between obesity and PCOS
on glucose production, which may highlight an important factor
of the pathogenesis of glucose intolerance.
Another approach was taken to determine the effects of insulin
resistance on PCOS. Researchers investigated the relationship between neuropeptide Y (NPY) and insulin resistance. NPY enhances appetite and is structurally and immunologically similar to the
pancreatic polypeptide, which has 36 amino acids. NPY is found in
the central and peripheral nervous system. NPY controls nutrient
intake and body weight. NPY also has an inhibitor effect on the
hypothalamohypophyseal-ovarian axis. A total of 45 patients with
PCOS and 44 healthy reproductive age individuals participated in
the study. At early follicular phase in patients with PCOS, insulin,
fasting blood sugar, follicle-stimulating hormone (FSH), luteinizing
hormone (LH), prolactin, testosterone, dehydroepiandrosterone
sulfate (DHEA-S), thyroid stimulating hormone (TSH), cortisol,
estradiol, and NPY levels were determined. Meanwhile, insulin,
fasting blood sugar, prolactin, DHEA-S, TSH, cortisol, and 17-OH
progesterone levels were obtained from the control group.
Fasting insulin levels and homeostatic model assessment for IR
(HOMA-IR) were more elevated in obese patients with PCOS
than in patients with normal weight and healthy controls. NPY
levels were also higher in obese-overweight women with PCOS
compared with the control and normal weight patients, but they
were not statistically significant. NPY levels did not differ in patients with and without IR (Koseci et al. 2019).
A study confirms the strong association between metabolic
aberrations such as IR and PCOS. IR is clearly manifested among
women with weight gain and who are genetically predisposed
to develop PCOS. Conversely, weight reduction of women
with PCOS reduces the negative impact of PCOS. Excluding
obesity and fat mass, PCOS is related to metabolic aberrations
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such as IR, dyslipidemia, and non-alcoholic fatty liver disease.
Mechanisms attributed to the development of IR in PCOS have
been established in previous studies. For example, the relationship between visceral adipose tissue and IR has been proven
in other studies. Further investigation suggests that abdominal
mass in women is proportional to the total fat mass regardless
of PCOS status. This condition alone cannot completely explain the occurrence of IR in PCOS, however, fat distribution in
women suggests an explanation as to why IR worsens as women
with PCOS gain weight (Barber et al. 2016).

Biochemical Indicators
Many studies have used biochemical indicators as an approach
to better understanding PCOS. One examined the impact of
hyperandrogenemia on IR. Research has shown that impaired
metabolism of glucose and IR is partially explained by high androgen concentrations. Women with PCOS have both hyperandrogenemia and IR. By activating androgen receptors, testosterone caused IR in subcutaneous adipocytes. This impairs glucose
metabolism due to defects in downstream protein phosphorylation, kinase-C protein, which usually mediates insulin’s impact
on glucose transport (Corbould 2007).
In another study, the rationale for IR in PCOS patients was
investigated. Adipocytes of women with PCOS had enhanced
glycogen synthase kinase-3 (GSK3) action. Consequently, insulin-stimulated glucose transport was impaired, and IR developed.
Furthermore, overexpression of GSK3 promoted androgen biosynthesis through direct stimulation of P450c17 enzyme activity
(Chang et al. 2008). Results from these two studies verify that
continuous exposure to androgens impairs insulin action and
contributes to the development of IR.
Androgens have an important role in body composition because they determine the location of fat stored in the body.
Androgens influence adipocyte function and distribution by the
inhibition of adipocyte differentiation, which modulates lipolysis and lipogenesis (Dicker et al. 2004). In general, males have
greater distribution of body fat in the upper portion of the
body, whereas females accumulate fat in the posterior region of
the body. Among women, distribution of adipose tissue differs
between women with and without PCOS. Adipose tissues of
women with PCOS have been found to be dispersed viscerally
similar to that of males. For a given waist circumference, abdominal subcutaneous fat in women has been found to be higher
than that of men regardless of age (Kuk et al. 2005).
To determine the possible developmental origins of PCOS, a
model was constructed to trace the pathophysiology of PCOS
involving excess androgens (including the signs and symptoms)
at every stage of the disease. Androgen excess occurs in a vicious perpetual cycle. The gene expression of excess androgens
in utero results in high LH and insulin concentrations, enhancing the enzyme activities in theca cells and encouraging the
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progression of primordial to preantral and small antral follicles.
These interactions elevate androgen levels. The process is completed and revived when a female with excess androgen procreates and bears a female fetus, suggesting the genetic path of the
syndrome (Homburg 2010).
Body fat distribution was researched among females with and
without PCOS. The subjects were matched for age and BMI.
They also looked at the connection between concentrations
of androgen, IR, and fat distribution. A total of 31 women with
PCOS and 29 healthy subjects as controls participated in the
study. Women with PCOS demonstrated higher fat mass value
in the trunk and arms. Fat accumulation occurs during puberty
in the hips, thighs, and buttocks and is preserved throughout
women’s fertile stage. However, there is more upper body fat
distribution for females who have been diagnosed with metabolic illnesses and PCOS. Excess androgens were ascribed to
this disease. As a consequence of obesity, the impact of high
androgens is increased due to lower concentrations of sex hormone-binding globulin (SHBG) and greater concentrations of
freely circulating bioactive androgens. Insulin increases testosterone’s impacts by suppressing SHBG. It functions as a co-gonadotropin and inhibits SHBG’s hepatic synthesis excluding sex
steroid impacts that contribute to hyperandrogenism. Insulin
stimulates the synthesis of ovarian androgen and decreases the
concentrations of SHBG circulation due to the high concentrations of complete serum and free testosterone. Consequently,
there was more upper body fat distribution among females with
PCOS. This research suggests that lowering the distribution and
structure of fat may be useful in decreasing PCOS-related metabolic aberrations (Cosar 2008).
The relationship between abdominal and upper-body fat,
glucose and lipid metabolism markers, and serum androgens
in women with PCOS were investigated. The study included 40 women aged 19-49 years with BMI 18.7 – 53.8 kg/m2.
The participants had at least two of the following features of
PCOS, namely, oligomenorrhoea or amenorrhea, clinical and/
or biochemical evidence of hyperandrogenemia, and polycystic
ovaries in ultrasound imaging. All obese subjects had increased
abdominal fat. A significant correlation was found between obesity and serum fasting glucose and insulin levels.The same result
was found in homeostatic model assessment index of IR. A positive correlation was observed between estimates of obesity and
serum triglycerides and between obesity and blood pressure.
Subsequently, the researchers confirmed direct positive correlations between free androgen index, body weight and BMI
(Kozakowski and Zgliczynski 2013).
Others also recorded the elevated incidence of upper-body
obesity as evidenced by enhanced waist circumference and
waist-hip ratio compared with BMI-matched control females,
confirming the same results. Studies using dual-energy x-ray absorptiometry have disclosed enhanced accumulation of core fat
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in females with PCOS in accordance with these results (Douchi
et al. 1995). Chronic exposure in females with PCOS to greater
concentrations of testosterone may alter the distribution of
body fat in these females. Studies of androgen administration
in non-obese females to male transsexuals leading to increased
visceral fat and adverse impact on insulin sensitivity provide
support for this hypothesis (Elbers et al. 1997). In both obese
and normal-weight females, exposure to androgens increases
visceral fat (Rosenfield 1999). In rats, administering a single
elevated dose of testosterone early in life contributes to the
growth of insulin resistance and centralization as an adult of adipose tissue mass (Nilsson et al. 1998). Early androgen exposure
may adversely affect future distribution of body fat with higher
core fat accumulation. Studies of isolated abdominal fat cells
from females with PCOS have shown that there is a preferential
abdominal accumulation of adipose tissue in both obese and
non-obese females with PCOS compared to control females
(Dunaif et al. 1992). In obese females with PCOS, femoral adipocytes are fewer than reproductively ordinary females, consistent
with a change to the distribution of upper-body fat in females
with PCOS. Observation of the increased distribution of visceral adipose tissue in PCOS can be ascribed to the impact of androgens, their metabolism, and tissue-specific steroid receptor
expression (Blouin 2009). Since this visceral fat is biologically
active (Kuchenbecker et al. 2011), it most probably contributes
to further metabolic and endocrine disorders in PCOS.
Women with upper-body obesity have PCOS symptoms such
as reduced sensitivity to insulin and are at greater danger of cardiac illness and diabetes (Vague 1956). It was observed that in
females with upper-body obesity, the incidence of diabetes, hypertension, and atherosclerosis was greater than in lower-body
obesity. Furthermore, it has been noted that the incidence of
upper body obesity rises in females after menopause and females with upper body obesity tend to have hyperandrogenic
characteristics such as hirsutism.
PCOS is defined by anomalies in the hormone releasing gonadotropin (GnRH), a pulse generator that leads to a rise in the
release of LH over the follicle stimulating hormone (FSH).These
abnormalities are obesity-independent. Healthy obese females
have no defects in levels of 24-hour LH and FSH. Excess insulin
stimulates hypothalamic GnRH secretion up to a certain point,
thus inducing gonadotropin secretion (especially LH) from pituitary cells, which in turn stimulates the development of androgen in the ovaries.When hyperinsulinemia is found, the pituitary
is led to secrete big quantities of LH, which tends to boost the
LH / FSH ratio. LH stimulates androgens synthesis in the ovaries,
and an absence of FSH impairs the aromatization of androgens
in granulosa cells to estrogens. These modifications cause the
tiny ovarian follicles to grow and hinder the maturation needed
for the development of the dominant follicle that then appears
as polycystic ovaries (Dunaif 2003).

Obesity and PCOS
Although it is true that obesity is a risk factor, the disease has
also been diagnosed in lean females, although reproductive issues are generally discovered more frequently in obese females,
regardless of PCOS. Obese females were more probable to
have irregular menstrual cycles and anovulatory infertility compared to ordinary weight females. The risk of anovulatory infertility rises by 24 kg / m2 at BMI and continues to increase as BMI
rises. But even a slight proportion of decrease in body fat can
restore these women’s menstrual cycles.
To understand which comes first, obesity or PCOS, studies
have investigated this relationship in girls and adolescents. It was
noted that girls with a high BMI in childhood had an increased
risk of oligomenorrhea and a diagnosis of PCOS in young
adulthood (age 24), yet the possibility that features of PCOS
were already present in these girls cannot be excluded. The researchers investigated if PCOS (or its features) in adolescents
is predictive of later class III obesity. Despite not using pelvic
ultrasonography, PCOS was diagnosed using the Rotterdam criteria in 12 (40%) of 30 oligomenorrheic girls at age 14 years.
Of these girls, 33% displayed class III obesity by 24 years of age
versus 8.4% of girls without PCOS. Other predictors of class
III obesity included low sex hormone binding globulin (SHBG),
oligomenorrhea, high childhood insulin levels, increased cFT and
MetS, all of which are recognized as PCOS phenotypes (Glueck
et al. 2011). Meanwhile, others conducted a prospective study
on 244 randomly selected postmenarchal girls from a large population-based birth cohort to investigate the influence of obesity on the development of abnormal ovarian morphology. They
found PCOS in 61.1% of the obese girls, but only in 32.1% of
the normal- weight girls, suggesting that obesity is a contributing
factor (Hickey et al. 2011). These studies illustrate that obesity
and PCOS are correlative in their pathogenesis.
Additional trials explored the differences between obese and
nonobese Croatian females with PCOS in clinical, hormonal and
metabolic characteristics. The research included a total of 74
obese and 208 nonobese females with PCOS. Obese females
with PCOS were discovered to be at greater danger of developing oligomenorrhea, but at a lower risk of developing hirsutism
and acne. Furthermore, obese subjects were more likely to
develop hyperandrogenemia, insulin resistance, hypercholesterolemia, hypertriglyceridemia, and high serum CRP concentrations than nonobese females. Among obese females with PCOS,
metabolic problems were more probable to happen than their
healthy counterparts (Baldani et al. 2013).
Especially in females with upper-body obesity, the discovery
of enhanced androgen production in obese females was revealed. Androgen clearance rates have also risen, however, the
circulation of bioavailable androgens remains within the normal
range. Similarly, due to hyperinsulinemia, SHBG concentrations
are decreased in this state. SHBG concentrations in females
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with or without PCOS are negatively associated with the circulating insulin concentrations or with the degree of insulin
resistance. Reducing insulin concentrations with diazoxide in
obese PCOS females, a drug that only reduces insulin secretion
without altering insulin sensitivity, has been discovered to increase SHBG concentrations. This finding indicates that insulin
may directly suppress the secretion of liver SHBG and compensatory hyperinsulinemia as opposed to IR, explaining low
concentrations of SHBG in obese females with PCOS. Due to
reduced SHBG secretion induced by insulin, hyperandrogenemia is further exacerbated. Consequently, obesity-related hyperinsulinemia is a significant contributor to ovarian production
of androgens in PCOS. By directly stimulating steroidogenesis
in ovarian theca and granulosa cells, hyperinsulinemia may lead
to hyperandrogenemia. Similar studies have been done on mice
and have shown that liver and muscle cells display insulin resistance during constant hyperinsulinemia, while insulin receptors
remain sensitive in pituitary and ovarian cells, an adaptation that
improves the secretion of pituitary hormones and ovarian androgen production (Nestler, et al 1991). This observation was
used as a model to describe the insulinemic contribution to the
advanced androgen production to PCOS in obese women.
A systematic and meta-analytical review on existing literature
was conducted to determine the prevalence of obesity among
women diagnosed with PCOS. Moreover, the researchers intended to determine whether ethnicity, geographic regions,
and the diagnostic criteria of PCOS had confounding effects on
this relationship. A total of 106 studies conducted before 2010
were included in the review. Among them, only 35 studies were
included in the meta-analysis because the rest did not include a
control group.They found that compared to non-obese women,
obese women with PCOS were more likely to have poor clinical
reproductive presentation. Evidence also suggested that PCOS
contributed to obesity. Increased androgen levels in women regardless of PCOS status were found to affect the appetite for
high-fat and carbohydrate rich foods. However, other metabolic
factors such as hyperinsulinemia, reduced postprandial thermogenesis, and basal metabolic rate and alterations contributed
to weight gain in women with PCOS. However, the question
remains whether PCOS contributed to obesity or vice versa.
Some studies showed that women with PCOS had a greater
tendency to accumulate fat in the upper body. This effect had
also been found even in normal weight women. Overall, it was
concluded that women with PCOS were more likely to be overweight or obese compared to healthy counterparts. Caucasian
with PCOS had greater risk for obesity than Asian women with
PCOS (Lim et al. 2012).

Conclusion
In most health issues around the world, obesity is a significant characteristic. Such observation does not exclude PCOS.
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However, most of the research in this review has not been able
to determine conclusively whether PCOS contributed to obesity or vice versa. However, the significant points raised in the
literature showed that PCOS could be predicted by obesity as a
significant factor. Overweight or obese females were at a higher risk of PCOS than ordinary weight females, but the weight
problem does not exclude ordinary weight females from getting
PCOS and its problems.
Researchers found that an elevated BMI among girls during
childhood increases the risk of oligomenorrhea and a diagnosis
of PCOS in young adulthood (age 24). They also investigated
whether PCOS or its features were present in these adolescents, which could predict later class III obesity during adulthood. Among 12 of 30 oligomenorrheic girls at age 14, 33% of
the girls were predicted to have class III obesity in a decade
compared to 8.4% without PCOS (Glueck et al. 2011). Another
study found PCOS in 61.1% of the obese girls, but only in 32.1%
of the normal- weight girls, suggesting that obesity is a contributing factor (Hickey et al. 2011). These studies illustrated that
obesity and PCOS are correlative in their pathogenesis.
By contrast, it was found that both lean and obese women
with PCOS had elevated βF regardless of BMI. Lean PCOS subjects had elevated DI values when OGTTs were determined.
Aside from body weight, insulin hypersecretion could be an important mechanism in the pathogenesis of PCOS. Early screening
of insulin action in women with PCOS regardless of BMI could
prevent serious metabolic complications (Vribikova et al. 2002).
Meanwhile, others found that both obese and lean women with
PCOS have lower product of insulin sensitivity compared to the
amount of insulin secreted in response to blood glucose levels
than weight-matched healthy women (Dunaif 1999).
Nevertheless, being overweight or obese is a significant contributory factor that aggravates the conditions of women with
PCOS. IR among women with PCOS had been found to increase
the risk of cardiovascular disease. Women with PCOS and IR
demonstrated depressed replenishment velocity and MBFR, but
no changes in endothelial dysfunction or IMT. However, women
with PCOS but without IR were found to have isolated depression in replenishment velocity, suggesting that this condition could be an early indicator of myocardial flow abnormality
(Aldrighi et al. 2015).
Other studies indicated that only a correlational relationship
(rather than a causal one) exists between obesity and PCOS on
glucose production. It was noted that IR and hyperinsulinemia
are intensified in obese individuals. Accumulation of excess intra-abdominal fat increases IR because of its sensitivity to lipolysis and releases more FFAs in circulation and produces several
cytokines (i.e. tumor necrosis factor-α [TNF-α], IL-6, leptin,
resistin) that occur in IR (Carpentier 2008). The mechanisms
causing IR in PCOS have many similarities with those seen in
relation to visceral adiposity (Kabir et al. 2005). A specific IR
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also known as hepatic IR is only present in obese women with
PCOS (Dunaif 1999).
Researchers concluded that evidence in the literature suggested
that PCOS contributed to obesity. Increased androgen levels in
women regardless of PCOS status were found to affect the appetite for high-fat and carbohydrate rich foods. However, other metabolic factors such as hyperinsulinemia, reduced postprandial thermogenesis, and basal metabolic rate and alterations contributed to
weight gain in women with PCOS. They also noted that women
with PCOS were more likely to be overweight or obese compared
to healthy counterparts. Caucasian with PCOS had greater risk for
obesity than Asian women with PCOS (Lim et al. 2012).
The literature reviewed yielded significant information on
PCOS. However, no conclusive evidence pointed to obesity
as the main cause of PCOS or PCOS could cause weight gain.
Biochemical and metabolic features that were impaired because
of PCOS were suggested in these studies. Metabolic rate anomalies found in women with PCOS were more likely to cause
their weight gain. Aside from weight gain, other PCOS features
such as insulin hypersecretion, overproduction of androgens,
reduced SHBG, relationship between IR and myocardial flow
abnormality have been mentioned as contributing factors to
more serious health issues among women with PCOS.
PCOS is not an exclusive condition for females who are overweight or obese. Normal weight females also exhibited PCOS,
especially females deemed to be PCOS candidates due to biochemical and metabolic dysfunctions. Due to the confounding
factors connected with body fat and PCOS, weight gain is feasible for these females. Nevertheless, it was discovered that more
than half of the females with PCOS studied in this research
were overweight or obese. To determine the connection between body mass and PCOS, a more comprehensive research
should be performed.

References
Alanbay, Ibrahim, et al. “A Macrophage Activation Marker
Chitotriosidase in Women with PCOS: Does Low-Grade
Chronic Inflammation in PCOS Relate to PCOS Itself or
Obesity?” Archives of Gynecology & Obstetrics, vol. 286, no.
4, Oct. 2012, p. 1065. EBSCOhost, search.ebscohost.com/login.
aspx?direct=true&db=edb&AN=79862133&site=eds-live.
Aldrighi, José M., et al. “Effects of Insulin Resistance on
Myocardial Blood Flow and Arterial Peripheral Circulation in
Patients with Polycystic Ovary Syndrome.” Echocardiography,
vol. 32, no. 8, Aug. 2015, pp. 1277–1284. EBSCOhost,
doi:10.1111/echo.12849.
Baldani, Dinka Pavičić, et al. “Clinical, Hormonal
and Metabolic Characteristics of Polycystic Ovary
Syndrome among Obese and Nonobese Women in the
Croatian Population.” Collegium Antropologicum, vol.
37, no. 2, June 2013, pp. 465–470. EBSCOhost, search.

ebscohost.com/login.aspx?direct=true&AuthType=shib&db=sih&AN=89603862&site=eds-live.
Barber, Thomas M., et al. “Polycystic Ovary Syndrome: Insight
into Pathogenesis and a Common Association with Insulin
Resistance.” Clinical Medicine, vol. 16, no. 3, May 2016, pp.
262–266. EBSCOhost, doi:10.7861/clinmedicine.16-3-262.
Bergman RN, Ader M: Free fatty acids and pathogenesis of type
2 diabetes mellitus. Trends Endocrinol Metab2000;11:351–356.
Blouin K,Veilleux A, Luu-The V, Tchernof A: Androgen metabolism in adipose tissue: recent advances. Mol Cell Endocrinol
2009;301:97–103.
Carpentier AC. Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes. Diabetes Metab.
2008;34(2):97–107.
Chang W, Goodarzi MO, Williams H, Magoffin DA, Pall M, Azziz
R: Adipocytes from women with polycystic ovary syndrome
demonstrate altered phosphorylation and activity of glycogen
synthase kinase 3. FertilSteril2008;90:2291–2297.
Corbould A: Chronic testosterone treatment induces selective
insulin resistance in subcutaneous adipocytes of women. J
Endocrinol 2007;192:585–594.
Cosar, Emine, et al. “Body Fat Composition and
Distribution in Women with Polycystic Ovary Syndrome.”
Gynecological Endocrinology: The Official Journal Of The
International Society Of Gynecological Endocrinology,
vol. 24, no. 8, Aug. 2008, pp. 428–432. EBSCOhost,
doi:10.1080/09513590802234253.
Dicker A, Rydén M, Näslund E, Muehlen IE, Wirén M, Lafontan
M, et al: Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia2004;47:420–428.
Douchi T, Ijuin H, Nakamura S, Oki T,Yamamoto S, Nagata Y.
Body fat distribution in women with polycystic ovary syndrome. Obstet Gynecol. 1995;86:516–519.
Dunaif A. Insulin action in the polycystic ovary syndrome.
Endocrinol MetabClin North Am. 1999;28:341–359.
Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A,
Licholai T. Evidence for distinctive and intrinsic defects
in insulin action in polycystic ovary syndrome. Diabetes.
1992;41:1257–1266. [
Glueck CJ, Morrison JA, Daniels S, Wang P, Stroop D: Sex
hormone-binding globulin, oligomenorrhea, polycystic ovary
syndrome, and childhood insulin at age 14 years predict
metabolic syndrome and class III obesity at age 24 years. J
Pediatr2011;159:308–313.e2.
Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S,
Norman RJ, et al: Clinical, ultrasound and biochemical features
of polycystic ovary syndrome in adolescents: implications for
diagnosis. Hum Reprod2011;26:1469–1477.
Homburg, R. “Pcos -- the Androgen Circle.” Reproductive
BioMedicine Online (Reproductive Healthcare Limited),
vol. 20, Oct. 2010, p. S95. EBSCOhost, doi:10.1016/

39

Sara Leah Rosenberg

S1472-6483(10)62622-3.

age in rats. J Clin Invest. 1998;101:74–78.

Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF,
Spiegelman BM. IRS-1-mediated inhibition of insulin receptor
tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271(5249):665–668. PubMed

Pasquali, Renato, and Alessandra Gambineri. “Metabolic Effects
of Obesity on Reproduction.” Reproductive Biomedicine
Online, vol. 12, no. 5, May 2006, pp. 542–551. EBSCOhost,
search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=mdc&AN=16790096&site=eds-live.

Kabir M, Catalano KJ, Ananthnarayan S, Kim SP,Van Citters
GW, Dea MK, et al: Molecular evidence supporting the
portal theory: a causative link between visceral adiposity and
hepatic insulin resistance. Am J Physiol Endocrinol Metab
2005;288:E454–E461.
Koseci, Tolga, et al. “Investigation of the Relationship between
Insulin Resistance and Neuropeptide Y Levels in Polycystic
Ovary Syndrome.” Marmara Medical Journal, vol. 32, no. 1, Jan.
2019, pp. 1–6. EBSCOhost, doi:10.5472/marumj.500032.
Kozakowski, Jarosław, and Wojciech Zgliczyński. “Body
Composition, Glucose Metabolism Markers and Serum
Androgens - Association in Women with Polycystic
Ovary Syndrome.” Endokrynologia Polska, vol. 64, no.
2, 2013, pp. 94–100. EBSCOhost, search.ebscohost.
com/login.aspx?direct=true&AuthType=shib&db=mdc&AN=23653271&site=eds-live.
Kuchenbecker WKH, Groen H, van Asselt SJ, Bolster JHT,
Zwerver J, Slart RHJ, et al: In women with polycystic ovary
syndrome and obesity, loss of intra-abdominal fat is associated
with resumption of ovulation. Hum Reprod2011;26:2505–2512.
Kuk JL, Lee S, Heymsfield SB, Ross R: Waist circumference and
abdominal adipose tissue distribution: influence of age and sex.
Am J ClinNutr2005;81:1330–1334.
Liu, Ai Ling et al. “Association between Fat Mass and Obesity
Associated (FTO) Gene Rs9939609 A/T Polymorphism and
Polycystic Ovary Syndrome: A Systematic Review and MetaAnalysis.” BMC Medical Genetics, no. 1, 2017, p. 1. EBSCOhost,
doi:10.1186/s12881-017-0452-1.
Lim, S.S., M.J. Davies, R.J. Norman, L.J. Moran. “Overweight,
Obesity and Central Obesity in Women with Polycystic
Ovary Syndrome: A Systematic Review and Meta-analysis.”
Human Reproduction Update,Volume 18, Issue 6, November/
December 2012, Pages 618–637, https://doi.org/10.1093/
humupd/dms030
McEwen, Bradley, and Georgia Hartmann. “Insulin Resistance
and Polycystic Ovary Syndrome (PCOS): Part 1. The
Impact of Insu in Resistance.” Journal of the Australian
Traditional-Medicine Society, vol. 24, no. 4, Summer 2018,
pp. 214–219. EBSCOhost, search.ebscohost.com/login.
aspx?direct=true&db=awh&AN=133207977&site=eds-live.
Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR,
Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels
in obese women with the polycystic ovary syndrome. J Clin
Endocrinol Metab. 1991;72(1):83–89.
Nilsson C, Niklasson M, Eriksson E, Bjorntorp P, Holmang A.
Imprinting of female offspring with testosterone results in
insulin resistance and changes in body fat distribution at adult

40

Raisbeck, E. “Understanding Polycystic Ovary
Syndrome.” Nurse Prescribing, vol. 7, no. 9, Sept. 2009,
pp. 390–396. EBSCOhost, search.ebscohost.com/login.
aspx?direct=true&db=ccm&AN=105323111&site=eds-live.
Reinehr T, de Sousa G, Roth CL, Andler W: Androgens before
and after weight loss in obese children. J Clin Endocrinol
Metab2005;90:5588–5595.
Rojas, Joselyn, Mervin Chávez, Luis Olivar, et al., “Polycystic
Ovary Syndrome, Insulin Resistance, and Obesity: Navigating
the Pathophysiologic Labyrinth,” International Journal of
Reproductive Medicine, vol. 2014, Article ID 719050, 17 pages,
2014. https://doi.org/10.1155/2014/719050.
Rosenfield RL. Ovarian and adrenal function in polycystic ovary
syndrome. Endocrinol MetabClin North Am. 1999;28:265–293.
Sam S, Dunaif A. Polycystic ovary syndrome: syndrome XX?
Trends Endocrinol Metab. 2003;14:365–370.
Soydinc, E., et al. “Increased Epicardial Fat Thickness Is
Related with Body Mass Index in Women with Polycystic
Ovary Syndrome.” European Review For Medical
And Pharmacological Sciences, vol. 17, no. 15, 2013, pp.
2111–2113. EBSCOhost, search.ebscohost.com/login.
aspx?direct=true&db=mdc&AN=23884834&site=eds-live.
Teede, Helena J. “Role of Insulin Resistance, Androgens,
Obesity and Gonadotrophins.” Fertility Weekly, Mar. 2015, p. 6.
EBSCOhost, search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=f5h&AN=101663448&site=eds-live.
Vague J. The degree of masculine differentiation of obesities: A
factor determining predisposition to diabetes, atherosclerosis,
gout, and uric calculous disease. Am J ClinNutr. 1956;4:20–34.
Vrbikova, J., et al. “Insulin Sensitivity and -Cell Function in
Women With Polycystic Ovary Syndrome.” Diabetes Care, vol.
25, no. 7, July 2002, pp. 1217-1222.

The Biophysical Study of the Efficacy of Various
Phospholipid Membranes on Daptomycin
Chaya Shor and Tamar Itzkowitz
Chaya Shor will graduate with an Honors B.S. degree in Biology in January 2021.
Tamar Itzkowitz will graduate with an Honors B.S. degree in Biology in January 2021.

Abstract
Daptomycin is an important lipopeptide antibiotic used in the treatment of systematic and life-threatening infections of the skin
and underlying tissue caused by Gram-positive bacteria. Calcium and phosphatidylglycerol (PG) must be present on the target cell
membrane for daptomycin’s mechanism of action to proceed. Calcium and PG also promote oligomerization, a formation that has
been assumed to aid in the bactericidal process.The purpose of the experiments conducted was to understand the basic biophysical properties of membrane phospholipids as they exist in their pure and mixed monolayer forms. Furthermore, the experiments
conducted attempted to discern how daptomycin penetrates the different lipids that were used. Data collected would be useful
for future experiments that aim to understand the naturally occurring bacterial membranes and how daptomycin interacts with
them. Using precise biophysical approaches, specifically monolayer studies involving a KSV NIMA-Langmuir Trough and Kibron
Langmuir Trough, our lab conducted basic research which could prove to be useful in revealing daptomycin’s ambiguity. Preliminary
results revealed differences in isotherms between phospholipids with anionic and zwitterionic head-groups. Further data collected
revealed daptomycin’s degree of insertion in phospholipids with and without the presentation of calcium. Given the limitations
of our retrospective studies, additional studies are needed to make definitive evaluations with these results. Because resistance
to daptomycin is rising, it is particularly imperative to conduct further research to understand its unsolved mechanism of action.
Introduction
Daptomycin is a lipopeptide antibiotic used clinically against
various Gram-positive bacterial infections. It is a naturally occurring compound found in the soil saprotroph streptomyces
roseosporus. Daptomycin was approved for clinical use in the
United States in 2003 to treat complicated skin infections such
as methicillin-resistant staphylococcus aureus, commonly known
as MRSA. The molecule is larger and structurally more complex
than most other antibiotics, with its mechanism of permeabilization still not completely understood (Taylor et al. 2016).
At present, it is believed that daptomycin works by disrupting Gram-positive cytoplasmic membrane function by creating
oligomers in the outer membrane of the bacterial cell and then
transferring them to the inner layer of the membrane.This causes leakage of ions, such as potassium, which ultimately leads to
loss of membrane potential that is fatal to the cell (Pogliano et
al. 2012).
The most current research suggests that the antibiotic binds
easily to cluster lipids (lipids with short, branched, and/or unsaturated fatty acyl chains). During the binding, the cell membrane
structure alters significantly causing many peripheral membrane
proteins, especially phospholipid synthase PlsX and lipid II synthase MurG, to lose their ability to bind effectively (Muller et al.
2016). This provokes rapid cell membrane depolarization and a
potassium ion efflux, which effectively causes DNA, RNA, and
protein synthesis cessation (Steenburgen et al. 2005).
Although the mechanism of action of daptomycin has yet to
be elucidated, it was discovered that daptomycin is calcium dependent (Zhang 2015, Ho et al. 2008). Additionally, binding and
oligomerization are mediated by phosphatidylglycerol, or PG
(Taylor et al. 2017). A lack of PG can result in bacterial resistance.
Phosphatidylglycerol (PG) is anionic at a neutral pH. Because
daptomycin is negatively charged, its insertion into an anionic
material would be inhibited. However, it has been shown that
calcium will facilitate the interaction of daptomycin within anionic

membranes by acting as a middleman, or electrochemical bridge,
to assist binding of oligomers of daptomycin to the membrane
(Zhang 2015, Ho et al. 2008, Taylor et al. 2017).
Cardiolipin (CL) is a membrane lipid associated with bacterial
resistance to the antibiotic.The reason for this is that CL confines
daptomycin to the outer membrane leaflet, thus preventing the
drug from penetrating the inner membrane leaflet and hindering
pore formation. It was also discovered in previous studies that
CL reduces the number of oligomer subunits by approximately
half. Subsequently, bacteria may become more resistant to daptomycin by increasing the content of CL in their cell membranes.
However, inhibition of pore formation may not suffice to prevent
bactericidal action. This is because daptomycin may damage bacteria by more than one mechanism, which has yet to be proven
(Zhang 2014).
Focus in the laboratory enhanced our understanding of daptomycin and how it interacts with various lipids. A phospholipid
layer arranges itself so that its polar, hydrophilic head group cooperates with the water. The fatty acid hydrocarbon tails act in a
hydrophobic manner by resisting the water and directing themselves toward the nonpolar air. Daptomycin is amphipathic, which
means it contains both polar and nonpolar parts. When injected,
it can either interact with the water or the membrane. This certainly aids the antibiotic in integrating effectively and quickly with
a bacterium because it does not require a carrier to enter the
cell. Studies show that Daptomycin is effective in as little as one
hour and this can be attributed to its quick insertion into the cell
(Steenburgen et al. 2005).
It would be necessary to research how many molecules of daptomycin interact with the water, and how many molecules interact
with the membrane. If the antibiotic does, in fact, insert into the
membrane, an increase in surface pressure would be expected due
to a more compact and crowded surface. Based on pressure, it can
be determined how effectively daptomycin inserted.
The lipids used in our laboratory were sought to mimic the
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bacterial cell membrane.The primary subphases used in our studies
and in other studies as well were Ultrapure water and buffer. The
buffer was used as a comparative subphase commonly exposed to
bacteria and blood in the human body. pH, in both subphases, are
similar enough to suggest that no inconsistency will result, even
with the slight differentiation between a pH of 7 for the water and
7.4 for the buffer. Langmuir monolayer studies provided us with the
information necessary to determine the nature of the lipids and
how daptomycin interacts with the various lipids.
Langmuir monolayer studies provide useful information other
than just surface pressure. Despite the 2-D nature of the monolayer, the molecules in monolayers exist in states that are analogous to that of the 3-D nature of liquids, solids, or gases. Just as
changing the pressure of a gas can change its phase, changing the
surface pressure of monolayer can do so as well. Surface pressure is a measure of the various forces between the molecules
of a monolayer. As pressure is often plotted against volume at a
constant temperature, so too surface pressure is plotted against
the mean molecular area. The mean molecular area is the average free space each molecule in a monolayer must occupy. It can
be viewed as the analog of volume- just as surface pressure is
the analog of pressure. As the molecules get closer, increased interactions change the surface pressure. A surface pressure-area
isotherm gives information about a monolayer such as its phase
and degree of interaction between the molecules.When the molecules in a Langmuir monolayer are spread very far apart, they
exert little force on one another. This, conceptually, is similar to
that of a gaseous state. In the gas phase, surface pressure is almost
undetectable. The behavior of the gaseous phase is treated as a
parallel to the ideal gas law, where PV=nRT. As the monolayer is
condensed, the molecules can enter a transition into the liquid
state.There are two stages in the liquid phase- the liquid-expanded phase (LE phase) and the liquid-condensed phase (LC phase).
In the LE phase, the π-A isotherm displays some curvature and
liftoff from π=0. As compression progresses, the molecules enter
a coexistent LE-LC phase, where the LE and LC phases are at
equilibrium with each other, displayed by a somewhat horizontal
line. The LC phase is typically marked by a steep slope, when the
molecules are compressed even further. Increased interaction between the tails occur, thereby causing a more “solid-like” phase to
transpire. Further compression of the monolayer can result in an
actual solid-like phase. However, further compression is extremely difficult and the molecules strongly interact with each other
until they reach the final phase where they collapse. The place of
collapse informs us of the extent of pressure the molecule can
withstand (Zhang 2014).

Materials and Methods
All experiments took place on a Langmuir Trough, which consisted of movable barriers. The Langmuir trough is filled with a
liquid called the subphase, typically water or buffer. The lipids
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were deposited on the surface dropwise. This dropwise technique is called “spreading” and involves a certain degree of manual skill (Zhang 2014). Movable barriers compress and expand
over the spread monolayer, altering the density of the molecules
on the surface. This change in density resulted in changes in the
surface pressure, which was detected and evaluated.
To ensure that the machine would consistently hold pressure,
the barriers were tested and then assigned to lie in a specific
orientation during every experiment. The softwares used along
with our MicroTrough were the complementary KSV NIMA and
Kibron softwares (Figures 1A and 1B). Ultrapure, distilled, and
R1 water were used for both cleaning (the machines and the
probe) and for the subphase. Ultrapure water and R1 were obtained through the Millipore Direct-Q 3 with UV Ultrapure.The
KSV NIMA Langmuir trough was disassembled and thoroughly
cleaned with R1 water, ethanol, and rinsed off with R1 once
more before and after every run. The probe was rinsed with
R1, ethanol, and R1, as well. Once water or buffer was added to

Figure 1A. KSV NIMA Langmuir Trough used in our laboratory for
the experiments conducted.

Figure 1B. Kibron Langmuir Trough used in our laboratory for the
experiments conducted.
the trough, the machine was calibrated by zeroing the balance.
The probe was raised out of the subphase to verify accurate
reading, after which it was inserted back into the subphase. The
surface was aspirated to remove any foreign substances. The
Kibron Langmuir trough followed a similar protocol, however,
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the probe was sterilized via a bunsen burner.
In addition to the standard trough used to carry out the
procedures in the laboratory, a modified trough was used, as
well. This trough contained a reduced and depressed area upon
which the subphase could reside. It included a small cavity that
was useful for insertion of daptomycin into the subphase. The
cleaning measures did not differ from the standard procedures.
Buffer or water served as the subphase and was applied to the
trough. A mini stirrer was positioned within the indented area
in order to stir the subphase. Lipid was meticulously applied to
the surface until a surface pressure of 5 mN/m or 10 mN/m was
achieved. Following that, 16 µl of 10 mM daptomycin was injected into the subphase, using a Stuart Pipette. Once stabilization
of surface pressure was attained, 5 µl of 1.6 M calcium buffer
solution was injected into the subphase using a Stuart Pipette
with a changed tip.
Daptomycin was acquired from Teva Pharmaceutical. The buffer that was used was a concentration of 100 mM NaCl and
10 mM Hepes, reaching a pH of roughly 7.4. To accomplish this,
2.383 grams of Hepes and 5.844 grams of NaCl were measured
out. They were then combined to dissolve until the neck of a 1L
volumetric flask filled with Ultrapure water. The solution was
then placed in a 1L beaker and evaluated with an electronic
pH meter. Via a Pasteur pipette, the pH was adjusted by adding
NaOH and HCl, respectively.
All lipids used were obtained in pure form from Avanti Polar
Lipids Inc. The lipids were prepared by dissolving 10 mg of lipid
in a 10 mL flask containing 3:1 chloroform methanol, resulting
in 1:1 mg/mL of lipid. All pipettes and other volume measuring
materials were tested for precision and accuracy.
Hamilton syringes were used to apply the lipid solution.
Chloroform was used to clean the syringes which were cleaned
consecutively approximately 5-10 times. For the KSV NIMA,
lipid solution was distributed by using a 50 µL syringe which was
filled with 15 µL of lipid. To distribute solution to the Kibron,
we used a smaller syringe filled to 8 µL. While administering
the lipid solution, the individual applying it would be cautious
to do so quickly and with minimal contamination (i.e. breathing,
sneezing, and coughing).This is crucial because the machine cannot distinguish between molecules of the lipid and molecules of
the contaminant. Start was delayed by 10 minutes to allow for
the lipid to spread.
The experiments focused primarily on lipids such as cholesterol, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1,2- dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3- phospho-(1’-rac-glycerol) (DPPG), 1,2- dimyristoyl-sn-glycero-3-phosphocholine (DMPC), and 1,2-dimyristoyl-snglycero-3-phospho-(1’-rac-glycerol) (sodium salt) (DMPG).
Our preliminary experiments sought to calculate the surface
pressure (π) over Å2/molecule for pure cholesterol, pure POPC,
pure DPPC, pure DMPC, pure DPPG, 50% cholesterol/50%

DPPC, 50% cholesterol/50% DMPC, and 50% cholesterol/50%
DPPG. Our research then shifted its focus toward DMPG and
its interaction with the daptomycin.

Results/Discussion:
Cholesterol Monolayer
Figure 4 shows the surface pressure-area (π-A) isotherm
obtained for a pure cholesterol monolayer. The curvature of

Figure 3A. Cholesterol.

Figure 3B. POPC.

Figure 3C. DPPC.

Figure 3D. DMPC.

Figure 3E. DPPG.

Figure 3F. DMPG.
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the isotherm indicates that cholesterol molecules remained in
a gaseous state upon compression until they sharply enter a
more condensed phase as the compression proceeded.
Following evaluation of our results, it was noticed that a
somewhat steep rise in surface pressure occurred at 45.5 Å2/
molecule. Collapse occurred at 44 mN/m. The relative domain
of cholesterol is quite minimal, attributing to the smaller values
of Å2/molecule.

POPC Monolayer

obtained for a pure DPPC monolayer. Five distinct regions, corresponding to different phases, were seen in the isotherm in a
varying study (Takeshita et al. 2017). These phases have been
assigned as gaseous, LE, the coexistence of LE and LC phases,
and the collapsed phases. The isotherm can be interpreted as
follows: in the gaseous phase, the molecules are random and
disordered, thereby giving rise to insignificant surface pressure.
Once in the LE phase, the molecules are more condensed than
they are in the gaseous phase, yet they are still considered
disordered. In the LC phase, the molecules are more ordered
and densely aligned than they are in the LE phase, causing them

Figure 4. Surface pressure (π, mN/m) vs. area per molecule (MMA)
isotherm of cholesterol monolayer on water obtained in our lab.

Figure 6. Surface pressure (π, mN/m) vs. area per molecule (MMA)
isotherm of DPPC monolayer on water obtained in our lab.

Figure 5 shows the surface pressure-area (π-A) isotherm
obtained for a pure POPC monolayer. Under experimental
conditions, POPC exists in a liquid-expanded (LE) phase during
compression. Further compression would cause the POPC to
exist in a liquid-condensed (LC) phase (Faye et al. 2013). The
isotherm revealed a rise in surface pressure at around 107.5
Å2/molecule, with a steady and smooth curve until a collapse at
around 44 mN/m.
Figure 5 exhibits the curve of a typical unsaturated molecule.
POPC contains a double bond (Figure 3B), rendering it unsaturated. Since unsaturation hinders effective packing of molecules,
the isotherm displays a smooth and continuous curve, lacking

to adopt a somewhat crystalline configuration (Takeshita et al.
2017). Finally, a kink in the isotherm suggests that the monolayer
collapsed.
Due to the saturated nature of DPPC (Figure 3C), the tails
can pack efficiently against one another, causing a phase change
to take place. The isotherm begins with minimal to no surface
pressure, which is indicative of the fact that the molecules are
in the gaseous phase. The DPPC then entered the LE phase at
around 96 Å2/molecule, where the molecules rearranged themselves in a more disordered fashion. Moving onward, it is difficult
to determine where exactly the molecules entered the LE-LC
phase, although perhaps it occurred from 56-72 Å2/molecule.
Nonetheless, that area of the curve is not distinct enough to be
certain that the coexisting phase happened then. It seems that the
LC phase, i.e. the area where the slope steepened, occurred at 70
Å2/molecule. Finally, the monolayer collapsed at around 55 mN/m.

DPPG Monolayer

Figure 5. Surface pressure (π, mN/m) vs. area per molecule (MMA)
isotherm of POPC monolayer on water obtained in our lab.
phase changes.

DPPC Monolayer
Figures 6 illustrates the surface pressure-area (π-A) isotherm
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Figures 7 displays the surface pressure-area (π-A) isotherm
obtained for a pure DPPG monolayer. According to other studies, a “knee” is present at around 75 Å2, until a plateau forms.
Above this plateau, a steep rise in surface pressure occurs upon
decreasing area. There is an apparent coexistence of the LE
phase and LC phase. These observations agree with the typical
anionic nature of DPPG (Figure 3E). Although it should be noted
that the exact position of these transition phases can vary based
on compression rates, subphase conditions, or temperature, as
with every experiment (Kim et al. 2012).
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Figure 7 displays an increase in surface pressure at 75 Å2/

curve) monolayer isotherms. Due to the cohesive forces between cholesterol (Figure 3A) and saturated DPPC (Figure 3C)
(Ohe et al. 2007), the isotherm values are lower than those
expected by the rule of additivity (Cruz Gomes da Silva et al.
2017), however the values are only insignificantly lower.The rule
of additivity informs us of the area that would be occupied if
the lipids were to be mixed ideally. The interaction between
the smooth hydrophobic part of cholesterol and DPPC is due

Figure 7. Surface pressure (π, mN/m) vs. area per molecule (MMA)
isotherm of DPPG monolayer on water obtained in our lab.
molecule. It is difficult to tell where the coexisting LE-LC phase
resides. Still, the slight elevation from 48-56 Å2/molecule may
be attributed to that. The area past 48 Å2/molecule represents
the LC phase.
In another study conducted in our laboratory, 1 M daptomycin solution was tested without lipid. No reaction occurred.
Then, an additional solution of daptomycin with 4 µL DPPG and
2 µL of calcium was prepared. In this experiment, the (π-A) isotherm increased immediately and dramatically, illustrating that
daptomycin requires PG and calcium ions to work effectively.

DMPC Monolayer
Figure 8 establishes the surface pressure-area (π-A) isotherm
obtained for a pure DMPC monolayer. As illustrated by the isotherm, the DMPC monolayer exhibits a smooth and continuous
curve due to its shorter acyl chain (Figure 3D), characterized
by a steady and constant liquid phase for the lipid, lacking phase
changes. The results obtained in our lab follow this pattern of
DMPC’s molecular nature of interaction, with an even curve
beginning to rise at 105 Å2/molecule and a collapse at around
47 mN/m.

Cholesterol-DPPC (1:1) Monolayer

Figure 9. Surface pressure (π, mN/m) vs. area per molecule (MMA)
isotherm of DPPC:Cholesterol (1:1) monolayer on water obtained in
our lab.
to van der Waals forces (Sabatini et al. 2008). Nonetheless, due
to DPPC’s saturated and rigid acyl chain, it is difficult for bulky
cholesterol to penetrate, thus interfering with the molecular
packing and causing DPPC:Cholesterol to occupy less area per
molecule at constant pressure, but not significantly.
Additionally, it can be perceived from the results obtained
that the collapse pressure for pure cholesterol lies at around 40
mN/m, while pure DPPC lies at 52 mN/m, and DPPC:Cholesterol
lies at 50 mN/m. Pure DPPC creates the most stable monolayer
since it is able to withstand the highest surface pressure, as indicated by the higher collapse pressure value. DPPC:Cholesterol
withstood pressure at a value that lies slightly lower than pure
DPPC, due to destabilization of the film via cholesterol.
Lastly, the phase change observed in the DPPC:Cholesterol
monolayer at 48-72 Å2/molecule, has a broader range than the
phase change observed in the pure DPPC monolayer, occurring at 56-72 Å2/molecule. This is because cholesterol serves
as a contaminant or impurity, which broadens the phase change
upon compression.

Cholesterol-DMPC (1:1) Monolayer

Figure 8. Surface pressure (π, mN/m) vs. area per molecule (MMA)
isotherm of DMPC monolayer on water obtained in our lab.
Figure 9 showcases the surface pressure-area (π-A) isotherm
obtained for a DPPC:Cholesterol (1:1) monolayer (red curve),
relative to pure cholesterol (green curve) and pure DPPC (blue

Figure 10 displays the surface pressure-area (π-A) isotherm
obtained for a DMPC:Cholesterol (1:1) monolayer (green curve),
relative to pure cholesterol (red curve) and pure DMPC (blue
curve) monolayer isotherms. There must be cohesive van der
Waals forces present since the isotherm for DMPC:Cholesterol
illustrates that the DMPC:Cholesterol occupies less area per
molecule at constant pressure, thereby exhibiting lower surface
area values than those expected by the rule of additivity. Despite
the fact that bulky cholesterol interferes with the saturated
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DMPC acyl chain (Figure 3D), the chain is nevertheless shorter

Figure 10. Surface pressure (π, mN/m) vs. area per molecule
(MMA) isotherm of DMPC:Cholesterol (1:1) monolayer on water
obtained in our lab.
than DPPC’s chain. Thus, between DPPC and DMPC, effective
packing of cholesterol is more likely in DMPC.
Additionally, it can be observed from the results obtained that
the collapse pressure for pure cholesterol lies around 40 mN/m,
while pure DMPC lies at 48 mN/m, and DMPC:Cholesterol
lies at 45 mN/m. Pure DMPC creates the most stable monolayer since it is able to withstand the highest surface pressure, as indicated by the higher collapse pressure value. Like
DPPC:Cholesterol, DMPC:Cholesterol withstood pressure at a
value that lies slightly lower than pure DMPC, due to destabilization of the film via cholesterol.

that the collapse pressure for pure cholesterol lies at around 40
mN/m, while pure DPPG lies at 55 mN/m, and DPPG:Cholesterol
lies at 52 mN/m. Pure DPPG creates the most stable monolayer since it is able to withstand the highest surface pressure, as indicated by the higher collapse pressure value. Like
DPPC:Cholesterol and DMPC:Cholesterol, DPPG:Cholesterol
withstood pressure at a value slightly lower than pure DPPG,
due to destabilization of the film via cholesterol.
Lastly, the phase change observed in the DPPG:Cholesterol
monolayer at 45-58 Å2/molecule, has a more broad range than
the phase change observed in the pure DPPG monolayer, occurring at 48-56 Å2/molecule. This is because cholesterol serves as
a contaminant or impurity, which broadens the phase change
upon compression.

DMPG Monolayer Injected with Daptomycin
Daptomycin was put to the test, as portrayed in Figure 12. For
the experiment, DMPG was injected at that start with a steady
surface pressure achieved.At around 400 seconds, daptomycin was
injected and surface pressure increased to 12 mN/m until levelled
out. At 835 seconds, calcium solution was injected and surface
pressure increased to 20 mN/m.
Based on our results, it appears that daptomycin penetrated the
DMPG at 400 seconds, indicated by an increase in surface pressure,
even without the presence of calcium. As discussed, daptomycin
is calcium dependent. We would need to continue exploring this

Cholesterol-DPPG (1:1) Monolayer
Figure 11 displays the surface pressure-area (π-A) isotherm
obtained for a DPPG:Cholesterol (1:1) monolayer (green
curve) relative to pure cholesterol (blue curve) and pure DPPG
(red curve) monolayer isotherms. DPPG and cholesterol in the
1:1 mixture are repelling one another, as the DPPG:Cholesterol
occupies more area per molecule, thereby displaying higher surface area values than those expected by the rule of additivity.
This repulsion is perhaps due to the negative charge present on
DPPG and due to its longer acyl chain (Figure 3E).
Furthermore, it can be observed from the results obtained

Figure 12. Results of surface pressure (π, mN/m) vs. time (s) interaction of daptomycin with DMPG on subphase of water obtained
in our lab. DMPG applied, then daptomycin injected, followed by
insertion of calcium solution.
wondrous enigma as to why or how daptomycin inserted into the
membrane even when calcium was not yet present.

Conclusion and Future Studies:

Figure 11. Surface pressure (π, mN/m) vs. area per molecule
(MMA) isotherm of DPPG:Cholesterol (1:1) monolayer on water
obtained in our lab.
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The extent to which daptomycin inserts itself into the membrane was observed. How this correlates to effectiveness may
be the object of further research subsequent to the findings of
the experiments performed. For example, if daptomycin does
not penetrate the membrane at all, then a new experiment
may be suggested to show that the lack of insertion may have
been the cause of ineptitude. On the other hand, if the drug
inserts well, then an experiment may be pursued to determine
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if successful insertion may be the cause of effectiveness.
Moreover, using the Gibbs Adsorption Isotherm for daptomycin in water, we can determine the concentration of daptomycin
in contact with the surface, which in turn alters the surface
tension. Additional experiments would have to be conducted to
determine such a phenomenon.
Lastly, in keeping with daptomycin’s ability to treat MRSA,
some mutant strains of MRSA were found to be resistant to
daptomycin. As such, analogs of daptomycin may be studied to
determine if they might find a way to insert into MRSA with altered surface proteins, since those would be considered mutant.
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Abstract
Arthritis is a debilitating disease where joint inflammation occurs. There are different types of arthritis, such as Osteoarthritis and
Rheumatoid Arthritis. Osteoarthritis is the destruction of the articular cartilage that usually comes with age, whereas Rheumatoid
Arthritis is a chronic autoimmune disease. They both have symptoms which include reduced range of motion, pain and swelling.
There are various treatments to alleviate the pain and reduce the inflammation of arthritis. Among them are medication, physical
therapy, surgery and a whole food, plant-based diet. The whole food, plant-based diet yields the best results and is the most
effective and practical.
Introduction
evening and night hours and is a cool pain rather than hot.
Arthritis is a disease characterized by joint inflammation that
causes discomfort and eventually intense pain along with stiffness of the joints. Other symptoms include reduced range of
motion, muscle weakness, redness, and swelling. These symptoms can come and go at different intensities. Arthritis is also
characterized as a musculoskeletal disorder (Carter & Rizzo
2007). Arthritis is twice as common in women than in men;
however, men and children of all ages can experience it as well
(Lourdudoss et al. 2018). Though there are various kinds of
treatments that can alleviate the pain of arthritis, many say that
arthritis cannot be cured. It is a chronic disease that causes
pain, but that one can live a lifetime with. Between the years
2013 and 2015, approximately 54.4 million adults had arthritis,
of which 23.7 million adults were limited in activity. Arthritis
affects approximately a sixth of the American population today
and is predicted “to affect 78.4 million people by 2040” (Barbour
et al. 2017) (Juyoung et al. 2018).
There are many types of arthritis, some that occur in many
joints at once or other types that are isolated in one joint.
Arthritis can be found in the ankles, fingers, wrists, back, jaw,
and neck. Different causes give rise to different types of arthritis. Osteoarthritis and Rheumatoid Arthritis are two of the
most common types. The most rampant musculoskeletal disease amongst the elderly is Osteoarthritis (Hinman et al. 2007).

Along with Osteoarthritis comes crepitus which is a grinding,
clicking, or popping movement of the joint accompanied by a
sound (Witulski et al. 2014). Osteoarthritis is most commonly
found in elderly people, due to the wear and tear of many years
of living. It has a relatively slow onset that worsens with age
(Azumasa & Misako 2017).

Osteoarthritis

Methods

Osteoarthritis is when the articular cartilage begins to wither away and eventually disintegrates. The articular cartilage
allows for painless joint movement through load distribution
and reduces friction between the bones. In Osteoarthritis, the
bones rub against each other which can cause extreme pain.
For example, a person with Osteoarthritis of the knee will have
difficulty walking and climbing the stairs. Researchers believe
that the cartilage destruction has a chemical and mechanical
cause; however, the direct mechanism is unknown. Mechanical
factors that can increase the risk of Osteoarthritis are obesity, heavy lifting, abnormal loading of joints from trauma, and
joint instability (Beasley 2012). Osteoarthritis is asymmetrical,
meaning that if one experiences pain in a joint on one side of
the body, this does not mean that they experience it in the
same joint on the other side. The pain is most intense in the

The Touro College Online Library allowed access to Ebsco and
Proquest which were the two databases used to find the proper
scholarly articles needed. Analysis of these studies helped develop the answer to whether or not a whole food, plant-based
diet is the most effective treatment of arthritis.
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Rheumatoid Arthritis
Rheumatoid Arthritis is different in that it’s a chronic autoimmune disease. The body attacks itself causing inflammation
of the joints, which overtime erodes the bones. Normally,
joints have synovial fluid which provides lubrication. In
Rheumatoid Arthritis the synovial fluid becomes less viscous,
causing further cartilage damage because of the reduced joint
lubrication (Beasley 2012). In contrast to Osteoarthritis,
Rheumatoid Arthritis most often occurs symmetrically, meaning that if one has arthritis in the left shoulder, they usually
also have it in the right shoulder as well. Further, the sites
of Rheumatoid Arthritis are warm, and sufferers experience
the most pain during the morning hours. The flare ups of
Rheumatoid Arthritis are random unlike the constant pain of
Osteoarthritis. The symptoms of Rheumatoid Arthritis can
get better, only to worsen again. Rheumatoid arthritis can be
found in people of all different ages.

Discussion
Treatments of Arthritis
Popular treatments of arthritis include medication, physical
therapy and sometimes surgery.
Another less popular but
interesting approach is a whole food, plant-based diet. Studies
have shown that a whole food, plant-based diet can alleviate the
pain and possibly cure arthritis. This paper will try to answer
the question: is a whole food, plant-based diet actually the most
effective treatment of arthritis?

Is a Whole Food, Plant-Based Diet the Most Effective Treatment of Arthritis?

Medication
Although various medications are anti-rheumatic, they come
along with many possible negative side effects as well. Names
of different arthritis medications are Leflunomide, Sulfasalazine,
Methotrexate, Etanercept, Adalimumab, Anakinra, Canakinumab,
Abatacept, Infliximab, Rituximab, and Tocilizumab. Leflunomide
and Sulfasalazine can be taken orally. Methotrexate can be
taken orally or given as an injection. Etanercept, Adalimumab,
Anakinra, and Canakinumab all only come in an injection form.
Abatacept, Infliximab, Rituximab, and Tocilizumab can only be
given intravenously. Some of the common side effects are included below (Table 1). While medication may alleviate the pain
of arthritis, the patient may have to deal with other annoying
and sometimes painful side effects (Brinkman et al. 2017).
Another downside of taking medication is the cost, which can
be very high without insurance. For example, Etanercept costs
around one thousand dollars per weekly injection (Brinkman
et al. 2017).

Common Medications Used to Treat Arthritis
and Their Side Effects
Medication

Common Side Effects

Leflunomide

Headache, diarrhea, upset stomach, cold symptoms

Sulfasalazine

Headache, diarrhea, upset stomach, cold symptoms

Methotrexate

Headache, upset stomach, mouth sores, nausea

Etanercept

Headache, upset stomach, sinus infection, common
cold, itchy or allergic rash, redness or soreness
where needle enters skin

Anakinra

Headache, upset stomach, sinus infection, common
cold, itchy or allergic rash, redness or soreness
where needle enters skin

Adalimumab

Headache, upset stomach, sinus infection, common
cold, itchy or allergic rash, redness or soreness
where needle enters skin

Canakinumab

Headache, upset stomach, sinus infection, common
cold, itchy or allergic rash, redness or soreness
where needle enters skin

Abatacept

Headache, upset stomach, common cold, sinus or
throat infection

Rituximab

Headache, upset stomach, common cold, sinus or
throat infection

Infliximab

Headache, upset stomach, common cold, sinus or
throat infection

Tocilizumab

Headache, upset stomach, common cold, sinus or
throat infection

Table 1. Medications retrieved from www.cincinnatichildrens.org
Arthritis Medication Choice Cards

Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
These drugs are preferred to treat arthritis over acetaminophen,

aspirin and mild opiates. Many people often take aspirin for
arthritic pain and although it mitigates the pain, they get gastrointestinal toxicity from it. This gastrointestinal toxicity inhibits
NSAIDs and thus the preferred medical treatment cannot be
used (Lisse et al. 2003).

Disease Modifying Anti Rheumatic Drug
Another approach to healing Rheumatoid Arthritis is a modern
type of drug known as a disease modifying anti rheumatic drug.
This type of drug suppresses the immune system to inhibit the
body from attacking itself and causing joint inflammation. It was
designed to get rid of pain and tenderness of the joints and
improve joint function long term. Yet, this was true for only
10-50% of patients treated with this drug. Many Rheumatoid
Arthritis patients still suffer intense pain (Winkvist et al. 2018).
Because of this result, disease modifying anti rheumatic drugs
do not sound promising.

Physical Therapy
A study was done where the physical therapists did exercises
with the arthritis patients. At the end of the treatment period
they saw improvement in grip strength. Physical activity improved the functional status of arthritis patients. Some therapists use a paraffin wax bath for distal joints to reduce pain. The
moist heat of the wax soothes the joints and makes the exercise
of physical therapy less painful (Shinde & Varadharajulu 2017).
This study is not an accurate assessment of a good treatment
for arthritis. The study was flawed in that their subjects ranged
from ages twenty to fifty-five. While the physical activity may
improve the symptoms of younger and middle-aged people, it
probably would not have the same effect on the elderly. Elderly
bodies are often fragile and worn out. It is harder for old people to recover from diseases. This study does not effectively
prove that physical therapy is the most effective treatment for
arthritis across the board.

Hydrotherapy
In addition to traditional physical therapy, hydrotherapy, physical
therapy done in an aquatic environment, is another treatment
for arthritis. During hydrotherapy, physical therapists treat patients through exercises in heated pools. There are multiple
benefits of hydrotherapy that standard physical therapy does
not have. Firstly, “buoyancy reduces loading across joints affected by pain and allows the performance of functional closedchain exercises that otherwise may be too difficult on land.”
Another benefit is that the water movement and pressure can
be used as resistance which makes the exercises more effective.
Furthermore, pain relief, swelling reduction, and ease of movement increase due to the warmth and pressure of the water.
The warm water leads to muscle relaxation, enhancing movement (Hinman et al. 2007).
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Electrotherapy
Electrotherapy is another effective form of physical therapy:
“Electrotherapy consists of the application of electrotherapeutic procedures (ionization and ultrasound) to the affected
regions, with an analgesic, anti-inflammatory and decontracturing indication” (Tosa et al. 2016). It uses electrical energy as
a medical treatment and reduces inflammation and decreases
pain. Electrotherapy is amongst the most frequently used physical therapy treatments of Rheumatoid Arthritis.

Analysis of Physical Therapy
Different kinds of physical therapy can be helpful in treating
arthritis; however, physical therapy is often not so practical.
Physical therapy is costly and Medicare may limit access or coverage of services like these. Thus, elderly patients with arthritis
are less likely to receive physical therapy (Carter & Rizzo 2007).
Hydrotherapy is costly and pools are not always accessible in
every community. Hence, hydrotherapy is not available for all
arthritic patients. Additionally, although hydrotherapy somewhat
reduced the pain in Osteoarthritis patients, studies have shown
that after six weeks of treatment the pain relief was minimal.
Hydrotherapy only reduced pain, stiffness and hip strength
slightly. Therefore, it appears that hydrotherapy is not the most
effective treatment of arthritis (Hinman et al. 2007).

Joint Replacement Surgery
Joint replacement is another approach to healing arthritis, yet
this option is a last resort for most people. People get joint
replacements once the articular cartilage is almost completely
destroyed and they are in a debilitating state. A preventative
cure is more preferred (Clinton et al. 2015).

Whole Food, Plant-Based Diet
Whereas all the treatments mentioned thus far were costly, an
effective approach called the whole food, plant-based diet is inexpensive. Besides for being affordable, this method of treating
arthritis is also doable, practical, and easy. Anyone can do it; it
does not require higher education. A study was done where
patients with arthritis kept a whole food, plant-based diet and
eliminated meat and dairy foods for six weeks. Researchers
observed that the patients’ Rheumatoid Arthritis symptoms decreased while the patients were off of meats and dairies. The
whole food, plant-based diet has been shown to improve the
pain and other symptoms of Osteoarthritis patients as well.
After only the first two weeks of this six-week study researchers saw clinical results. This demonstrates the diet’s effectiveness in lessening the pain, and the pain got less and less as time
went on. After being on a whole food, plant-based diet, people
had increased levels of alpha and beta carotene, lycopene, lutein,
vitamin C and vitamin E in their sera. These are all beneficial
and healthy antioxidants or vitamins. According to the USDA
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pyramid, a human should ingest solid and liquid animal protein
daily, such as meats and dairies. This is not in accordance with
the whole food, plant-based diet (Clinton et al. 2015).

Arachidonic Acids and Omega-3 Fatty Acids
Arachidonic acids are precursors to proinflammatory eicosanoids and prostaglandins and are found in cell phospholipids.
Prostaglandins are hormones that are created during chemical
reactions due to an injury or disease and they can increase inflammation. An eicosanoid is a signaling molecule that can increase inflammation as well. More than 80% of ingested arachidonic acids are used to produce eicosanoids (Adam et al. 2003).
Animal products are high in arachidonic acids whereas a whole
food, plant-based diet is low in arachidonic acids. By keeping
to a diet low in arachidonic acids, inflammation in patients with
Rheumatoid Arthritis can decrease (Clinton et al. 2015).
Studies show that Omega-3 fatty acids reduce arthritic pain.
Omega-3 fatty acids from fish oil stop the formation of cytokines and eicosanoids. This is because they compete with the
Omega-6 fatty acids for a spot in the cell phospholipids and
for the binding sites of cyclooxygenase and lipoxygenase. Since
the eicosanoids cause inflammation, eating Omega-3 fatty acids
reduces inflammation, reducing arthritic pain (Adam et al. 2003).
In a study, Omega-3 fatty acid levels were highest in the
serum of whole food, plant-based dieters. Omnivores and fish
eaters had less Omega-3 fatty acids. Alpha-linoleic acid is found
in legumes, vegetables and soy. When alpha-linoleic acid is metabolized, it produces anti-inflammatory prostaglandins. These
anti-inflammatory prostaglandins help reduce arthritic symptoms (Clinton et al. 2015).
There was a study done over the span of eight months, in
which the subjects were divided into two groups. One group
was put on an anti-inflammatory diet and the other on a western diet. There was a positive correlation between arachidonic
acid consumption and the percent of arachidonic acids in erythrocyte lipids. Those on an anti-inflammatory diet (AID), where
they ate a minimal amount of animal products, had a lower percent of arachidonic acids in their blood than those on a western
diet (WD) (Adam et al. 2003).
Populations with high fish consumption include the Alaskan
Natives, Greenland Eskimos, and Japanese living in villages
where fishing is constant (Zheng et al. 2012). In these areas,
the percent of arachidonic acids in plasma phospholipids was
approximately 2%, whereas in industrialized countries it was
approximately 16% (Adam et al. 2003). Rheumatoid Arthritis is
not nearly as prevalent in populations with high fish consumption as it is in industrialized countries due to the Omega-3 fatty
acids in fish.
In the eight-month study mentioned above, in addition to the
diet they were instructed to follow, some subjects in each group
received placebo or verum pills and some fish oil capsules.
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Those in the anti-inflammatory diet group who received the
placebo had a 14% decrease in tender and swollen joints collectively. Those in the anti-inflammatory diet group who received
fish oil had a 28% decrease in tender joints and a 34% decrease
in swollen joints. Those in the western diet group who received
fish oil had an 11% decrease in tender joints and a 22% decrease
in swollen joints. Overall, the anti-inflammatory diet with a fish
oil capsule decreased the tenderness and swelling of joints
more than the western diet with a fish oil capsule. It is also
clear that the fish oil which is rich in Omega-3, had an effect and
decreased the tenderness and swelling of the joints more than
the placebo did (Adam et al. 2003).
Two different capsules were administered to patients that
were not real fish oil. The placebo was corn oil and the verum
was menhaden oil. Even without fish oil, which has a greater effect than the other oils, the anti-inflammatory diet is significantly
more effective in reducing symptoms of arthritis than the western diet is. This is a good study, adequately proving how a diet low
in arachidonic acids and including fish oil supplements can greatly
alleviate pain, improve arthritic symptoms and reduce production
of eicosanoids and cytokines (Adam et al. 2003).
Another study compared two groups. One group kept to an
ordinary, omnivorous diet, while the other kept to a whole food,
plant-based diet. The results were that the whole food, plantbased diet caused the swelling of the joints to decrease, less pain
and increased functional status. Compared to the omnivorous
diet, the whole food, plant-based diet was more effective in pain
reduction (Clinton et al. 2015).
As an added bonus, a whole food, plant-based diet can result
in weight loss and blood pressure reduction (Silberman et al.
2010). Excess weight can add abnormal mechanical stress on
the knee joint; obesity makes arthritis worse (Cianflocco 2011).
As a result of weight loss, the mechanical load on arthritic joints
decreases, alleviating the pain caused by arthritis (Messier et al.
2005). Knee Osteoarthritis symptoms can greatly improve even
from small weight losses (Bartlett et al. 2004). For someone
with arthritis in the knee, “for every pound of weight lost, there
is a four-pound reduction in mechanical load exerted on the
knee during daily activities” (Clinton et al. 2015).
Due to articular cartilage disintegration there is a loss of
space between the femur and tibia in this Osteoarthritis patient.
The bone rubbing against bone can cause extreme pain to this
patient. The more weight the patient has to carry around on
that knee, the more the bones will rub and the more pain there
will be (Cianflocco 2011). For this reason, it is worth attempting to lose weight through a whole food, plant-based diet.
It is a common misconception that a diet without animal
protein causes malnutrition. A whole food, plant-based diet
provides enough protein, fats, vitamins, minerals and calories
(Clinton et al. 2015).

Conclusion
After analyzing the different treatment options to alleviate the
pain of and possibly cure arthritis, it is apparent that the whole
food, plant-based diet has the most promising results. One on
this diet must not eat any animal proteins in order to maintain a
low level of arachidonic acids to prevent or reduce inflammation.
Along with this diet, dieters should take fish oil capsules for better results. Fish oil contains Omega-3 fatty acids which further
reduce inflammation and prove beneficial to those with arthritis.
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Abstract
Symptoms of acute Infectious Mononucleosis (IM), which develops after Epstein-Barr virus (EBV) in half the cases, is strikingly like
those of Hodgkin’s Lymphoma (HL).This, combined with the findings that many patients with HL had a history of EBV and/or IM,
triggered an interest in scientists to learn if the two were biochemically related. Many studies in this field unanimously concluded
that the development of IM after EBV infection presented a higher risk of developing HL. However, whether this relationship is
coincidental or pathological remains a matter of controversy until this day. In the last decade, there has been a lot of research and
advances in this field.Various studies have looked at the correlation of EBV and HL considering age factors, genetic predispositions,
and immunity and susceptibility dynamics. Researchers discovered that development of HL after EBV was most prevalent in
young adults and old patients, pointing to immune system function, or lack thereof. It was also found to be more common in men,
suggesting that this may be a sex-related disease. Specific genes activated or mutated in both EBV and HL have proposed that
the development of HL after EBV/IM may be genetically regulated. By tracing geminal centre B cell replication patterns, EBV gene
expression, and lytic cycle proteins, different mechanisms for the pathogenesis of HL from EBV were proposed. Various studies
made use of statistics and patients’ medical records to make assumptions. Other methods employed in these studies included
probe hybridization to extract DNA and RNA samples from tumor specimens, flow cytometry and polymerase chain reactions
(PCR) to identify genetic sequences, and immunohistochemistry to study antigens specific to EBV and related diseases.
Introduction
Is there a correlation between Epstein - Barr virus and Hodgkin’s
Lymphoma? If so, what is the nature of this relationship? The
objective of this paper is to briefly discuss some studies which
initially led health professionals to believe that Hodgkin’s lymphoma (HL) is caused by EBV. Then, possible causes and mechanisms which may lead the viral disease to transform infected
cells to malignant tumors will be expounded upon.
The lymphatic system is an important regulatory mechanism involved in the immune response of the body. It is comprised of lymphatic channels which conduct the lymphatic fluid
throughout the body and converge regionally to form discreet
lymph nodes (Freeman and Matto, 2018). The function of the
lymph node is to evaluate and initiate an immune response
when necessary. It functions as an antigen filter consisting of
a multi-layered sinus that successively exposes B-cell lymphocytes and T-cell lymphocytes to an afferent extracellular fluid
(Evans, 1974). B and T lymphocytes are subtypes of white blood
cells that contribute to the immune system. For example, by
secreting antibodies, the B cells thus play a central role in immunity. In addition, T cells exhibit cell-mediated immunity. In
the course of an immune response, where foreign proteins
are recognized and attacked, the immune cell line undergoes
multiplication, thereby causing the lymph node to increase in
size. Generalized or localized lymphadenopathy, an abnormality
in the size or consistency of lymph nodes, is the most common
feature in lymphoproliferative disorders. These disorders refer
to potentially fatal conditions in which lymphocytes are produced in excessive quantities. Included in this broad category of
disorders, are Epstein-Barr Virus, Infectious Mononucleosis, and
Hodgkin’s Lymphoma.
EBV is a tumorigenic double stranded DNA herpesvirus that
commonly develops in the first decade of life of an individual.
It infects more than 90% of the human population worldwide

(Yang, et. al., 2015). EBV consists of the EBV-1 and EBV-2 subtypes, with EBV-1 being more prevalent in western societies.
An immune response consisting of natural killer (NK) cells and
EBV-specific cytotoxic CD8+ T lymphocytes controls the primary infection and reactivation that occurs in all EBV-positive
individuals. While EBV is often found in B cells in its latent episomal form, lifelong persistence of EBV in infected individuals
involves occasional reactivation to the lytic state, resulting in
lyses of infected cells and the release of virus particles which
triggers acute infection (Babcock, et. al., 1998).
Primary EBV infections in children are usually asymptomatic
yet can result in infectious mononucleosis (IM) development in
50% of adolescent patients (Jenson, 1996). It was not until 1968
that EBV was first associated with IM, followed by further research which ultimately confirmed that EBV was a causative agent
of IM. Most of the symptoms of infectious mononucleosis are attributed to the proliferation and activation of T cells in response
to infection. It is characterized by abnormally high numbers of
circulating CD8+ T cells and B cells. Among its many symptoms,
lymphadenopathy and lymphocytosis – abnormal numbers
of lymphocytes in the circulating blood (Sawari, et. al., 2016) acutely resemble HL. In fact, IM is occasionally misdiagnosed as
Hodgkin’s Lymphoma due to the similarity in their symptoms and
small biopsy specimens in the Waldeyer’s ring (WR), which may
be difficult to differentiate (Delecluse, et. al., 2007). This similarity,
among other factors had led researchers to suspect that one disease may derive from the alteration of the other.
According to the World Health Organization (WHO),
Hodgkin’s lymphoma is a disorder characterized by an abnormality in the lymph node’s architecture (Tzankov and Dirnhofer,
2006). HL, also commonly known as Hodgkin Disease (HD), encompasses four histological subtypes, with 40% of sclero-nodular type and 80% of mixed cellularity type carrying the EBV
virus (Delecluse, et. al., 2007). It is comprised of characteristic
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neoplastic cells known as Hodgkin’s Reed-Sternberg (HRS) cells.
These interspersed cells only constitute approximately 2% of
the total tumor mass while the rest of the tumor consists of T
cells, B cells, eosinophils, macrophages, granulocytes, and others
(Yang, et. al., 2015). The classic Hodgkin Reed–Sternberg cells
are large cells with two or more round nuclei.The mononuclear
form is referred to as the Hodgkin cell (Ok, et. al., 2015). HRS
cells communicate with other cells via cell contact dependent
interactions, including proliferative and anti-apoptotic signals
favoring tumor cell survival and expansion. EBV is most commonly associated mixed-cellularity subtype, the most common
type of classical Hodgkin disease.
Using data from discharge records of patients hospitalized for
Hodgkin’s Lymphoma and/or Infectious Mononucleosis, studies
were performed by compiling the prevalence of the disorder
relating to age and gender. Tracking the medical history of these
patients allowed for the determination of how many patients
with HL have a past history of EBV/IM. B and T lymphocytes in
blood of patients with Hodgkin’s disease, infectious mononucleosis, and normal controls were collected and compared. Due
to the rarity of EBV-infected B cells in healthy virus carriers, it
is complicated to analyze them directly (Caldwell, et. al., 1998).
To resolve this issue, Thorley-Lawson developed a method in
which human B cells are separated via flow cytometry, which
works by suspending cells in a fluid and passing them through
an electronic detector. Then, using polymerase chain reaction
(PCR), cells are analyzed for the presence of EBV infection.
Additionally, using, viral DNA and RNA segments from tumor
specimens were extracted and studied via southern blot hybridization with probes speciﬁc for parts of the EBV genome.
Reverse transcriptase of RNA can also be used to identify the
genetic sequence of specific genes (Khan, et. al., 1996). EpsteinBarr virus’ early RNA transcripts were detected in tumor tissues, via fluorescein-labeled oligonucleotides complementary to
the RNA sequence. The fragments were then visualized under a
microscope by tetramethyl rhodamine isothiocyanate (TRITC),
a bright orange-fluorescent dye. Other studies have applied
immunohistochemistry techniques, the detection of antigens in
cells of a tissue by introducing antibodies binding specifically to
these proteins. Finally, experiments with transgenic mice were
useful for studying genes. Control and experimental groups of
mice were infected with either wild type (WT) or knockout
(KO) genes to see how they affect the course of the disease.

Discussion
It is generally held that a lymph node is considered enlarged when
it is larger than 1 cm, however, this can vary depending on the location of the node and the age of the patient (Cheng and O’Connor,
2017). Patients with a diagnosis of EBV, IM, and HD presenting with
lymphadenopathy, were studied. The goal was to determine if and
how these diseases are correlated. Different propositions as to
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the nature of their relationship have been reviewed.
Using data from the Oxford Record Linkage Study (ORLS),
a cohort of 2797 patients admitted to the hospital with an
International Classiﬁcation of Diseases (ICD) code for infectious mononucleosis on the discharge record were studied.
Patients studied were mostly ages <20-30 at the time of admission. Admission was substantially more common in males than
in females. Those with a diagnosis of cancer either before or at
the same time as admission for IM were excluded. Tracking the
medical records of these patients showed an increased risk for
the development of HD with a relatively short follow up period
ranging from 1-7 years post discharge (Goldacre, et. al., 2008).
A similar study looked at 233 cases of HL in children recorded
between 1957 and 2001. Reliable data concerning the onset of
symptoms was available in 172 cases, and in 31 of these patients,
EBV status was unknown. Of the 141 tumors, 69 (48.9%) were
EBV-positive (Reiman, et. al., 2003). In another unrelated cohort
study on young adults, it was indicated that individuals who had
a history of IM were three times more likely to develop HL
(Jarrett, 2003). The incubation period of infectious mononucleosis after EBV was observed to be between 32 and 49 days.
(Balfour, et. al., 2015).The follow up period between EBV and HL
varied with different genders, ethnic groups, and age.
Both IM and HL typically develops in adolescence and early
adult life. In fact, the development of IM after EBV is now considered to be a risk factor for Hodgkin’s disease. However, the
nature of this association remains unclear. Examining blood
samples from patients with HD, showed EBV latency in B cells.
However, it must be noted that not all subtypes of HL harbor
EBV to the same degree. Some data suggests that the incidence
of EBV-positive HL may be age-related. The observed age-incidence pattern suggests that risk of HD is increased among
younger people, with a peak in incidence at 25 to 30 years and a
second rise after the age of 45 (Khanna, et. al. 1995). An increase
in the severity of infection in young patients leads to the development of cancer. In one study, a similar pattern was recorded
among aging patients suggesting that the immunologic status of
the patient plays a crucial role in the subsequent development
of pathologies (Mueller, 1987). Dr. Evans proposed that perhaps
HD represent the host’s response to an EBV infection that is
delayed until adolescence/early adulthood (1974). Another plausible explanation would be that HD develops as a secondary
response in patients with genetic susceptibility, low immunity,
or a combination of both.
A study was done in which a samples of B and T lymphocytes
in patients with HD, IM, and a normal control were analyzed.They
then compared the results of each group to the others. In overall counts, the number of T lymphocytes significantly exceeded
that of B cells. However, while in infectious mononucleosis the
count of T-lymphocytes was elevated, there was a slight reduction
in Hodgkin’s Disease. It was also observed that in patients with
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HD there was an increase in the number of DNA synthesizing
lymphocytes was found when compared to normal controls. The
ability of the disease to persist despite potential immune responses against it indicates that the virus has invented pathways to
evade the immune system. Also, untreated patients differed from
their treated peers in their absolute lymphocyte counts; treated
patients presented with a lower number of DNA-synthesizing
blood lymphocytes. Cells observed in the blood of patients with
Hodgkin’s disease and infectious mononucleosis were indistinguishable. Based on these findings, it was inferred that transformed lymphocytes represent normal lymphocytes that have
undergone a proliferative response signaled by tumor surface
antigens or viral infections (Huber et. al.1975).
EBV-associated lymphoproliferative disorders (LPDs) are
life-threatening diseases commonly found in those with a compromised immune system, especially children. T-cell dysfunction
can cause development of mature B-cell lymphoma by impairing
immune function. Additionally, a partial lytic infection plays a role
in EBV-induced B-cell tumors. Although the main targets of EBV
are B cells, EBV may also infect other cells, such as T cells and
epithelial cells (Rickinson and Kieff, 2001).
Once infected, EBV persists in rare peripheral blood lymphocytes for the rest of the host’s life, usually as a harmless passenger
residing in B cells (Ohashi, et. al., 2012). Since there is limited viral
protein expression in the latent form, EBV reduces the number
of viral proteins that permit the recognition of infected cells by
cytotoxic T cells. During its reactivation, which takes place during
the lytic life cycle, memory B cells are activated and differentiate
into plasma cells. People who have EBV can transmit the disease
through oral secretions because the virus replicates in cells in
the oropharynx. Generally, the number of infected lymphocytes is
stable over time. However, in rare instances, infection of epithelial
cells by EBV in vitro results in active replication, and consequently,
lysis of the cell which spreads the virus to other cells (Cohen,
2000). Although the primary site of virus replication is in the
pharyngeal epithelium, circulating B lymphocytes can become infected too, thereby generalizing the infection. In B cells, persistent
infection can transform the cell, which may result in the development of malignant lymphomas, especially Hodgkin lymphoma. Like
all herpes viruses, EBV has latent and productive (lytic) phases in
its life cycle (Niedobitek, et. al., 2001). Therefore, EBV establishes
a life-long infection in individuals which is generally harmless unless the host–virus balance is upset. The latent genes which keep
the virus in the host’s B lymphocytes induce immortalization and
oncogenic potential too. EBV differs from other herpes viruses
though in its capacity to transform B cells. Latent infection of B
cells by EBV in vitro can result in a transformation to lymphoblastoid cells, thereby leading to immortalization of the cells. In
fact, the International Agency for Research on Cancer classified
EBV as a group 1 carcinogen.
In more recent years, studies of tissue cultures of Epstein-Barr

virus growth in peripheral blood lymphocytes has shed some
light on the molecular events associated with B cell growth
transformation and virus replication (Ohashi, et. al., 2012). Studies
have shown that the main type of EBV-associated B-cell lymphoma — that is, Hodgkin lymphoma— seems to derive from
germinal-Centre B cells, a structure found in lymphoid tissues
that is composed of proliferating B cells. This indicates that EBVinfected germinal-Centre B cells are at the greatest risk for malignant transformation (Küppers, 2003). After B cells are infected,
virus–receptor interaction induces activation of the infected cells
which enter the mitotic cycle, leading to lymphoblastoid cell lines
(LCLs). LCL has the phenotype of an activated B-blast, expressing
activation, adhesion, and anti-apoptosis proteins. Since lymphoblasts resemble activated B cells both in their phenotype and
molecular features, the virus is thought to push infected naive B
cells into the memory state by switching the cell from the growth
program to the default program. Normally, the latently infected
memory cells shut down the viral expression entering the latent
state. However, when the latently infected memory cells divide,
they express the EBNA-1 protein causing the viral DNA to replicate. Ultimately, the latent virus is reactivated and proliferates,
spreading to other hosts. It is therefore derived that the virus can
remain latent in the memory cells for long periods of time without causing any harm to the host. A risk arises if memory cells
are accidentally triggered into expressing the growth program
(Thorley-Lawson and Gross, 2004).
In germinal centre B cells, a more restricted EBV gene expression pattern is detected in which only EBNA1, LMP1 and
LMP2A proteins are expressed (Bancock, et. al., 2000). Also,
in the germinal centre expansion causes the number of EBVinfected B cells to increase. These germinal centre B cells then
differentiate into memory B cells, which are the long-term latent form of EBV (Babcock, et. al., 1998). In EBV-associated HL,
viral genomes were found in their monoclonal form, indicating
that infection of the tumor cells occurred prior to their unrestrained replication (Kapatai and Murray, 2007). Therefore, it
can be concluded that EBV infects mostly germinal-centre and/
or memory B cells, and some naive B cells before they begin to
replicate and proliferate (Kurth, 2000). HRS cells are believed
to derive from germinal-centre B cells that evaded apoptosis by
restricting their own gene expression and by receiving survival
signals through stimulation of CD40 (Kanzler, et. al., 1996). EBVpositive malignant cells provide proliferative and anti-apoptotic
signals, assisting in survival and growth of the tumor (Kapatai
and Murray, 2007). It remains unclear however, under which
conditions EBV+ B cells enter germinal centres and how the
EBV-gene expression in these cells is regulated, leading to the
development of Hodgkin’s Lymphoma.
The EBV genome consists of a linear DNA molecule that encodes nearly 100 viral proteins. During the lytic state, these proteins regulate the expression of viral genes causing viral DNA to
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replicate. After infecting B cells, the linear EBV genome becomes
circular, forming an episome. In these cells, the episome can replicate independently of the host cell, regulated by the cell as
part of the normal mechanism of memory B-cell homeostasis,
thereby establishing a latent infection (Sarwari, et. al., 2016). The
EBV viral genome is encased within a nucleocapsid surrounded
by the viral envelope. Entry of EBV into B cells is initiated when
the envelope glycoprotein, gp350, binds to the viral receptor
on the surface of the B-cell called the CD21 molecule (Kojima,
et. al., 2010). Infection of B lymphocytes with EBV results in
persistent latent infection and immortalization of the cells to
perpetual proliferation.
Studies done using flow cytometry and PCR in biopsy specimens demonstrated reactive B lymphocytes (Kojima, et. al., 2010).
Based on these studies, it was observed that EBV infects naive B
cells. This was derived from the fact that these are the only cells
that were observed expressing all the latent EBV genes.The naïve
EBV-infected B cells then undergo an expansion phase, thereby
making use of normal B-cell differentiation pathways to establish
a lifelong persistence in the B-cells. When tracking the primary
infection of naive or memory B cells, Latent Membrane Protein
1 (LMP1) and Latent Membrane Protein 2A (LMP2A) were both
detected which suggests that they provide the signals for antigen-independent replication in the germinal centre (Macsween
and Crawford, 2003). In most HD cases the neoplastic cells are
derived from B-cells as indicated by a sequence analysis of the immunoglobulin V region genes revealing mutations. In some cases,
nonfunctional genes have been detected by stop codons in their
sequence.Another study concluded that the site of persistence of
EBV within the body must be the resting memory B cells based
on the observation that “shedding of EBV from the oropharynx is
abolished in patients treated with acyclovir whereas the number
of EBV infected B cells in the circulation remains the same as
before treatment” (Cohen, 2000) .
In one important study, biopsy specimens of Hodgkin’s tumors
revealed a 40-50% proportion of EBV positive tumors (Hjalgrim,
et. al., 2003). Using southern blot hybridization viral RNAs (referred to as EBERs) and DNA fragments of EBV were detected
in 20-25% of specimens. Likewise, patients with Hodgkin’s disease
were often found to have higher titers of antibody to EBV proteins before or with the onset of lymphoma, suggesting a correlation between the two. Immunohistochemistry was performed on
biopsy specimens from patients with HD. Using the immunoperoxidase technique, LMP-1-antibody was applied to the tumor
section. Epstein-Barr virus early RNA transcripts (EBERs) were
detected in tumor tissues via fluorescein-labeled oligonucleotides
complementary to EBER (Alexander, et. al., 2000). The fragment
was visualized under a microscope by tetramethyl rhodamine isothiocyanate (TRITC), a bright orange-fluorescent dye.
One study went so far as to suggest that EBV infection is
actually the beginning of tumor development. EBV infection
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permanently induces B-cell activation, ultimately leading to uncontrollable cell division. EBV-positive HRS cells exhibit a type of
virus latency and express different combinations of EBV nuclear
and latent membrane proteins. In the first type, only EBNA-1 and
EBER are expressed, while in the second, EBNA-1, LMP-1, LMP-2,
and EBER are expressed. In the third pattern, all the latency genes
are expressed. An additional pattern of latency was found in B
cells obtained from the peripheral blood of patients with a past
infection of EBV, in which only EBER and LMP-2, and in some cases,
EBNA-1 have been detected (Mandage, et. al., 2017). Epstein-Barr
virus nuclear antigen 1 (EBNA1) is a protein-encoding gene that is
expressed in all EBV malignancies. EBV latent membrane protein
1 (LMP1) is a gene which induces cellular activation and proliferation while inhibiting apoptosis through expression of the B-cell
activation markers, CD23 and CD40 (Kapatai and Murray, 2007).
EBV latent membrane protein 2 (LMP2A) expression enhances
cell survival and inhibits normal B cell transduction. LMP2A does
this by mimicking an activated B cell receptor (BCR), replacing
the signals that are normally supplied to the B cells and suppresses cell immunity (Caldwell, et. al., 1998). Expression of LMP-2 in
transgenic mice allowed B cells to survive even in the absence of
normal B-cell–receptor signaling. It was also noticed that during
primary infection, many EBV-positive cells appear to express all
latent genes associated with viral-driven lymphoproliferative diseases. (Steven, 1997).
BLF1 is a lytic cycle protein found to be involved at both initial
and late stages of viral infection. It is involved in DNA replication,
repair, and ultimately, immune avoidance. A recent study on EBV
BPLF1-knockout mice demonstrated that the BPLF1-knockout
mice were approximately 90% less likely to be infectious than
wild-type (WT) mice. Without the BPLF1 there was a reduction
in transformed human B cells. Overall, humanized mice infected
with BPLF1-knockout virus survived longer than mice infected
with the WT virus. Additionally, tumors were formed in 100% of
mice infected with WT EBV but in only 25% of mice infected
with BPLF1-KO virus (Whitehurst, et. al., 2015). These findings
suggest that BRLF1 is required for activation of lytic replication
and expression. Additionally, ten million cells were injected with
either WT or BPLF1-knockout virus and after labeling with B- cell
antibody, the total percentage of B-cells in each group was determined using flow cytometry. There was rarely B-cell outgrowth
in cells infected with delta BPLF1 virus, suggesting that BPLF1 is
necessary for immortalization of B-cells. This provides evidence
that BPLF1 plays a role in B-cell transformation, and therefore
contributes to EBV’s oncogenic role in cells. As of now, the mechanism by which BPLF1 inhibits these processes is still unknown.
Another EBV lytic gene expressed during infection of B cells
is BALF1. This gene is known for its anti-apoptotic properties
leading to B cell transformations. BARF1 is a secreted protein
that blocks Colony Stimulating Factor 1 (CSF-1) signaling, functioning as a trap to block the action of the cytokine. This helps
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the virus evade the host’s immune system during acute EBV
infection or reactivation of virus from latently infected cells
(Ohashi, et. al., 2012).
Since the Epstein-Barr virus is associated with an increasing number of diseases, including infectious mononucleosis
and Hodgkin’s disease in both immunocompetent and immunocompromised individuals (Yang, et. al., 2015), some research
suggests that this correlation may be due to genetic factors. The
SH2D1A gene provides instructions for the synthesis of a protein called signaling lymphocyte activation molecule associated
protein (SAP). SAP interacts with other proteins to activate
signaling pathways that are involved in the control of immune
cells.These cells are important in that they help control immune
reactions and signal apoptosis. The SH2D1A gene is expressed
primarily in T and NK cells as well as in some B-cells (Parolini,
et. al., 2002). Therefore, a defective gene causes an alteration
of these lymphocytes which most likely results in the inability
to control EBV infected cells. To test the possibility of SH2D1A
gene involvement in the pathogenesis of Hodgkin’s disease, a
SH2D1A gene analysis was studied in patients with a history
of EBV and EBV- related diseases like Hodgkin’s lymphoma. A
group of healthy patients was also analyzed to serve as the
control group. Results showed an alteration in the 5′ region of
the SH2D1A gene in the majority of patients with a diagnosis
of mononucleosis, of which 25% went on to develop malignant
B cell lymphomas. This indicates that there may be a genetic
correlation between EBV and HL.
The SH2D1A gene is located on the X-chromosome, which
may contribute to the fact that males are more prone to develop Hodgkin’s Lymphoma after EBV (Robinson, 1976). Unlike
females, males do not have another X chromosome to counteract the mutated gene. In one study 23 patients with HD, consisting primarily of males, had their X-chromosomes analyzed.
Analysis by reverse transcriptase polymerase chain reaction
(RT-PCR) found EBV genome or protein in 16 of 23 tumor samples. The risk of contracting Hodgkin’s disease was found to be
significantly increased in males who had a positive reaction to
the Paul-Bunnell test, a heterophile antibody test that screens
for IM. (Rosdahl, et. al., 1974). Notably, anti-EBNA-1 antibody
levels showed 43% heritability.
In a study on transgenic mice, EBNA1 and LMP1 proved to play
a key role in lymphoma development. EBNA1 is essential during
cell division ensuring equal partitioning of a cell, while contributing to immortalization of cells by allowing for the maintenance of
newly synthesized plasmids. The central part of EBNA1 consists
of Gly-Ala repeats, which are believed to block the processing of
proteins by proteasomes.This functions in inhibiting immune recognition and apoptosis of infected cells because viral proteins are
normally broken down by proteasomes to peptides for recognition by cytotoxic T cells (Kojima, et. al., 2010). In turn, the infected
cells that accumulate have oncogenic potential. During recovery

from the acute phase, CD8+ T cells return to normal levels and
antibodies develop against EBV nuclear antigen-1 (Balfour, et. al.,
2015). LMP-1 mimics CD40 and activates the nuclear factor-kappa B, promoting cellular proliferation (Ok, et. al., 2015). LMP-1
also induces BCL-2 and cyclin-dependent kinase 2, activating cell
replication and inhibiting cell death.

Conclusion
Although an association has been identified, the pathogenetic
role of EBV in these diseases is still unclear (Flavell, et. al., 2000).
Likewise, the exact factors responsible for cancer development
remains a matter of debate. Researchers are limited in their
investigation of the relationship between viral infection and the
development of cancer due to the lack of small animal models that can accurately reproduce the biology of EBV. Yet over
the past few years, some important advances have been made
in understanding the biology of EBV and its role in the development of EBV-associated lymphomas. The observation that a
significant proportion of cases of HL contain the Epstein–Barr
virus genome strongly suggests that the virus contributes to the
development of the lymphoma. Significant progress has been
made in understanding the functions of EBV-encoded genes in
B cells (Sarwari, et. al., 2016) and viral protein functions. Several
key issues remain to be clarified.
Additionally, whereas EBV infection in tumors has been firmly
established by several independent research groups, its association remains controversial. Many still believe that it is by coincidence, mainly due to the fact that the origin of Hodgkin’s can
be regarded as heterogeneous because only half of the cases
are known to be associated with EBV (Tamayose, et. al., 2004).
Others maintain that Hodgkin lymphoma is a multi-factorial
disease which depends on both biological and environmental
factors and therefore, a specific causative agent cannot be pinpointed (Huang, et. al., 2012).
There is no current approved treatment for EBV. Ongoing research is currently trying to develop vaccines to prevent or treat
these conditions. This is a difficult task due to a lack of an animal
model to study the pathogenesis of the disease. It is further complicated by the fact that the number of virus-infected cells in the
body would amplify and establish latency before immune mechanisms develop. A future approach would be to synthetize therapeutic vaccines designed to generate specific immune attacks
for the latent virus. Adoptive immunotherapy and EBV-specific
pharmacologic therapies offer promise for future treatment.
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Abstract
Inflammatory Bowel Disease encompasses two diseases, Crohn’s Disease and Ulcerative Colitis. During the last 70 years the
evolving of diet in the industrialized countries has led to the utilization of foods that have been processed rather than those in
their more natural original state. This increase in the processing of foods has been correlated with the more recent occurrence
of metabolic diseases such as Inflammatory Bowel Disease. Patients suffering from this problem exhibit lesser amounts of anti-inflammatory bacteria such as Roseburia and Faecalibacterium and increased amounts of pro-inflammatory bacteria Escheria
and Fusobacterium. Since diet directly alters the composition of the gut biome, this review aims to define the role of diet in the
pathogenesis and management of Inflammatory Bowel Disease.
Abbreviations:
IBD – Inflammatory Bowel Disease
CD – Crohn’s Disease
UC - Ulcerative Colitis

Introduction
What is Inflammatory Bowel Disease?
Inflammatory Bowel Disease (IBD) encompasses two diseases,
Crohn’s Disease (CD) and Ulcerative Colitis (UC). CD is characterized by inflammation of the digestive tract anywhere from
mouth to anus. In CD inflammation may reach through many
layers of the walls of the gastrointestinal tract causing severe
tissue damage. However, UC occurs when there is an inflammation of the colon and the rectum. In UC, the inflammation only
affects the innermost layer of the lining of the colon. There are
many symptoms for CD and UC. Some of the more common
ones include diarrhea, abdominal pain, cramping, blood in stool,
reduced appetite, unintended weight loss and severe bowel constriction (Conners, et al., 2017). Many times, inflammation is so
severe that the intestinal tissue is damaged beyond repair. In the
event of such inflammation the damaged tissue is removed via
colectomy. IBD tends to affect individuals of all ages. However,
IBD is most commonly found in individuals at a young age, interfering with education, work ability, social interaction and basic
quality of life. Therefore, researchers feel compelled to find resolutions for this disease (Lovasz, et.al., 2013).

How the Diet has Changed
Over the centuries the western diet has changed incredibly. In
the traditional diet, food was produced and consumed shortly
after harvest. In contrast, much of today’s food supply is processed, modified, and transported over great distances before
being ingested. In recent years, the western diet has been dominated by an increased consumption of refined sugars, omega-6
polyunsaturated fats and fast food, in addition to a deficiency
in fruits, vegetables and fiber. The western diet is prevalent in
industrial countries such as the United States, Canada, Western
Europe, Australia, and New Zealand, and has been spreading
and reaching newly developing countries as well (Lovasz, et.al.,
2013).This change in diet has led to the worldwide development
of many metabolic diseases, such as IBD. (Ng, 2013) (Moschen,
2012). Recent studies indicate that the incidence rate of IBD in
developing industrial countries has been increasing in the past
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50 years. This increase suggests that IBD may be triggered by an
environmental factor (Martinez & Chang, 2013). Although many
studies have been done, there is still no definite pathogenic
pathway nor cure for this disease.
Recent research suggests that diet is the key environmental risk factor in IBD pathogenesis. IBD is an intestinal disease
and is associated with a dysbiosis in the gut microbiota, the
microbe population found in the intestine (Reddavide, et al.,
2018). In general, IBD patients have been found to have lower
amounts of anti-inflammatory bacteria such as Roseburia and
Faecalibacterium and have increased amounts of pro-inflammatory bacteria Escheria and Fusobacterium (Aleksandrova, et.al.,
2017). Many studies have shown that one’s diet directly alters
microbe composition, making diet a pivotal risk factor of IBD.
Moreover, changes to the traditional diet of newly industrialized
countries can be linked to the increasing incidence of IBD. The
purpose of this review is to define the role of diet in the pathogenesis and management of IBD.

Methods
Critical analysis of peer reviewed articles and clinical research
papers were used to write this review paper. Articles were obtained from the Touro College online library in order to determine the relationship between diet and IBD.

Discussion:
IBD and Gut Microbes
The gut microbiome is an ecosystem, often referred to as a
Super Organ (Dolan, 2017). The microbes live in a symbiont
relationship with the host, performing beneficial tasks such as
nutrient production, development and maturation, regulation
of immune system and preventing the growth of harmful microorganisms (Aleksandrova, et.al. 2017). Dysbiosis, which is an
alteration to the gut flora, can cause disruption to these vital
tasks. Several studies show that IBD is correlated with altered
composition of gut microbes in the intestines.
Interestingly, Studies have shown, that there is an age-related
variation of IBD onset with three distinct stages. Early onset is
less than 10 years of age, with a peak onset at 15-30 years old, and
late onset cases occur at 60 years old.These changes correspond
to the change in the microbiome’s stability and diversity. Early
life is associated with a microbiome of minimal complexity and
stability and can be affected by diet change, illness and puberty.
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As individuals reach adulthood, the microbiome stabilizes and
shows improved resilience, but the composition may be altered.
Correspondingly, decreased stability is often observed in the elderly (Kostic, et.al., 2013). Considering this, the microbe composition and stability in the gut is a key factor in IBD progression.
One role of the microbiota is to maintain a healthy mucosa
by the production of anti-inflammatory interleukins. This is the
production of SCFA- short chain fatty acids such as butyrate,
succinate, lactate, phenols, thiols, and indoles (Reddavide, et al.,
2018). These SCFA act as energy for colonocytes which protect
against inflammatory responses (Frank, 2007). Patients suffering from IBD have reduced levels of beneficial SCFA producers
Bacteroidetes, Lachnuspiraceace, and Ruminococcaceae (Martinez &
Chang, 2013). An Additional study shows that IBD patients show
reduced levels of several other SCFA producing bacteria such as
Calibacterium praunsnizti and Roseburia (Dolan, 2017). This shows
a direct link between dysbiosis and IBD.
Another task of the gut microbiome is to maintain the mucus
layer of the colon and the small intestine. If the mucus layer is intact the gut flora will not directly interact with the epithelial cells
and inflammation will not occur. However, there is an adherent
invasive strain of E. coli that is found in abundance in IBD patients
compared with controls. These invasive bacteria can potentially
invade epithelial tissue and induce granuloma formation during
inflammation. A second group of invasive bacteria Fusobacteria
is found in abundance in the colon mucosa of IBD patients.
Fusobacterium varium have been found to cause colon mucosa
erosion, indicating the possibility of the influence of Fusobacterium
varium on the pathogenesis of IBD (Kostic, et. al. , 2013).
Bile Acid signaling is another point where host, microbe and
even dietary factors all come together. Bile acids assist in digestion and emulsification of fats to be absorbed in the intestines.
These bile acids are made in the liver from cholesterol. After
undergoing conjugation to glycine or taurine, the bile acids are
released in to the digestive tract. In the intestines, deconjugation of bile acids occurs through Bile Salt hydroxylase (BSH)
enzymes, making the bile acids functional. These BSH enzymes
are made exclusively by bacteria, making the bile acid composition in the intestine dependent on the microbiota composition.
The two products of bile acid metabolism act as ligands for
FXR (Farnesoid X receptor) and TGR5 (G protein-coupled bile
acid receptor 1), which act as signals for anti-inflammatory and
barrier function. It was found that IBD patients have increased
levels of conjugated bile acids compared to the control group,
making these patients prone to inflammation. Furthermore,
when bile acids are increased in the gut, it can promote growth
of pathobionts such as Bilophila Wadsworth, which is known to
induce inflammation (Dolan, 2017).
On the other hand, many microbes perform protective tasks
when enriched in the host. Bacteroides and Clostridium species
have been shown to cause expansion of T-cells and reduce

inflammation. Additionally, many bacteria can reduce intestinal
inflammation by regulating nuclear factor (NF)κB activation.
Faecalibacterium praunsnizti has anti-inflammatory properties
and is underrepresented in patients with IBD. Many species, such
as Bifidobacterium, Lactobacillus and Faecalibacterium, protect the
host from mucosal inflammation by down regulating inflammatory cytokines or stimulating IL-10 anti-inflammatory cytokines
(Kostic, et. al., 2013). Lastly, intestines rich in Bacteroidetes are
shown to initiate host responses that protect the host from
lethal infectious colitis (Brown, et. al., 2012).
Due to this connection between IBD and dysbiosis, there
are many current treatments for IBD that are directed at the
microbiota. Many antibiotics such as ciprofloxacin, metronidazole, the combination of both rifaximin and anti-tuberculous
regimens are used to treat IBD (Nitzan, et.al., 2016). Normally
antibiotics may cause thinning of the mucus layer, weakening the
barrier function, leading to increased gut infections. Additionally,
antibiotics tend to cause an increase in E. coli composition in
the gut, which is a distinctive feature in intestinal inflammation.
However, studies show that brief exposure to antibiotics causes
slight changes to the microbiota in IBD patients that provides
relief from symptoms. Alternatively, repeated exposure of the
same antibiotic causes persistent changes to the microbiota
leading to infection (Kostic, et.al., 2013). Due to this controversy of antibiotics, in the last few years methods to repopulate the gut with healthy beneficial microbes has been gaining
popularity as a potential treatment for IBD. Evidence shows
that Fecal Microbiota Transplantation (FMT) can be effective in
replenishing a healthy microbiota. FMT, also known as a stool
transplant, is the transplantation of gut microbes from the stool
of a healthy individual into the recipient. There has been a high
success rate for FMT in many other metabolic diseases such
as relapsing C. difficile infection. Therefore, researchers are considering FMT for other gastrointestinal illnesses such as IBD.
Additional studies are needed to determine the outcome of
FMT on IBD patients (Kostic, et.al., 2013).
It is now clear that IBD is inherently linked with dysbiosis.
There are many factors that can cause dysbiosis such as genetics, immune function, and diet. Genetic susceptibility is the most
obvious factor. IBD patients carrying a mutation in a NOD2
related gene, have increased numbers of mucosa adherent bacteria, as well as significant alterations in bacterial composition
(Kostic, et. al., 2013). Studies have shown that CD is common in
the Ashkenazi Jewish population. Many studies were done using
large families of Ashkenazi Jews to determine a genetic variant cause to CD. One study found the haplotype 268SJW1 on
chromosome 16 to contribute to the risk of CD in Ashkenazi
Jews (Sugimura, 2003). Although genetic susceptibility cannot be
ignored, due to the increasing incidence rates of IBD, researchers believe that environmental factors are the core triggers.
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Dietary Factors effecting the Microbiome
Diet is suspected to be the prime contributor to the pathogenesis of IBD. Dietary composition has been proven to be
associated with intestinal inflammation by directly or indirectly modifying the gut microbiome (Reddavide, et al., 2018). So,
current research is aimed at examining how diet changes the
microbiome and how these changes affect the host, in order
to determine foods that can cause or prevent inflammation
(Kostic, et.al., 2013).
In a study done, subjects were put on a western-style diet for
one month and showed a 71% increase in plasma endotoxins.
The western diet is characterized by a high fat diet and therefore
may cause endotoxemia by causing changes in the intestinal barrier function or microbiota composition (Pendyala, et.al., 2012).
Another study showed that mice fed a high fat diet were associated
with endotoxemia and systemic inflammation. These mice showed
lowered amounts of Bifidobacterium spp, indicating that this species
of bacteria have anti-inflammatory properties (Cani, 2007).
Variations in long term diet patterns change the ratios of
Bacteroides, Prevetolla, and Firmicutes. However, modifications in
short term diets have no significant influence. It has been determined that enriched protein and animal fat diets, common in the
western diet, favored Bacteroides. Diets rich in carbohydrates,
such as in agrarian societies, favored Prevetolla (Wu, 2011).
Switching to a high fat diet causes a decrease in Bacteroides and
an increase of Firmicutes and Proteobacteria (Hildebrandt, 2009).
It has been proven that protein rich diets increase enzymes that
produce toxic metabolites which trigger inflammatory response
(Brown, DeCoffe, et.al., 2012).
Another microbe often associated with IBD inflammation
is Bilophila Wadsworth, a sulfite producing bacteria. In a recent
study when mice were fed a milk fat enriched diet, it led to
a series of reactions that ultimately led to an abundance of
Bilophila Wadsworth. Although there is no precise mechanism for
how it causes inflammation, there are many hypotheses (Frank,
2007). Furthermore, an interesting study concluded that refined
dietary glucose intake can change microbe composition and increase intestinal inflammation (Whitehead, 2011). A strict Vegan
or Vegetarian diet led to a significant reduction in Bacteroides
spp, Bifidobacterium spp, and the Enterobactericeae which helps
manage inflammation of IBD (Enck, 2011).
A further connection between diet, microbes, and host inflammation has been discovered through studies of the intestinal function of the aryl hydrocarbon receptor (AhR). AhR is
a nuclear receptor that activates certain metabolic genes. AhR
also plays a key role in adaptive immunity through the regulation of T-cell activity. IBD patients have a decreased expression
of AhR which may cause pro-inflammatory immune activation
conditions. It has been discovered that certain gut microbes can
produce AhR agonists. IBD patients contain less amounts of the
microbes necessary to produce these agonists. An important
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dietary source of AhR ligands are found in cruciferous vegetables such as cauliflower, broccoli, brussels sprouts and bok choy.
This may explain why these vegetables have a protective effect
on IBD risk (Dolan, 2017).
One major role of the microbiota is to act as an immune system of the host. The gut flora protects the host from pathogens
by maintaining the integrity of the intestinal mucosa. Dysbiosis
can cause a disruption in the intestinal mucosa and allow access
for pathogens which can lead to reactions which cause inflammation and eventually tissue damage. Many studies were conducted
to determine the influence of micro and macro nutrients on immunity. Many micronutrients are essential for immunonutrition
such as vitamins A, C, D, E, folic acid, zinc, and iron (Reddavide, et
al., 2018). Deficiencies in vitamins A and D may reduce function
of natural killer cells, while supplemental zinc and vitamin C
can increase their activity. Vitamin D is important in intestinal
function for it is known to suppress microbial invasion into the
epithelium. 82% of IBD patients have been found to have vitamin
D deficiencies which have been linked to a weakened epithelial
barrier. Although studies have been done to determine the effects of vitamin D supplements on IBD patients, more research
is needed. Furthermore, Iron deficiencies have been associated
with faulty T cell response and weakened cytokine production.
However, iron supplements have been shown to have a negative
effect on IBD patients by increasing an individual’s susceptibility to infections. It is evident that micronutrients can affect the
immune system thereby causing dysbiosis and the onset of IBD
(Aleksandrova, et.al., 2017). More research is needed to recognize optimal nutrient levels and therapeutic options.
These findings support the fact that the microbiota is directly related to food quality. Diet influences the composition
of the microbiota and thereby controls IBD pathogenesis. The
current diet is significantly different than the diet of previous
generations when the prevalence of IBD was not as widespread.
Countless experiments were performed to see the effects of
diet on IBD. Dietary factors can have a negative effect on IBD
and increase inflammation, or they can have a protective or even
healing effect on patients with IBD.

Dietary Risk Factors of IBD
Refined and processed carbohydrates are risk factors for IBD,
but complex carbohydrates, such as fruits, vegetables, or fibers
can help manage IBD. A diet high in animal protein was correlated with a 3.3-fold increased risk in IBD (Reddavide, et al.,
2018). Individuals that consumed milk products including milk,
yogurt and cheese, had a lower chance of developing IBD. This
suggests that dairy intake has no risk effect on IBD and may
even have a protective effect (Malavia, 2017). Many studies were
done on the effects of fat intake on IBD. Although it is known
that a typical high fat western diet has a negative effect on IBD,
it is unclear which specific fats cause that. One study showed
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that an increase in poly-unsaturated fatty acids was positively
associated with IBD (Parekh, 2015). Another study concluded
that long term intake of trans-unsaturated fatty acids is associated with a trend towards IBD. Evidence shows that excessive
consumption of omega-6 poly-unsaturated fatty acids increases
the risk of IBD, while consumption of omega-3 poly unsaturated
fatty acids is associated with a decrease in one’s risk for the
onset of the disease (Brown, et. al., 2012).

Dietary Management in IBD
Interestingly, research has shown that the Mediterranean Diet, due
to its unique balance of fat, is directly correlated with decreased
inflammation. The Mediterranean Diet (MD) is characterized by
fruits and vegetables rich in fiber, vitamins, and antioxidants, whole
grains, and nuts, as well as olive oil and oily fish that are high in
poly and mono unsaturated fatty acids. Each item in the diet provides benefits to patients with IBD (Serra-Majem, 2009).
Legumes, a major part of the MD, contain soluble fibers that
do not aggravate the gut microbes. Furthermore, legumes tend
to have a prebiotic action and promote the growth of beneficial
SCFA producing microbes which protect the gut mucosa. Fruits
and vegetables have a naturally high fiber content and therefore
using a juicer to extract the essential vitamins and minerals
showed best results when treating IBD patients. Recent studies
claim that olive oil has ani-inflammatory effects.This is due to the
synergic action of its oleic acid with other antioxidant molecules.
Grains that were proven to have the most beneficial effect were
unmodified grains. These grains have low immunogenic impact
and do not cause inflammation in the gut mucosa. Bluefish, which
is popular in the MD, is shown to have anti-inflammatory effects
due to its omega-3 fats EPA and DHA (Reddavide, et al., 2018).
An alternative diet that has shown promise in IBD management is the Specific Carbohydrate Diet (SCD). This diet works
with the hypothesis that patients with IBD can not break down
disaccharides and amylopectin. Large amounts of disaccharides
can lead to an over growth of microbes and cause IBD related symptoms. Therefore, the SCD is a strict monosaccharides
diet excluding disaccharides and most polysaccharides. The diet
includes vegetables with a high amylose to amylopectin ratio.
The real potential for this diet is in the maintenance of IBD
patients in remission to help maintain a healthy gut microbiome
(Reddavide, et al., 2018). A similar diet the FODMAP – Low
Fermentable oligosaccharide disaccharide monosaccharide and
polyols diet also showed significant improvement of symptoms
in patients with IBD (Dolan, 2017). Although these findings
clearly define the effects of diet on IBD, the role of diet does
not stop there.

Dietary Factors and Epigenetics
New emerging evidence points to epigenetics as a major component of IBD pathogenesis. Epigenetics is the study of heritable

changes in gene expression that do not involve changes in the
actual DNA sequence.This leads to a change in phenotype without a change in genotype. Epigenetic modifications, such as histone modifications, influence DNA accessibility and chromatin
structure, thereby effecting the regulation of gene expression.
The body uses epigenetic modifications as natural ways to control gene expression as needed throughout one’s life. However,
epigenetic changes can also be induced by external factors including age, the environment, lifestyle, and disease state. Dietary
factors have been shown to contribute to IBD in an indirect
manner via epigenetics (Reddavide, et al., 2018).
Over time, researchers have discovered new methylation
patterns emerging for IBD. Many therapeutic studies were done
to try to counteract this methylation using drugs and other
processes. However, researchers found it difficult to pinpoint
the methylation in specific tissue and to predict drug response
in clinical trials so other strategies were considered. Dietary
factors have been known to alter epigenetics which can influence an immune response that can potentially offset inflammation. Therefore, scientists looked at dietary components
for a solution to IBD methylation patterns. It was discovered
that secondary plant metabolites, such as polyphenols, have
been demonstrated to inhibit DNA methyltransferase activity.
Furthermore, gut microbiome has been shown to alter host
histone acetylation and methylation in human colon tissues.
Interestingly, SCFA, which is generally produced from microbial
fermentation of fibers, is shown to be important in epigenetic
regulation of inflammatory responses. It was determined that
a lack of SCFA can disturb chromatin effects. This deficiency of
SCFA can be a result of a diet low in fiber or a decrease in beneficial SCFA producing bacteria. As mentioned previously, IBD
patients have been found to have low amounts of Bacteroidetes,
Lachnuspiraceace, Ruminococcaceae, Calibacterium praunsnizti, and
Roseburia, SCFA producing bacteria, making IBD patients susceptible to epigenetic changes which can lead to inflammation.
(Reddavide, et al., 2018).

Other Environmental Factors
Although diet has been presumed to be the primary trigger for
IBD, there are many other environmental factors that can prompt
IBD symptoms. Smoking, and stress are such factors that have
also been shown to influence IBD pathogenesis. Interestingly,
Smoking has been found to be negatively associated with UC
but positively associated with CD. Patients who did smoke
only developed UC after they ceased smoking. Additionally,
male UC patients who smoked during disease progression, reported reduced symptoms and had lower hospitalization rates
compared to non-smokers. Increased colectomy rates were
seen in non-smokers and ex-smokers than in current smokers. Also, reduced rates of relapse were seen in patients who
began smoking after the onset of UC. On the other hand, many
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studies show an increased risk of CD in smokers compared to
non-smokers. There is a 34% increased relapse rate for CD in
smokers. Furthermore, severe lesions at the anatomic sight have
developed more in smokers than non or ex-smokers in CD
patients (Thomas, et.al., 2000).
There are many theories for the possible mechanism of the
influence smoking has on IBD. Firstly, due to the interrelationship
of gut microbes and immunity, researchers studied how smoking influences the immune system. Studies show that changes in
T cells, such as increased levels of suppressor OKT8+ cells and
a decreased ratio of OKT4+ to OKT8+ cells have been seen
in heavy smokers. Remarkably, these changes revert to normal
range once a patient terminates smoking. The low levels of IgA’s
in the saliva and intestinal secretion of smokers dictates an additional immune effect.The IgA antibody is a vital component of secretions that lubricate the mucosal surfaces which act as the first
line of defense in the immune system. Therefore, patients who
smoke will already have a weakened immune system. Another
possible mechanism involves the inflammatory pathway. Nicotine,
a substance found in most cigars and cigarettes, is known to
effect cytokine production in the body, specifically by reducing
pro-inflammatory cytokines. Also, certain eicosanoids, which are
correlated with inflammation, are seen in decreased amounts in
smokers. This may be the cause to the negative effect of smoking
on UC patients. Nevertheless, smokers show lower levels of two
interleukins, IL-1β and IL-8, which help regulate inflammatory
response. Lastly, smoking may also influence IBD via intestinal
mobility. One major symptom of IBD is issues with bowel movement and defecation. It has been found that nicotine can affect
the intestinal motility at many sites. Nicotine relaxes the smooth
muscles of the intestine and therefore reduces contractile activity
during bowel movement (Bhatti, 1997). These mechanisms portray the direct influence that smoking may have on IBD.
Another environmental factor that researchers have discovered to be effective in the pathogenesis of IBD, is stress related
influences. In earlier years IBD was classified as a psychosomatic
disorder. Although this classification had been long disproved, it
does represent the deep relationship between stress and IBD.
In general, stress acts as a threat to an organism’s homeostasis.
Therefore, the body will exert mechanisms to maintain equilibrium in the face of any stress. There are two interconnected
pathways in the body that govern stress related responses; the
HPA axis - hypothalamic pituitary adrenal axis and the ANS - autonomic nervous system. The pathway of the HPA axis begins
when stress stimulates the release of corticotropin releasing
hormone from the hypothalamus. This causes the release of adrenocorticotropic hormone from the anterior pituitary gland
which then stimulates the secretion of cortisol from the adrenal cortex. Cortisol then travels throughout the blood stream
causing changes all around the body to help deal with stress. The
pathway of the ANS involves the stress induced activation of
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pontomedullary nuclei, which control autonomic responses. As
a response to stress, adrenaline and noradrenaline are released
from the adrenal medulla via the stimulation of the sympathetic
nervous system. Furthermore, The HPA axis and ANS are key
modulators of the rich nerve supply of the gut, the ENS – enteric
nervous system. The ENS is composed of 100 million neurons
that regulate functions of the gastrointestinal tract. The term
“Brain-Gut Axis” refers to this complex network of neurons of
the HPA axis, ANS, and ENS (Mawdsley, 2005).
The actual pathway of the Brain-gut axis response to stress is
complex. Various interconnected activities occur in both the gut
and around the body in response to stress that can lead to inflammation. Specifically, in the gut, in response to stress, inflammatory
cytokines, SCFA, and microbial products can alter the ANS and in
turn lead to the secretion of cortisol and adrenaline. Also, under
stress, the gut microbiota and mast cells can release various
chemicals such as histamine or serotonin which are known to
impair the intestinal secretion and intestinal mucosa, which can
lead to inflammation.There are many stressors that can affect the
intestinal mucosa’s permeability, making a host predisposed for
infections and inflammation (Brzozowski, 2016).
Due to this intimate correlation between the nervous system
and the gut, it is obvious that stress can influence the pathogenesis of IBD. Chronic heightened stress has been determined
to have an important role in predicting the relapse of IBD in
patients in remission (Mawdsley, 2005). Also, mice that were
induced with depression demonstrated an increase in inflammation which was modulated by an increase in pro-inflammatory cytokines secreted by macrophages (Brzozowski, 2016).
Although researchers have not determined an absolute direct
pathway for the control of stress on inflammation, there are
many suggestions. Many propose that patients with IBD have
altered HPA axis functioning, which may explain the relation
of stress to IBD symptoms. Interestingly, cortisol, which is
released under stress, is known to have anti-inflammatory effects. However, in patients with UC, levels of cortisol showed
no correlation to the levels of inflammatory cytokines. On the
other hand, others hypothesized that due to the high levels of
inflammatory cytokines in the blood of active IBD patients, the
response of the HPA axis and thereby the response of cortisol
may be dampened. Likewise, stress is known to impact gastrointestinal motility, and water and ion secretion. While these are
non-inflammatory effects, they may contribute to the non-inflammatory symptoms of IBD patients (Mawdsley, 2005). The
above mechanisms demonstrate the correlation between stress
and IBD, making psychological factors a key influence in the
pathogenesis of IBD.

Conclusion
The intestinal microbiota performs vital jobs in host metabolism making its composition vital to the host’s health. Dysbiosis,
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which is found in IBD, can be caused by several different factors.
While genetics and other environmental factors cannot be ignored, an altered microbiota resulting from diet-induced dysbiosis may also be a factor that contributes to the inappropriate
inflammatory responses that occur. As our understanding of the
microbiota continues to grow, promoting microbes to prevent
or control inflammatory-mediated diseases through diet may
represent an exciting therapeutic avenue.
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Abstract
Anorexia Nervosa (AN) is a psychiatric disorder characterized by significantly low body weight and over-evaluation of weight and
shape in self-identity. The complex etiology of Anorexia Nervosa renders many current treatments ineffective, thereby prolonging
the course of the illness. Among the many psychological and behavioral features of AN, cognitive features like obsessiveness,
rigidity, and perfectionism are often described. Patients hold firm beliefs about an ideal body weight and find it difficult to alter
their thinking patterns. Recent studies have identified a pathway to understanding this disorder through characterization of it’s
cognitive features. With this research, advances have been made in identifying cognitive processes that likely mediate symptom
expression in AN.This paper will describe the cognitive rigidity observed in patients with AN and will include a discussion of therapeutic approaches to target this feature.
Introduction
Anorexia Nervosa (AN) is an eating disorder characterized by
restricted food intake and inability to maintain an appropriate
body weight. Individuals with AN engage in extreme weight
control behaviors, such as caloric restriction and compulsive
exercise. According to the National Institute of Mental Health
(2017), AN has an estimated prevalence of 0.6% in adults and
has the highest mortality rate of any psychiatric disorder. The
onset on AN typically occurs during adolescence and can persist into adulthood, increasing the risk of mortality. Research
has demonstrated that risk of mortality is higher for patients
with a comorbid psychiatric condition, such as depression and
substance abuse disorder (Jordan et al., 2003). One study found
that substance use disorders, particularly alcohol use disorder,
was associated with increased mortality in individuals with AN
(Kask et al., 2016). Furthermore, a meta-analysis of 36 studies showed that the weighted annual mortality for AN was 10
deaths per thousand people (Arcelus et al., 2011).The incidence
proportion for AN (10 death per thousand people) is higher
than the one for other eating disorders, like Bulimia Nervosa (3
deaths per thousand people).
Diagnostic criteria for AN include: 1. Restriction of energy intake leading to significantly low body weight 2. Intense fear of
weight gain or persistent behavior that interferes with weight
gain 3. Disturbance in the way in which ones’ body weight or
shape is perceived (American Psychiatric Association, 2013). The
Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
includes severity specifiers for AN based on current body mass
index (BMI).The level of severity can reflect clinical symptom expression and degree of functional disability in patients with AN.
The etiology of AN is complex; many factors contribute to the
development and maintenance of the disorder. Predisposing genetic and personality factors can render an individual susceptible,
while environmental and social factors can trigger the onset of
the disorder at a vulnerable time. Aside from individual personality factors, previous research has found that cognitive factors
play a role in the development and maintenance of the disorder.
Specifically, cognitive deficits in working memory, mental flexibility, and set-shifting have been observed in patients with AN.
This paper will examine the neurocognitive deficits found in
patients with Anorexia Nervosa, particularly cognitive rigidity and
set-shifting. Etiology, maintenance, and therapeutic approaches for

the disorder will be discussed, with a focus on specific treatments
targeted at decreasing rigidity in patients with AN.

Methods
This review was conducted using databases like PubMed and
ProQuest, through the Touro College library system. Peerreviewed articles were also retrieved using Google Scholar and
Semantic Scholar.

Discussion
Much of the research on AN has been conducted with patients
undergoing treatment. Study samples often exclude those individuals who are not actively engaged in outpatient or residential treatment. However, many individuals with AN do not
seek treatment due to perceived stigma (Dimitropoulos et al.,
2016). As a result, they are not included in study samples and
the data obtained may not fully represent the general population.Therefore, this literature review is largely limited to studies
that have used clinical samples to obtain data.

Neurocognitive Deficits found in AN
Numerous studies have identified neurocognitive impairments
in patients with AN (Phillipou et al., 2015, Chan et al., 2013).
Neurocognition encompasses processes, such as planning, attention, visuospatial function, working memory, and concept
formation. A broad range of neurocognitive functions have
been found to be compromised in patients with AN, particularly
cognitive flexibility and set-shifting. Cognitive flexibility refers to
the capacity to adapt cognitive processing strategies in the face
of new and unexpected conditions in the environment. In patients with AN, this ability is compromised and thus contributes
to the behavioral symptomatology of the disorder.

Personality Traits in AN
Personality traits associated with AN include perfectionistic
tendencies, introversion, and rigidity. These traits impact the
way patients with AN perceive and react to people and their
environments. Patients with AN have been described as having
high harm avoidance and persistence, and low novelty seeking.
These dimensions correspond with behaviors exhibited by
those with AN, such as avoidance of weight gain and determination to reach a low body weight. Additionally, patients with
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AN often endorse a rigid cognitive style and are unable to alter
their cognitions related to eating behavior. They exhibit inflexible behaviors such as counting calories, compulsively exercising,
and preoccupation with rigid rituals.

Possible Causes of Cognitive Rigidity in AN
A considerable amount of research supports the familial nature
of neurocognitive deficits in AN. One study found that when
compared to healthy controls, mothers of patients with AN
displayed a more rigid thinking style on a neuropsychological
measure of cognitive rigidity (Lang et al., 2016). Neurocognitive
impairments have also been noted in healthy siblings of patients
with AN, suggesting that these disturbances are not solely the
result of the illness (Hason et al., 2011). Rather, these individuals
may have biologically-based predispositions to respond to their
environments in particular ways. Another study found that patients with AN had poor cognitive flexibility irrespective of the
duration of their illness, highlighting the trait nature of cognitive
rigidity in patients with AN (Tchanturia et al., 2011).
From a neurocognitive perspective, a rigid cognitive style
stems from a lack of mental flexibility. Mental flexibility is the
ability to think about multiple concepts simultaneously and to
transition from thinking about one concept to another. Mental
inflexibility can result in rigid thinking patterns, such as dichotomous thinking (black-and-white thinking) and inability to alter
cognitions and behaviors. Individuals with rigid cognitive style
are unable to change beliefs or behaviors that are ineffective in
helping them achieve their goals. There are several processes
that are compromised in individuals with cognitive rigidity; one
example is set-shifting ability. Individuals with impaired set-shifting ability cannot efficiently adapt to new situations in response
to changing environmental demands. Similarly, individuals with
AN have been found to perform poorly on tests of mental flexibility in relation to healthy controls. For example, one study
found that compared to healthy controls, patients with AN
showed fewer fluctuations in their patterns of response in a test
of perceptual judgement, even when their answers were incorrect (Tchanturia et al., 2001). In other words, patients with AN
did not attempt to change their incorrect response patterns as
frequently as healthy controls.

Assessment of Cognitive Rigidity in Patients with AN
One commonly used neuropsychological measure of cognitive
rigidity is the Wisconsin Card Sorting Test (WCST). The WCST
assesses set-shifting ability which is the ability to move back and
forth between tasks, operations, or mental sets in response to
changing goals or environmental demands. In this test, an individual must classify items according to one of four rules, while receiving feedback only when the rule that was used is correct.The
classification rule changes every ten cards; therefore, once the
participant has figured out the rule, the rule may quickly change.
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This task measures how well individuals can adapt to the changing
rules and if they are able to change their behavior accordingly.
In one study, researchers hypothesized that patients with AN
will have lower set-shifting scores on the WCST when compared to healthy controls. In their study, the AN group consisted
of 24 adolescent females, and the control group consisted of 37
healthy adolescent females with no prior history of eating disorders. The adolescents in the AN group had lower set-shifting
scores than the healthy controls (McAnarney et al., 2011). In
a similar study, the WCST was used to measure of set-shifting ability in two groups: one had patients with AN and one
was healthy controls. All participants were female and ranged
in age from 18 and 55 years. Results of the study indicated that
patients with AN performed poorly in relation to the healthy
controls (Tchanturia et al., 2012). Another study demonstrated
that children and adolescents share a similar cognitive profile
with adults with AN, providing support to the idea that these
cognitive deficits may be underlying traits in all patients with
AN (Lang et al., 2015). However, in contrast to this finding, a
meta-analysis found that problems with set-shifting that are observed in adults with AN were not as prevalent in children with
AN (Lang et al., 2014). This observation suggests that set-shifting inability may directly result from long-term starvation and is
related to duration of the illness.

Neural Basis for Cognitive Rigidity in AN
In addition to causes like heritability, research has pointed to
neurological differences between patients with AN and healthy
controls. These differences in brain structure may be responsible for features of cognitive rigidity. Prior research has established the role of the prefrontal cortex in executive function
and cognitive control. Specifically, one prefrontal subregion, the
anterior cingulate cortex, mediates complex cognitive functions
such as affect regulation, cognitive control, and decision making
(Stevens et al., 2011). Cognitive control is required during neuropsychological tests that measure cognitive flexibility, such as
the WCST. During this test, individuals must change their behavior if previously successful responses fail to yield reinforcement.
Researchers used animal models to determine the role of the
anterior cingulate cortex in cognitive control. After creating lesions in the anterior cingulate cortex of rats, they found that
the rats had difficulty adjusting cognitive control, demonstrating
that hypoactivity in this brain region can interfere with cognitive
function (Newman et al., 2015).
Similarly, in a literature review on cognitive rigidity in AN,
researchers suggested that the hippocampi and anterior cingulate showed a reduced thickness in gray matter in individuals
with AN; therefore, processes associated with these structures,
like working memory and set-shifting, have been impaired in
AN patients (Kucharska et al., 2019) Likewise, another study
found that during a test of set-shifting, patients with AN showed
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hypoactivity in the dorsal anterior cingulate cortex (Zastro
et al., 2009). This finding suggests that patients with AN have
reduced motivation and initiative to complete tasks in a nonroutine way.

The Effect of Cognitive Rigidity on Treatment
Outcomes
A rigid cognitive style can influence treatment outcomes for
patients with AN. Patients commonly have rigid rules about
how many calories they can consume and the restricted range
of foods they can consume (Tchanturia et al., 2001). This rigid
thinking style can prevent behavioral change and can negatively
affect treatment outcomes. Behavioral therapies intended to
change perceptions of eating behavior can be ineffective for
patients with a rigid and inflexible thinking pattern. Therefore,
treatments aimed at decreasing cognitive rigidity can help promote new and adaptive thinking patterns in patients with AN.
Recent translational research has begun to focus on characterizing the cognitive features of AN and adapting existing treatments accordingly.

Therapeutic Approaches Aimed at Decreasing
CognitiveRigidity in AN
Cognitive remediation therapy (CRT) is a method designed to
improve neurocognitive abilities, such as cognitive flexibility,
set-shifting, and attention. This form of therapy can lead to improved psychosocial functioning in individuals who have cognitive distortions. CRT consists of a set of mental exercises aimed
at improving cognitive strategies and increasing holistic thinking.
CRT was initially developed for patients with brain injuries and
has more recently been adapted for patients with AN. It aims to
address two primary features found in patients with AN: a lack
of cognitive flexibility, and a preoccupation with details. Unlike
traditional treatments for AN, CRT does not directly address
behaviors related to eating disorders. Rather, CRT interventions
for AN address these deficits by focusing on the patients’ process of thinking, rather than on the content of their thoughts,
thus helping patients develop a metacognitive awareness of
their own thinking style.
A study on the efficacy of CRT in improving cognitive function has demonstrated that cognitive flexibility improved significantly after a ten-week CRT training (Kucharska et al., 2019).
Furthermore, one study noted clinical changes following ten CRT
sessions, notably, patients became more aware of their own cognitive deficits and were able to apply alternative strategies that
were demonstrated during the CRT sessions (Wood et al., 2011).

Conclusion
Anorexia Nervosa is a complex illness with both behavioral and
cognitive features. One of the main cognitive deficits found in
AN is cognitive rigidity, or an inability to think about multiple

perspectives simultaneously and to change one’s view on an
issue. Several studies have suggested that this deficit is heritable and is found in healthy siblings and parents of AN patients.
Other studies have shown that level of cognitive rigidity is correlated to duration of illness, suggesting that this deficit may be
a result of long-term starvation. Cognitive rigidity contributes
to the maintenance of AN by making it difficult for patients
to alter their cognitive distortions surrounding the disorder.
Treatments that address secondary symptoms of the disorder,
such as weight loss and food avoidance, can be ineffective if the
underlying cognitive features of the disorder are not properly
addressed. A considerable body of research has demonstrated
that cognitive remediation therapy is effective in increasing cognitive flexibility in patients with AN. This form of treatment can
allow patients to see their behaviors as maladaptive and can
help promote behavioral change.
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